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 1 
1 Introduction 
Bacteria need to adjust their metabolism and gene regulation to constantly changing 
environments in order to colonize a broad variety of habitats. Pathogenic bacteria in 
particular have to adapt rapidly to dramatic environmental alterations inside and outside 
the host. For successful and effective invasion, colonization and persistence, they have 
evolved sophisticated regulatory networks that control their virulence gene regulation. 
Virulence gene expression in pathogenic bacteria is tightly regulated as the pathogen 
requires a different subset of genes for host invasion than for persistence and defense 
against the host immune system. However, the complexity of this regulation is not 
completely elucidated to date as new virulence factors, that play an essential role for 
pathogenicity are constantly being discovered. This study focuses on the novel virulence 
regulator RovC of Yersinia pseudotuberculosis and its role in virulence and the regulation 
of the T6SS operon 4. 
 
1.1 The genus Yersinia 
The genus Yersinia belongs to the family of Enterobacteriaceae and was named after the 
bacteriologist Alexandre Émile Jean Yersin. Yersinia are Gram-negative, rod-shaped 
bacteria that grow facultative anaerobically at temperatures ranging from 4°C to 43°C, 
although their optimal growth temperature is between 20°C and 30°C. To date, the genus 
Yersinia comprises 18 different species among which there are three that are pathogenic 
to humans: Y. pestis, the causative agent of plague, and the two enteropathogenic 
species Y. enterocolitica and Y. pseudotuberculosis (Savin et al., 2014; Carniel et al., 
2006). All three human pathogens exhibit a zoonotic life cycle. The main reservoir of 
Y. pestis are rodents from where it is taken up by fleas and further transmitted to humans 
via bites of infected fleas (Perry & Fetherston, 1997). This pathogen is responsible for 
three human pandemics: the Justinian’s plague (5th to 7th century), the Black Death (13th 
to 15th century) and the modern plague (late 18th century to present). In the 21st century, 
rare cases of plague were reported in the USA, whereas especially in Africa severe 
plague outbreaks occurred with many deaths (Butler, 2013; Forrester et al., 2017). The 
highly infectious Y. pestis, which evolved from Y. pseudotuberculosis about 1,500 to 
20,000 years ago by lateral gene transfer, causes distinctly different diseases than the two 
enteropathogenic yersiniae (Achtman et al., 1999; Wren, 2003). Infections with Y. pestis 
can lead to highly severe and fatal diseases such as pneumonic, bubonic, and septicemic 
plague with manifestations such as fever, swelling of lymph nodes (buboes) and infections 
of the bloodstream or the respiratory tract. 
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 The enteric Yersinia species, Y. pseudotuberculosis and Y. enterocolitica, exhibit a 
zoonotic lifestyle similar to Y. pestis. In addition, soil, plants, insects and domestic or wild 
animals were found to be reservoirs for the two enteropathogenic Yersinia species 
(Fredriksson-Ahomaa et al., 2006; Heroven & Dersch, 2014). Both pathogens are food 
borne and transmitted to humans via the fecal-oral route by ingestion of contaminated 
food or water. Y. pseudotuberculosis is often found in vegetables and lettuce, whereas 
raw or undercooked pork meat is considered to be the main source of infection with 
Y. enterocolitica (Bottone, 1997; Heroven & Dersch, 2014). Both species cause gut-
associated diseases, commonly called yersiniosis, with symptoms such as diarrhea, fever 
and vomiting. The manifestations range from self-limiting enteritis/gastroenteritis to 
terminal ileitis and mesenteric lymphadenitis. In rare cases severe diseases such as 
reactive arthritis or erythema nodosum can result from systemic infections (Fahlgren et al., 
2014; Gupta et al., 2015) (Figure 1.1).  
 
 
Figure 1.1: Transmission and pathogenesis of pathogenic Yersinia species. 
Y. pestis is mainly found in rodents and the transfer to humans occurs via the flea vector. Infections with 
Y. pestis cause either bubonic or pneumonic plague in humans. The two enteropathogenic species 
Y. pseudotuberculosis and Y. enterocolitica are taken up by ingestion of contaminated food or water. After 
passage through the M-cells of the epithelial layer they reach the lymphatic Peyer’s Patches. From here, both 
pathogens can disseminate to the mesenteric lymph nodes and spread further to systemic organs like liver or 
spleen. Both species cause a variety of gastrointestinal diseases (McNally et al., 2016)1. 
All three pathogenic Yersinia species encode specific virulence factors either on the 
                                               
1 Adapted by permission from Springer Nature: Springer Nature, Nature Reviews Microbiology, 'Add, stir and reduce': 
Yersinia spp. as model bacteria for pathogen evolution, McNally et al., Copyright © 2016. 
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chromosome or on virulence plasmids. The two enteropathogenic Yersinia species harbor 
the chromosomally encoded inv gene which encodes the initial invasion factor invasin 
crucial for penetrating the intestinal epithelium (Pepe & Miller, 1993; Marra & Isberg, 
1997). Other key virulence traits for pathogenicity and defense against the host immune 
system are the virulence plasmid-encoded genes. The plasmid (pCD1 in Y. pestis and 
pIB1 in Y. pseudotuberculosis) encodes the type III secretion system, its Yop effector 
proteins and the adhesion YadA. In contrast to the enteric Yersinia species, Y. pestis 
possesses two additional virulence plasmids pPCP1 and pMT1, encoding genes like the 
plasminogen activator and the F1-antigens, respectively. These plasmids are essential for 
transmission of Y. pestis and for colonization and survival inside the flea gut (Kaman et 
al., 2011; Rajanna et al., 2010).  
 
1.2 Pathogenesis of enteropathogenic Yersinia species 
The infection process of the enteric Yersinia species is characterized by the expression of 
specific virulence genes that enable the pathogen to efficiently colonize the intestinal tract. 
It can be divided into two phases: the early infection phase and the ongoing infection 
phase. During the early infection phase, genes that are essential for survival in the 
environment and genes required for initial attachment, invasion and passage through the 
M-cells (microfold cells) are expressed. Transition of Yersinia through the epithelial layer 
means adaptation of their metabolism to the nutrient supply in the underlying lymphatic 
tissue. Consequently, Yersinia changes its gene expression in order to survive and evade 
the host immune response (Heroven & Dersch, 2014). 
 The enteropathogenic Yersinia species enter the host via the fecal-oral route. After 
oral uptake, the bacteria pass thorough the gastrointestinal tract until they reach the 
terminal part of the small intestine, the ileum. In this part of the gut, Yersinia has to 
overcome the intestinal epithelial cell layer that protects the host from pathogen invasion 
to reach the underlying Peyer’s patches (Barnes et al., 2006). However, pathogenic 
Yersinia species have developed effective mechanisms to invade the host tissue. Initially, 
Yersinia attaches to specialized cells in the gut lumen, the M-cells, in order to reach the 
lymphatic tissue beneath the epithelium. Adhesion to the M-cells is mediated by the 
chromosomally encoded outer-membrane protein invasin which efficiently binds to β1-
integrins expressed on the apical surface of the M-cells (Isberg & Leong, 1990; Leong et 
al., 1990). Thus, invasin exhibits a much higher binding affinity to β1-integrins than the 
natural extracellular matrix ligand fibronectin (Tran Van Nhieu & Isberg, 1993; Gillenius & 
Urban, 2015). Receptor binding brings Yersinia in close contact with the host cell and 
results in the formation of pseudopods around individual bacterial cells. This leads to 
INTRODUCTION 
 
 4 
internalization of the bacteria into membrane-bound phagosomes via the zipper-like 
mechanism (Dersch & Isberg, 1999). After transcytosis through the epithelial layer, 
Yersinia reaches the basolateral site and invades the lamina propria, particularly the 
Peyer’s patches. Here, Yersinia has to evade the macrophages present in the underlying 
lymphatic tissue. Subsequently, Yersinia disseminates to the mesenteric lymph nodes and 
to deeper organs such as liver and spleen via the bloodstream (Barnes et al., 2006; 
Fahlgren et al., 2014) (Figure 1.2). 
 
Figure 1.2: Schematic representation of Y. pseudotuberculosis and Y. enterocolitica host entry. 
During the early infection phase Yersinia is flagellated and expresses the outer-membrane protein invasin 
which allows adhesion to β1 integrins on the surface of the M-cells. Subsequently, the bacteria are internalized 
and reach the underlying lymphatic Peyer’s patches where expression of late virulence genes such as the 
T3SS and the corresponding Yop effector proteins is induced. This leads to Yop secretion into host immune 
cells, preventing phagocytosis by macrophages (According to Sansonetti, 2002, and modified from 
Steinmann, R., 2013)2. 
 
Immediately after passing through the gut epithelium and reaching the basolateral site, 
expression of the early virulence genes like invasin is downregulated and expression of 
the plasmid-encoded late virulence factors is induced. Late virulence genes comprise the 
Ysc proteins that form the type III secretion systems (T3SS) and the corresponding type III 
secreted Yop (Yersinia outer protein) effector proteins. Additionally, expression of the 
                                               
2 Adapted by permission from BMJ Publishing Group Ltd., Gut, Host–pathogen interactions: the seduction of molecular 
cross talk, Sansonetti, Copyright © 2002. 
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adhesin YadA (Yersinia adhesin A) is induced, which mediates tight interaction with the 
eukaryotic host cell and allows secretion of effector proteins via the T3SS into the host cell 
cytosol. The T3SS, the Yop proteins and the adhesin YadA are all encoded on the 
Yersinia virulence plasmid pYV and are crucial for Yersinia in order to resist and evade 
the host immune responses (Heroven et al., 2012; Mühlenkamp et al., 2015). 
Furthermore, the T3SS and the Yop effector proteins are essential for survival and 
replication of Yersinia within the host. The T3SS forms a needle-like structure that 
mediates close contact between the bacterial and the host cell cytosol and allows direct 
injection of the Yop effectors YopE, YopH, YopJ, YopK, YopM, YopO, and YopT. The 
YopB and YopD proteins form the translocation pore that enables delivery of effector 
proteins into the host cell cytoplasm. Inside the host cell, the Yop proteins disrupt various 
cellular processes such as actin cytoskeleton rearrangements, protein phosphorylation, 
signaling pathways important for innate and adaptive immunity, blocking of phagocytosis 
and induction of apoptosis in phagocytic cells (Zwack et al., 2015; Viboud & Bliska, 2005; 
Zhang et al., 2008). 
 Expression of the plasmid-encoded virulence genes is controlled by the 
transcriptional activator LcrF (low calcium response F) and strongly dependent on 
temperature and host cell contact (Pettersson et al., 1996). LcrF is mainly expressed at 
37°C, since YmoA (Yersinia modulator A) represses transcription of lcrF at moderate 
temperatures. At 37°C, the YmoA protein is degraded by Clp and Lon proteases (Jackson 
et al., 2004). Additionally, translation of lcrF is blocked at moderate temperatures, as the 
lcrF 5’UTR forms a thermo-responsive RNA element consisting of a two stem-loop 
structure. The second hairpin contains a stretch of four uridine nucleotides (fourU motif) 
that base pair with the ribosomal binding site (RBS) of lcrF and consequently prevents its 
translation at moderate temperatures (25°C). Elevated temperatures (37°C) lead to partial 
unfolding of the RNA structure that allows ribosome binding and results in lcrF translation 
(Cornelis et al., 1991; Böhme et al., 2012). The AraC transcriptional activator LcrF 
positively regulates expression of various T3SS genes encoded on the pYV plasmid. 
Direct binding of LcrF to the promoter region of these genes initiates their transcription (Li 
et al., 2014).  
 
1.2.1 Regulation of early virulence gene expression 
Regulation of virulence gene expression in Yersinia is tightly controlled by various 
parameters such as temperature, growth phase, pH and nutrients. The initial invasion 
factor invasin has its highest expression level at moderate temperatures in stationary 
growth phase as commonly found outside the host. This leads to increased synthesis of 
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invasin and allows rapid penetration of the intestinal tract after ingestion (Heroven et al., 
2007). However, expression of invasin is part of a strictly controlled regulatory cascade. 
Expression of the inv gene is activated by the transcriptional MarR-type regulator RovA 
(regulator of virulence A) in a temperature dependent manner (Nagel et al., 2001; Herbst 
et al., 2009). The RovA protein belongs to the SlyA/Hor/Rap family. It is a homodimer that 
possesses a winged-helix DNA-binding motif and preferentially binds to palindromic AT-
rich sequences (A/TATTATA/TT) within the inv promoter (Heroven et al., 2004; Tran et al., 
2005). 
 RovA transcription is tightly autoregulated and driven by two different promoters, 
P1 and P2, located -76 and -343 bp upstream of the translational start site (Nagel et al., 
2001; Heroven et al., 2004). Activation of rovA transcription is mediated by binding of 
numerous RovA proteins to AT-rich sequences upstream of the P2 promoter. However, 
when a certain threshold of RovA is reached in the cell, a low-affinity binding site 
upstream of the P1 promoter is occupied and further expression of RovA is prevented 
(Heroven et al., 2004). In addition, RovA expression is strictly controlled by temperature 
since autoactivation can only occur at moderate temperatures but not at 37°C. Stationary 
growth phase and nutrient-rich growth medium result in RovA mediated autoactivation 
(Nagel et al., 2001; Heroven et al., 2006). 
 Furthermore, expression of RovA is controlled by the DNA-binding protein H-NS 
(histone-like nucleoid-structuring protein), which is known to facilitate temperature 
regulation of virulence genes. Similar to RovA, H-NS recognizes AT-rich sequences 
constituting an intrinsic DNA curvature. The H-NS binding sites upstream of the P2 
promoter of rovA and the inv promoter region overlap with the RovA binding site. At 
moderate temperatures, RovA acts as an antirepressor by disrupting the H-NS silencer 
complex (Heroven et al., 2004; Beloin & Dorman, 2003). 
 In addition to H-NS mediated silencing, rovA expression is also repressed by the 
LysR-type regulatory protein RovM (Regulator of virulence M). RovM binds directly to a 
sequence located between position -80 to -47 upstream of the rovA promoter P1. RovM 
and H-NS exhibit distant binding sites within the rovA promoter region that do not overlap 
and, hence, can bind simultaneously. Both regulators act independently but are essential 
and required for efficient rovA silencing (Heroven & Dersch, 2006; Heroven et al., 2008). 
 
1.2.2 The carbon storage regulator (Csr) system 
The expression of virulence genes in pathogenic bacteria is often tightly controlled by 
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complex regulatory networks that enable rapid adaptation to changing environments. 
Transcription in bacteria is well studied as for example sigma factors, promoter sequences 
and transcriptional activators/repressors are known to control the conditions under which 
a specific gene is transcribed. However, recently post-transcriptional networks were 
shown to play an important role in coordinating the expression of virulence genes. Post-
transcriptional regulation includes small non-coding RNAs, RNA-binding proteins and 
RNA structures like RNA thermometers and riboswitches (Schiano & Lathem, 2012). 
 The Csr (carbon storage regulator) or Rsm (regulator of secondary metabolism) 
system is a global, post-transcriptional regulatory system that plays a major role in the 
adaptation of various pathogens to changing environmental conditions. Csr/Rsm systems 
were first described in E. coli in 1993, but homologous systems have also been found in a 
great number of other bacterial species like Salmonella enetrica serovar Typhimurium, 
Legionella pneumophila and Pseudomonas aeruginosa. Csr/Rsm systems are involved in 
a variety of metabolic-, stress- and virulence-related processes (Romeo et al., 1993; 
Heroven et al., 2012; Romeo et al., 2013; Kusmierek & Dersch, 2018). These systems 
contain RNA-binding proteins referred to as CsrA/RsmA or RsmE that specifically bind to 
target mRNA transcripts and affect their stability and/or translation. Small non-coding 
RNAs (ncRNAs) that harbor multiple CsrA binding sites (CsrB and CsrC in Yersinia) 
antagonize CsrA function by sequestering the proteins (Liu et al., 1997; Weilbacher et al., 
2003; Babitzke & Romeo, 2007; Heroven et al., 2012).  
CsrA generally interacts with GGA-motifs in the 5’ untranslated region of target 
transcripts. GGA-motifs located within loops of short hairpin structures are beneficial but 
not indispensable for CsrA-binding. In addition, CsrA recognizes GGA-motifs in 
unstructured single-stranded RNA molecules, either adjacent to or overlapping the 
ribosomal binding site (RBS). Binding of CsrA to the RBS of target transcripts represses 
translation due to competition of CsrA with the 30S subunit of the ribosome. 
Consequently, CsrA binding to the Shine-Dalgarno (SD-sequence) promotes target mRNA 
degradation by RNases. The two small ncRNAs CsrB and CsrC antagonize CsrA function 
by sequestering the protein. In Yersinia CsrB and CsrC are highly structured RNA 
molecules that contain multiple hairpins with GGA-motifs within the single-stranded loop 
structures. CsrB harbors approximately 18 GGA-motifs while CsrC possesses about 14 
CsrA of these binding-motifs. Sequestration of free CsrA molecules by the small ncRNAs 
prevents CsrA binding to it target transcripts and results in mRNA translation (Heroven et 
al., 2012) (Figure 1.3). 
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Figure 1.3: General mechanism of the Yersinia Csr system. 
The homodimeric RNA-binding protein CsrA recognizes GGA-motifs within the 5’UTR of target mRNAs, 
located adjacent to or within the SD-sequence of the transcript. Binding of CsrA generally represses 
translation of the RNA due to competition of CsrA with the 30S ribosomal subunit. This results in mRNA 
degradation by RNases. The two small ncRNAs, CsrB and CsrC, harbor several GGA-motifs and antagonize 
CsrA by sequestering free CsrA molecules. Sequestration of CsrA resulting in mRNA translation (Heroven et 
al., 2012)3. 
 
CsrA is a highly conserved protein in prokaryotes but no analogues have yet been found 
in archaea or eukaryotes. The 18.6 kDa CsrA protein forms a homodimer with one 
monomer consisting of five antiparallel β-strands (β1-β5), one short α-helix and an 
unstructured C-terminal part. CsrA dimers are connected via pairing between the β-sheets 
of the two monomers, forming a stabilizing hydrophobic core. The interface of the two 
interacting polypeptide subunits forms the RNA-binding surface. The dimeric structure 
enables CsrA to simultaneously interact with two binding sites at once, preferentially 
separated by 10-63 nucleotides (Gutiérrez et al., 2005; Schubert et al., 2007; Mercante et 
al., 2009; Kusmierek & Dersch, 2018). 
Apart from the repression of mRNA translation, CsrA binding can also protect the 
mRNA from cleavage/degradation by RNases. Moreover, CsrA binding can prevent the 
formation of inhibitory secondary structures. In this case, the target transcript is stabilized 
and translation is enhanced (Yakhnin et al., 2013; Ren et al., 2014). 
 
                                               
3 Adapted by permission from Taylor & Francis, RNA Biology, The Csr/Rsm system of Yersinia and related pathogens, 
Heroven et al., Copyright © 2012. 
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1.2.3 Regulation of the Csr system in Yersinia 
The Csr system in Yersinia, in particular the RNA-binding protein CsrA, controls the 
expression of RovA and the initial invasion factor invasin by indirectly activating RovM 
expression. Apart from regulation of invasin, CsrA is known to control the expression of a 
large number of open reading frames (ORFs) in Y. pseudotuberculosis. Furthermore, 
CsrA was recently shown to be absolutely essential for Y. pseudotuberculosis to establish 
an infection in mice (Heroven & Dersch, 2006; Heroven et al., 2008; Nuss et al., 2017). 
Regulation of the Csr system itself is extremely complex and occurs on multiple regulatory 
levels. 
 
Autoregulation of the Csr system 
 
The Csr system of Y. pseudotuberculosis is tightly autoregulated via interconnected 
feedback loops, controlling the expression, stability and/or activity of each component. 
Upregulation of one small ncRNA results in downregulation of the other and vice versa. 
Moreover, both ncRNAs are rapidly degraded in the absence of CsrA, indicating that CsrA 
is essential for the presence and stability of CsrB and CsrC. Consequently, the Csr 
system displays a strong interdependency between the individual components (Heroven 
et al., 2008). In addition, CsrA of E. coli was found to regulate its own expression. 
Transcription of the csrA gene is driven from five different promoters, with P2 and P5 
depending on σ70 and P1 and P3 on σS. CsrA indirectly activates its transcription from P3, 
which is mainly responsible for increased csrA expression upon transition into the 
stationary growth phase. On the post-transcriptional level, CsrA blocks its own synthesis 
by binding to its mRNA transcript. Upstream of the csrA start codon, four putative CsrA 
binding sites were identified. CsrA binds to these sites and represses translation of its own 
transcript due to competition with the 30S subunit of the ribosome (Yakhnin et al., 2011). 
 
The two-component system BarA/UvrY 
Further regulation of the Yersinia Csr system is mediated by the two-component signal 
transduction system BarA/UvrY, comprising the BarA sensor kinase and its cognate 
response regulator, UvrY. In bacteria this two-component system (TCS) is generally 
responsible for sensing external signals in order to adapt to and switch between different 
metabolic pathways and changing environments. The BarA/UvrY TCS of E. coli is 
triggered by components of the carbon metabolism like carboxylic acids as well as by 
acetate and formate. It activates transcription of the E. coli Csr-type sRNAs CsrB and 
CsrC (Chavez et al., 2010; Heroven et al. , 2012). For Y. pseudotuberculosis, the 
activating signal of the TCS is still mostly unknown and supposed to be an extracellular 
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signal. In contrast to other pathogens, regulation of the Csr system by the Yersinia 
BarA/UvrY system is restricted to transcriptional activation of CsrB (Heroven et al., 2008). 
Expression of the small ncRNA CsrC is activated by the response regulator PhoP of the 
PhoP/PhoQ TCS. Direct binding of PhoP to csrC results in the activation of RovA 
synthesis via the CsrABC-RovM-RovA cascade (Nuss et al., 2014). 
 
The cAMP receptor protein Crp 
Additional regulation of the Csr system is mediated via global regulatory proteins such as 
the cyclic adenosine monophosphate (cAMP) receptor protein Crp (cAMP receptor 
protein). In numerous Enterobacteriaceae, Crp represents a key regulator of the carbon 
catabolite repression (CCR) system. Crp is activated by cAMP and controls transcription 
of various genes and operons in dependence on glucose and other utilizable sugars. In 
Yersinia, Crp is also important for the activation of early-stage virulence genes by 
controlling the Csr system. Crp regulates expression of CsrB and CsrC via indirect 
repression of the response regulator UvrY. In addition, Crp exerts a positive effect on 
CsrC independent of CsrB (Heroven et al., 2012).  
 
The RNA chaperone Hfq 
Another regulator of the Csr system is the RNA chaperone Hfq (host factor of phage Qβ). 
Hfq is an RNA-binding protein that is conserved in all three domains of life (Wilusz & 
Wilusz, 2005). It comprises a ring-like hexameric structure and contributes to post-
transcriptional regulation by facilitating interactions between sRNAs and target mRNAs. 
Hfq-sRNA pairings can lead to repression of mRNA translation by blocking the RBS and 
making it inaccessible for the 30S and 50S ribosomal subunits. Binding of Hfq-sRNA 
complexes can also initiate translation by exposing the RBS, thus enabling 30S subunit 
binding (Vogel & Luisi, 2011). In P. aeruginosa, Hfq stabilizes the Csr-RNA RsmY and 
simultaneously permits RsmA sequestration, consequently preventing RNase E mediated 
cleavage of RsmY. Hfq in Yersinia exerts a positive effect on both Csr RNAs (Böhme, 
2010). 
Taken together, regulation of the Y. pseudotuberculosis Csr system is versatile 
and tightly controlled by autoregulatory feedback-loops and global regulators like Crp. In 
addition, Csr system control occurs by regulation via the signal transduction TCS 
BarA/UvrY and the RNA chaperone Hfq. Although there are similarities between the 
function of the Yersinia Csr system and those of other Enterobacteriaceae, differences 
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regarding the regulation exist. In Yersinia, the Csr system plays a major role in early 
virulence gene expression, since activation of invasin is under the control of the Csr 
system. Expression of invasin is induced at moderate temperatures in stationary growth 
phase by the transcriptional regulator RovA. Transcription of RovA is tightly autoregulated 
and temperature-dependent. Furthermore, expression of rovA is subject to silencing by 
the nucleoid-associated protein H-NS. (Heroven et al., 2004; Tran et al., 2005). In 
addition, the LysR-type regulatory protein RovM controls rovA gene regulation. CsrA, in 
turn, positively regulates expression of RovM (Heroven et al., 2008) (Figure 1.4).  
 
Figure 1.4: Regulation of the early-stage virulence genes in Y. pseudotuberculosis. 
Early virulence gene regulation in Yersinia is controlled by the post-transcriptional Csr system, comprising the 
RNA-binding protein CsrA and the two small ncRNAs CsrB and CsrC. Regulation of the Csr system is 
mediated via autoregulatory feedback-loops but also via global regulators such as Crp. The RNA chaperone 
Hfq activates transcription of the Csr-RNAs, the TCS BarA/UvrY exerts an indirect positive effect on CsrB 
expression and expression of CsrC is activated by the TCS PhoP/PhoQ. Expression of the initial invasion 
factor invasin underlies control of the Csr system. The transcriptional regulator RovA mediates activation of 
invasin. Expression of RovA is strictly autoregulated at moderate temperatures and is repressed by H-NS and 
RovM. Synthesis of RovM is indirectly activated by CsrA (modified from (Heroven et al., 2012))4.  
 
1.3 The Type VI secretion system (T6SS) 
Gram-negative bacteria possess different types of secretion systems in order to 
translocate effector proteins across membranes or into other prokaryotic or eukaryotic 
cells. To date, seven different secretion systems have been identified in both, Gram-
                                               
4 Heroven et al., (2012) is licensed under the terms of the Creative Commons Attribution License. 
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negative and Gram-positive bacterial species: Type I secretion system (T1SS) to Type VI 
secretion system (T7SS) (T. R. D. Costa et al., 2015). In contrast to T1SS to T6SS, the 
T7SS are specialized secretion systems restricted to mycobacterial virulence (Stanley et 
al., 2003; Houben et al., 2014). Generally, bacterial secretion systems can be divided into 
two categories according to the membrane they span. T1SS to T4SS and T6SS span 
both, the inner membrane (IM) and the outer membrane (OM), while the T5SS is only 
anchored in the outer membrane. Substrate secretion occurs either in a one-step (T1SS, 
T3SS, T4SS, T6SS) or in a two-step secretion mechanism (T2SS, T5SS) (T. R. D. Costa 
et al., 2015). 
 Type VI secretion systems (T6SS) are the most recently discovered bacterial 
secretion systems and present exclusively in Gram-negative bacteria. They are versatile 
nanomachines that exhibit structural similarities to contractile T4 bacteriophage tails 
(Pukatzki et al., 2007; Boyer et al., 2009). Bacterial T6SSs exert anti-prokaryotic and anti-
eukaryotic properties by translocating toxic effector proteins into target cells. Gene 
clusters of continuous genes encoding T6SS were found to be present in about 25% of all 
Gram-negative bacteria (e.g. Vibrio, Pseudomonas, Salmonella, Escherichia, Yersinia) 
and were first described to be functional in Vibrio cholerae in 2006. These gene clusters 
are generally composed of at least 13 genes, encoding the core components (Pukatzki et 
al., 2006; Ho et al., 2014; Boyer et al., 2009). Numerous bacteria harbor a single T6SS 
gene cluster, some, however, are described to encode up to six distinct copies (Yersinia 
pestis, Burkholderia pseudomallei) (Andersson et al., 2017; Schell et al., 2007). T6SS are 
composed of the following components: (1) the baseplate comprised of the TssAEFGK 
proteins, (2) the TssJML membrane complex, which spans the inner membrane, the 
peptidoglycan layer and the outer membrane, (3) the TssBC sheath, (4) the tail tube, 
formed out of Hcp hexamers and (5) the Vgr/PAAR spike located at the tip of the tail tube 
(Alteri & Mobley, 2016; Cianfanelli et al., 2016; Costa et al., 2015) (Figure 1.5). 
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Figure 1.5: Schematic model of the T6SS mode of action and the respective structural components. 
Type VI secretion systems (T6SS) exert structural resemblance of contractile T4 bacteriophage tails. (A) The 
T6SS is anchored in the inner and outer membrane of the bacterial cell, comprising a TssAEFGK baseplate 
and a membrane-spanning complex (TssJML proteins). (B) Extracellular signals or target cell contact trigger 
contraction of the sheath, the Hcp tail tube and Vgr/PAAR tip proteins, consequently pushing these through 
the target cell membrane. T6SS effectors are either associated with the Hcp tail tube and/or the Vgr/PAAR tip 
(C) Upon effector delivery into the target cell periplasm, the ATPase ClpV mediates disassembly of the TssBC 
sheath (modified from (Cianfanelli et al., 2016))5. 
 
Bacteria predominantly use their T6SSs for interbacterial competition although 
some eukaryotic targets are described as well. V. cholerae, for example, exerts T6SS-
mediated toxicity towards the amoebae Dictyostelium and mammalian J774 macrophages 
(Pukatzki et al., 2006). Recently, the T6SS of Serratia marcescens was reported to deliver 
antifungal effector proteins against fungi such as Candida albicans (Trunk et al., 2018). 
Interbacterial antagonism is best studied in V. cholerae and P. aeruginosa, both known to 
exert advanced fitness when co-cultivated with other T6SS-expressing bacteria. 
Furthermore, T6SS could function either to defend an already existing niche or in order to 
invade a new one. In addition, T6SS are associated with various bacterial processes such 
as biofilm formation or quorum sensing (MacIntyre et al., 2010; Russell et al., 2014; Hood 
et al., 2010).  
In order to attack antagonists, bacteria require close contact to the opponent cell, 
which enables translocation of effector proteins via their T6SSs. These effector molecules 
are primarily delivered into the target cell periplasm but also the target cell cytoplasm. 
Each effector protein is associated with its cognate immunity protein to prevent self-lysis 
of the bacterium. The effector proteins Tse1 and Tse3 secreted by the P. aeruginosa 
                                               
5 Adapted by permission from Elsevier, Trends in Microbiology Aim, Load, Fire: The Type VI Secretion System, a Bacterial 
Nanoweapon, Cianfanelli et al., Copyright © 2015. 
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T6SS are lytic antibacterial enzymes that degrade peptidoglycan. In order to prevent self-
intoxication, P. aeruginosa expresses cognate immunity proteins (Tsi1 and Tsi3) that 
specifically inactivate the toxic effector proteins in the periplasm. P. aeruginosa expresses 
another known toxic T6SS effector, Tse2, a protein injected into the target cell cytoplasm, 
which is supposed to be a nuclease. Secretion of all three Tse effectors demands direct 
interaction with the tail tube protein Hcp (Hood et al., 2010; Russell et al., 2011; Silverman 
et al., 2013; Robb et al., 2016). Additional effectors, apart from cell wall degrading 
enzymes that disrupt the peptidoglycan layer, are phospholipases that degrade cell 
membranes and nucleases that degrade nucleic acids upon translocation (Russell et al., 
2014). 
For the T6SS to deliver further effector proteins, the sheath first needs to be 
disassembled. This process is mediated by the AAA+ (ATPase associated with various 
cellular activities)-type ATPase ClpV that directly interacts with the T6SS sheath proteins. 
The ClpV ATPase facilitates TssBC sheath tubule depolymerization via ATP hydrolysis by 
recognizing the N-terminal helix of TssC (Cianfanelli et al., 2016; Pietrosiuk et al., 2011; 
Alteri & Mobley, 2016). Another ATPase was discovered in the plant pathogen 
Agrobacterium tumefaciens. The T6SS inner membrane protein TssM of the IcmF protein 
family exhibits ATPase activity and is involved in mediating Hcp secretion (Ma et al., 
2012). 
In addition, Type VI secretion systems can also be associated with virulence of 
various pathogens. For example, virulent P. aeruginosa strains were shown to express a 
T6SS that actively secretes Hcp1 during chronic cystic fibrosis infections (Mougous et al., 
2006) and recently, the T6SS of P. mirabilis was found to be involved in bacterial fitness 
during urinary tract infection (Debnath et al., 2018). 
 
1.3.1 Type VI secretion systems of Yersinia pseudotuberculosis 
T6SS gene clusters were identified in all three human pathogenic Yersinia species. The 
closely related Y. pseudotuberculosis and Y. pestis possess four and six T6SS copies, 
respectively, whereas Y. enterocolitica only harbors a single cluster. Studies on the 
different T6SS clusters of, for example, B. thailandensis and Y. pestis revealed that the 
T6SS copies are not functionally redundant and consequently play distinct roles with 
regard to virulence (Yang et al., 2018).  
Y. pseudotuberculosis strain YPIII harbors four different T6SS gene clusters, all 
encoding the 13 core components (Figure 1.6). T6SS operon 1 harbors 17 open reading 
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frames (ORFs) and exerts similarity to the V. cholerae N16961 T6SS. T6SS2 is located in 
two different regions of the chromosome and encodes a protease-sensitive bacteriocin 
and four ORFs coding for putative immunity proteins. In contrast to the other T6SS 
clusters the third T6SS operon (T6SS3) consists of 24 ORFs and encodes five genes 
associated with fimbrial biogenesis, similar to T6SS found in B. mallei and S. enterica. 
T6SS cluster 4 encodes 18 ORFs and is highly homologous in sequence and organization 
to T6SS clusters identified in B. mallei, B. pseudomallei and Y. pestis. In addition, this 
T6SS is the only operon that is under the control of a single promoter (Zhang et al., 2011). 
 
Figure 1.6: Genomic distribution of the T6SS clusters in Y. pseudotuberculosis. 
Y. pseudotuberculosis harbors four T6SS gene clusters, all containing the 13 T6SS core components. (A) 
Color code for all T6SS genes of the Y. pseudotuberculosis strain YPIII. (B) Localization of the single genes 
within the T6SS clusters 1 to 4 and predicted promoter location (modified from (Yang et al., 2018))6. 
 
Most research, however, has been devoted to T6SS cluster 4 (YPK_3548 to 
YPK_3566). In the last years, various regulators were described to control the expression 
of the T6SS operon 4 (T6SS4). These regulators are involved in processes such as 
virulence, quorum sensing or stress response. Furthermore, the T6SS4 was reported to 
be thermo-regulated with the highest expression at 26°C in stationary growth phase. 
Quorum sensing positively regulates T6SS4 expression via the AHL synthases YpsI and 
YtbI at moderate temperatures (Zhang et al., 2011). Additional T6SS4 regulation in 
Y. pseudotuberculosis mediates the response regulator OmpR of the EnvZ-OmpR TCS, 
which is responsive to cell envelope and osmotic stress. The T6SS4 is required for 
survival of osmotic stress through OmpR. Phosphorylated OmpR directly activates 
transcription of the T6SS4 operon by interacting with two different sites within the T6SS4 
promoter (Gueguen et al., 2013). However, a third OmpR binding site within the T6SS 
promoter sequence represses transcription of the operon. The T6SS cluster 4 was also 
implicated in acid tolerance in an OmpR dependent manner (Zhang et al., 2013).  
Moreover, in several studies the T6SS operon 4 is described to be associated with 
                                               
6 Yang et al., (2018) is licensed under the terms of the Creative Commons Attribution License (CC BY). 
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oxidative stress resistance. The oxidative stress regulator OxyR activates the 
Y. pseudotuberculosis T6SS4 in response to H2O2 induced stress. Mutation of oxyR leads 
to increased amounts of reactive oxygen species (ROS) within the cell. T6SS4 mediated 
Zn2+ ion acquisition was shown to be important under oxidative stress conditions. T6SS4-
dependent Zn2+ translocation is facilitated by the zinc-binding component YezP 
(YPK_3549). Furthermore, the metal-responsive transcriptional regulator ZntR positively 
regulates T6SS4 expression in order to maintain zinc homeostasis. Another regulator 
involved in T6SS4-associated resistance to H2O2 oxidative stress is the stationary 
phase/stress σ factor RpoS (σS) (Wang et al., 2015; Wang et al., 2017; Guan et al., 2015).  
The virulence regulator RovM also controls expression of the type VI secretion 
operon 4, depending on nutrient availability. RovM directly interacts with the T6SS4 
promoter and activates expression of the operon (Song et al., 2015). The above-
mentioned T6SS4 regulators were all shown to activate the expression of the T6SS 
cluster 4 and to directly interact with the T6SS4 promoter region (Figure 1.7). 
 
Figure 1.7: Position of the binding sites of direct T6SS4 activators. 
Known T6SS4 regulators bind to sequences of the overlapping promoter regions of the T6SS4 and the 
downstream gene YPK_3567. Transcriptional start sites are marked with black arrows and +1. YPK_3566 is 
marked as the first gene of the T6SS4 operon and is encoded on the antisense strand. The downstream gene 
YPK_3567 is encoded on the sense strand. The T6SS4 regulating proteins and their respective binding sites 
are colored as follows: OmpR (green), ZntR (olive), RovM (orange), OxyR (brown) and RpoS (red). The OxyR 
and RpoS binding sites are not specifically defined.  
 
1.3.2 Regulator of virulence associated with CsrC (RovC) 
RovC was discovered in a genetic screening approach for the identification of additional 
regulators controlling the small non-coding RNA CsrC of Y. pseudotuberculosis 
(Seekircher, 2014). The screening revealed one clone exhibiting a negative effect on a 
csrC-lacZ reporter fusion. This clone encodes a hypothetical protein consisting of 247 
amino acids (YPK_3567) and was designated as regulator of virulence associated with 
CsrC (RovC) (Seekircher, 2014). Surprisingly, RovC is highly conserved only in 
Y. pseudotuberculosis and Y. pestis but not in the third pathogen Y. enterocolitica or any 
other Yersinia species. Accordingly, BLAST analysis revealed that RovC is unique in 
Y. pseudotuberculosis and Y. pestis. Comparison of RovC with known proteins or protein 
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RpoS 
binding 
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RovM 
binding 
site 
OmpR 
binding 
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ZntR 
binding 
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domains did not reveal any homologies (Seekircher, 2014). However, a secondary 
structure alignment using Phyre2 (http://www.sbg.bio.ic.ac.uk/phyre2/phyre2_ output/ 
3debc240fe95cd11/summary.html) predicted homology of the C-terminus of RovC to a 
DNA-binding motif. The analysis indicated that 20% of the amino acid residues show 
homology (50.2% confidence) to the Trp repressor of Staphylococcus aureus (Knittel, 
2015). In further structural analysis, the crystal structure of RovC was solved to a 
resolution of 2.3 Å. Crystalized RovC comprises two domains, an N-terminal domain 
consisting of α-helices and β-strands, adopting a distinct fold, and a C-terminal domain 
containing a helix-turn-helix motif (HTH). Six RovC monomers form the hexameric RovC 
protein. SAXS (small-angle X-ray scattering) and MALS (multi angle light scattering) 
experiments confirmed the hexameric structure and showed that RovC forms a ring-like 
structure (Sadana, 2017) (Figure 1.8). 
 
 
Figure 1.8 RovC protein structure. 
(A) Crystal structure of the RovC hexamer is made up out of six identical monomers. (B) SAXS analysis of 
RovC revealed a ring-like structure. (C) RovC crystal structure and SAXS structure match perfectly and 
confirm the hexameric ring-form (modified from Sadana, 2017). 
 
 Since the expression levels of RovC in Y. pseudotuberculosis are much higher in 
comparison to E. coli, RovC seems to be a Yersinia specific protein that requires a 
Yersinia specific activator (Seekircher, 2014). RovC has its highest expression at 25°C in 
stationary growth phase and regulation of rovC involves early virulence genes such as 
CsrA and Crp and the regulator YmoA, all exerting a negative effect on rovC transcription 
(Seekircher, 2014; Knittel, 2015). Analysis of the post-transcriptional regulation of rovC 
showed that the rovC 5’UTR has a length of 39 nucleotides and contains putative CsrA 
binding motifs. First interaction studies of CsrA with the rovC transcript also suggest a 
post-transcriptional effect of CsrA on rovC expression (Knittel, 2015) and preliminary 
analysis demonstrated that RovC for activating the T6SS4 operon (Figure 1.9). 
Furthermore, RovC is part of the whole CsrABC-RovM-RovA-invasin cascade (Figure 
1.9). RovC strongly represses csrC transcription although, in turn, the Csr system controls 
expression of rovC. The regulators YmoA, Crp and CsrA all exert a negative effect on 
rovC transcription and translation. Clp/Lon proteases seem to be involved in the regulation 
of RovC protein stability (Seekircher, 2014; Knittel, 2015).  
A B C 
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 In addition to the regulation of the Csr RNA CsrC, microarray analysis comparing 
the Y. pseudotuberculosis wild type strain YPIII and the isogenic rovC deletion mutant 
revealed RovC to positively regulate nine genes belonging to the type VI secretion 
operon 4 (T6SS4). The rovC gene is located directly downstream of the T6SS4 cluster in 
the opposite direction. Further analysis confirmed that RovC is required for the activation 
of T6SS4 expression at moderate temperatures (25°C) in stationary growth phase 
(Seekircher, 2014) (Figure 1.9). 
  
 
Figure 1.9: Schematic model including the novel virulence regulator RovC in early-stage virulence 
gene expression cascade.  
The new virulence regulator RovC was discovered as a repressor of the small ncRNA CsrC, which is part of 
the Csr system. The Csr system that consists of the RNA-binding protein CsrA and the ncRNAs CsrB/C 
controls expression of invasin through RovM and RovA. RovC is genetically linked to the T6SS4 operon 
(YPK_3566 to YPK_3549), encoded in the opposite direction and was shown to activate expression of the 
operon. The global regulators Crp, YmoA and CsrA repress transcription of rovC. In addition to the 
transcriptional regulation, CsrA exerts a post-transcriptional effect on rovC expression by interacting with the 
rovC mRNA transcript. This interaction could either result in transcript stability and/or inhibition of translation. 
Black arrows show positive effects and T-bars repressive effects. Dashed lines indicate putative regulatory 
influences. 
 
1.4 Aim of the study 
The aim of the study was to investigate the novel regulator RovC and its importance for 
the regulation of the T6SS4 operon. qRT-PCR results from a previous study revealed that 
tested genes belonging to the T6SS4 operon were significantly downregulated in the 
absence of rovC. Consequently, RovC seems to positively affect the expression of the 
T6SS4 (Seekircher, 2014). Thus, one aim of this study was to analyze whether RovC is a 
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direct activator of the T6SS4 that interacts with the promoter region of the operon. In 
addition, this work aimed at identifying specific amino acids that are essential for DNA-
binding and for in vivo induction of T6SS4 expression. Functionality of the T6SS4 
regarding effector translocation in dependence of RovC was another objective of this 
work. Since recent studies identified additional regulators of the Y. pseudotuberculosis 
T6SS4, the effect of these regulators on T6SS4 and RovC expression was addressed. 
Moreover, this study intended to show whether RovC is essential for the activation of the 
T6SS4 independent of other regulators. As RovC represents a completely new and 
uncharacterized regulator of the T6SS4, another objective of this study was to investigate 
the regulatory mechanism controlling rovC expression. Previous studies already indicated 
that rovC expression is strongly repressed by the global regulator CsrA. Thus, the 
transcriptional and post-transcriptional regulation of rovC by CsrA were analyzed. 
Especially, direct binding of CsrA to the rovC transcript, possible effects on rovC transcript 
stability and translation initiation were examined. 
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2 Material and Methods 
2.1 Material 
2.1.1 Strains oligonucleotides and plasmids 
The Y. pseudotuberculosis and E. coli strains used in this study are indicated in Table 2.1. 
 
Table 2.1: Bacterial strains 
Strain Description Reference 
   
E. coli 
 
BL21λDE3 F- ompT gal dcm lon hsdSB(rB - mB -) λDE3 (Studier & Moffatt, 1986) 
DH10β 
F- endA1 recA1 galE15 galK16 nupG rpsL ΔlacX74 
Φ80lacZ ΔM15 araD139 Δ(ara,leu)7697 mcrA  
Δ(mrr-hsdRMS-mcrBC), λ- 
Invitrogen 
S17-1λpir recA thi pro hsdR– M1+(RP4--2Tc::Mu--Km::Tn7), λpir (Simon et al., 1983) 
CC118λpir 
F- Δ(ara-leu)7697 Δ(lacZ)74 Δ(phoA)20 araD139 galE 
galK thi rpsE rpoB arfEam recA1, λpir (Manoil & Beckwith, 1986) 
 
Y. pseudotuberculosis  
YPIII pIB1, wild type (Bolin et al., 1982) 
YP53 YPIII, ΔcsrA, KanR (Heroven et al., 2008) 
YP72 YPIII, ΔrovM (Heroven et al., 2012) 
YP89 YPIII, Δcrp (Heroven et al., 2012) 
YP107 YPIII, ΔrovA (Quade et al., 2012) 
YP148 YPIII, ΔrovC, KanR S. Seekircher 
YP154 YPIII, ΔrovC S. Seekircher 
YP300 YPIII, ΔompR/envZ, KanR M. Pimenova 
YP318 YPIII, ΔcsrA, ΔrovC, KanR This study 
YP338 YPIII, ΔrovM, ΔrovC This study 
YP351 YPIII, 3xFLAG-YPK_3563, ∆clpV A. Kiesewetter 
YP360 YPIII, 3xFLAG-YPK_3563 This study 
R resistance cassette  
 
The oligonucleotide primers used for molecular cloning are listed in Table 2.2 and 
plasmids are indicated in Table 2.3. 
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Table 2.2: Oligonucleotides for DNA amplification 
Oligonucleotide Sequence (5'>3') Restriction site 
131 GTCCTGGCCTGAATCGACAGCG  
132 GGCTACGAAATGAGCATCGC  
350 CGTCGTGACTGGGAAAACCC  
I477 GATTAGCGGATCCTACCTG  
I478 ACCACCGCGCTACTG  
I515 GCAGTTCATTTGGATCAATAC  
I661 GTGTAGGCTGGAGCTGCTTC  
I662 CATATGAATATCCTCCTTAGTTCC  
I984 TAAGAAACCATTATTATCATGAC  
II126 GATACTGTCGTCGTCCCCTC  
III286 CGCGCGGTCGACCATATTCAACGCCGAATAATGC  
III287 CGCGCGGGATCCCTAGAGGAAGTTCAGGTAGCC  
III393 CCGACGTAAAGCCGCGATAC  
III394 CCTCGTTCATAAGCACTCGTC  
III779 GCATAAAGCCATCATAGAG BamHI 
III780 GGACATAGATATGAGAAAGAA BamHI 
III845 GCGCGAGCTCGGCAGAGTTAATGTAATGTTCC SacI 
III920 GCGCGAGCTCGGCTTGCTCACTGATATG SacI 
III921 GAAGCAGCTCCAGCCTACACATCTATGTCCTCTTATTTTGGC  
III922 ACTAAGGAGGATATTCATATGTGTCCTATCTGACATGC  
III981 TGAACGGCAGGTATATGTG  
III982 CACTTAACGGCTGACATGG  
IV91 GCGCGAGCTCGCTCCTCTTTGCATTCCAC  
IV735 GCGCGGATCCCAGCTCTGATTGGATTAATTCAG BamHI 
IV736 GCGCGTCGACATGTCACTCATATTATTGTCCATC SalI 
V647 ATGTATTTACGGCGTCTTTACGATC  
V648 TTAGATGCTATCCGGCTGGTGG  
V649 GCTCACCTTACGTGCCAGCGT  
V650 CCGCATTATCGATCCACCCTATG  
V651 CGGCCCAACTGGATGTGCTC  
V652 CATGCAGATGGCGGCTTTGC  
V653 CATCTTCGACATTATTTTTAACTGTC  
V654 GTTCACAATGCAGTTGGTAACTC  
V700 GGGCGCGTAATACGACTCACTATAGCAACAATACCGTGAAATGC  
V773 GTAATACGACTCACTATAGGATGACGTGGATGAATAGCC  
V775 GTAATACGACTCACTATAGCAAAATAAGAGGACATAGAT  
V777 CAT TCC CAC GCG AAG TCA TTA T  
V993 GGCGGG GTCGAC GATGACGTGGATGAATAGCCAA SalI 
V995 GGAAGG AAGCTT CTAGAGGAAGTTCAGGTAGCC HindIII 
VI138 GTGGCCTAAGTTGTTATTCC  
VI209 CACGCGAAGTCATTATATAGCTTC  
VI270 CCTATCACAACAGAGAATAGC  
VI648 CGAAGTCATTATATAGCTTCTTTCTC  
VI649 GTGCTAATGGTTATGTAAATTTAATAAATG  
VI650 CTACTACTGTTTTTTGTCCTAGGTTATTTC  
VI651 GAAATAACCTAGGACAAAAAACAGTAGTAG  
VI652 CTTAAATAAGAAAAAAATAAAGAC  
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VI699 GGCAAG GAGCTC GGCCCGTTTACCTTACATTTTTG  
VI700 GGCAAG GAGCTC GATCGTAACCAGCCTTAATCACG  
VI723 CGTCATGGTCTTTGTAGTCCATTTTTTCACTCCTGAATTAATG  
VI724 CGATAAATCTGCTGGCGCGAGTGCAGCAGCTTTAGTCGATTACTTTC  
VI826 CCTGATTTACATACCTGTTATAGG * 
VI917 GCCTTTATCGGGTCGTGCACCCTG  
VI918 GATAACGCAACTCTTCGTTGTATAG  
VII248 CTAATGGAGGGGGTATACCCGATG  
VII249 CTGAACGGTTACTTAATTTTAGTGACC  
VII250 CGCGTGTTCAGAATGATTTTCCCAC  
VII251 CCCGTGCAATATAGGTCTTCTTGGG  
VII533 CGCCGGGTACCCATATTCAACGCCGAATAATGC  
VII534 GCGGCCCCCGGGCTAGAGGAAGTTCAGGTAGCC  
VII536 CCTACTCAGGAGAGCGTTCACC  
VII647 GTCCTGAGCAATCACCTATGAACTG  
VII773 GCAGCTTTAGTCGATTACTTTC  
VII774 CGGTTGTTCAATTTCAGATCG  
VII836 GAGTTTGTAGAAACGCAAAAAGG  
VII928 GGCGGGGTCGACGATGACGTGTATGAATAGCCAA  
VIII293 GTTGAAGTTGAACTCAGTAATACTGGAAATGTCAAAGGGGG  
VIII294 ACTGAGTTCAACTTCAACTGAACGGTTACTTAATTTTAGTGACC  
VIII295 TTAGAACTCTTGGAAACCATAGATGACAGAAAACAAGGCTTC  
VIII296 GGTTTCCAAGAGTTCTAAATATTGCTCCTCTTTGCATTCCAC  
VIII297 AAAATCGAATATCGTATAAAGAAGGCGAATGCACTTATTAATTAC  
VIII298 TATACGATATTCGATTTTTGCTCTGACCCAACTGTCAGC  
VIII299 GAAAAAGAATGGGGAGTAATGAAATATATTGATCCTTATAACTCTG  
VIII300 TACTCCCCATTCTTTTTCTGCATTCAAATCCAGCTCTGATTG  
PS114 GAATGGGAAGAAGACAGTTGGGTCAGAGCAAAAATCCGC  
PS115 ACTGTCTTCTTCCCATTCATTTTTTACCAGTTCCTTACC  
PS130 ATTTTCTACCAGTTCTTCACCAAAAATTTCTGAAGCGATATCCCGGTG  
PS131 CACCTCTATCTCGTGATTAACAATGCTCTGTAATAACTC  
PS150 TGGGTCGAAGCAAAAATCCGCTATCGTATAAAGAAGGCG  
PS151 TTTTGCTTCGACCCAACTGTCAGCAGACCATTCATTTTTTAC  
PS156 GTTTTTGCTGAAAATATTGAGTTATTACAGAGCATTGTTAATCAC  
PS157 CTCAATATTTTCAGCAAAAACATCAGATTCAAGGTTCAAAGG  
PS158 TCCCACGAAGATATCGCTTCAGAAATTTTTGGTAAGGAAC  
PS159 GATATCTTCGTGGGAGAAGCCTTGTTTTCTGTCATC  
PS160 GGTGAAGAACTGGTAGAAAATGAATGGTCTGCTGACAGTTGGG  
PS161 ATTTTCTACCAGTTCTTCACCAAAAATTTCTGAAGCGATATCCCGGTG  
Underlined: restriction site, *: digoxygenin labeled, bold: T7 promoter 
 
 
  
Table 2.3: Plasmids 
Plasmid Description Reference 
   
pACYC184 cloning vector, ori p15A, TetR, CmR (Chang & Cohen, 1978) 
pBAD30 cloning vector, ori p15A, AmpR (Guzman et al., 1995) 
pIV2 cloning vector, ori p29807, KanR (E. Strauch et al., 2000) 
pK18 cloning vector, ori ColE1, KanR (Pridmore, 1987) 
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pTS02 pGP20,  ori pSC101, lacZ, AmpR (Böhme et al., 2012) 
pZA24 cloning vector, Plac/ara-1, ori p15A, KanR (Lutz and Bujard, 1997) 
pAKH3 pGP704, ori R6K, sacB+, CmR (Heroven et al., 2012b) 
pAKH30 pK18, ori pMB1, hns’, KanR A. K. Heroven 
pAKH56 pACYC184, ori p15A, csrA+, CmR (Heroven et al., 2008) 
pAKH63 pGP20,  ori pSC101, rovM'-'lacZ (41)c, TetR (Heroven and Dersch, 2006) 
pAKH64 pIV2, rovM+, ori p29807, KanR A. K. Heroven 
pAKH74 pACYC184, p15A, Δtet, hns+ CmR A. K. Heroven 
pAKH85 pACYC184, p15A, Δtet, CmR (Heroven and Dersch, 2006) 
pAKH172 pET28a(+), ori 3286 ,csrA+, KanR A. K. Heroven 
pAKH189 pTS03, ori pSC101, rovC-lacZ (-618 to -39)b, AmpR A. K. Heroven 
pSSE11 pACYC184, ori p15A, rovC+, CmR (Seekircher, 2013) 
pSSE32 pTS02, ori pSC101, rovC'-'lacZ (3)c, AmpR (Seekircher, 2013) 
pSSE64 pTS02, ori pSC101, YPK_3566’-‘lacZ (3)c, AmpR (Seekircher, 2013) 
pVK01 pBAD33, ori p15A, 5’UTR-rovC (-39)b, CmR (Knittel, 2014) 
pVK03 pTS02, ori pSC101, rovC’-‘lacZ (-402 to +50)a (Knittel, 2014) 
pVK10 pAKH3, ori R6K, ∆rovC, CmR This study 
pVK25 pBAD30, ori p15A, 5’UTR-rovC (-39)b, CbR This study 
pVK30 pAKH3, ori R6K, YPK_3563, 3xFLAG-tag, SAGASA-
linker 
This study 
pVK43 pBAD18-lacZ, 5’UTR-rovC, ori ColE1, AmpR This study 
pVK46 pZA24, ori p15A, rovC+, KanR This study 
pVK47 pZA24, ori p15A, rovC+ K163E, KanR This study 
pVK48 pZA24, ori p15A, rovC+ K175E, KanR This study 
pVK49 pZA24, ori p15A, rovC+ K211E/K215E, KanR This study 
pVK50 pZA24, ori p15A, rovC+ R202E, KanR This study 
pVK51 pZA24, ori p15A, rovC+ R225E, KanR This study 
pVK52 pZA24, ori p15A, rovC+ S219E/A220E, KanR This study 
pVK56 pZA24, ori p15A, rovC+ R85E/K87E, KanR This study 
pVK57 pZA24, ori p15A, rovC+ G187E/K190E, KanR This study 
pVK58 pZA24, ori p15A, rovC+ R229E, KanR This study 
pVK59 pZA24, ori p15A, rovC+ K56E, KanR This study 
a relative to transcriptional start 
b relative to translational start 
c amino acids 
 
2.1.2 Media and supplements 
Liquid media (listed in Table 2.4) were prepared with H2Odest. For the preparation of solid 
media, 15 g agar were added to 1 l of liquid media. Media supplements for selective 
media are indicated in Table 2.5 and were added after autoclaving of the media. 
 
 Table 2.4: Media 
Media Composition  
LB medium (Luria-Bertani) 5 g Bacto yeast extract, 10 g Bacto Tryptone, 5 g NaCl  
BHI medium (Brain Heart Infusion) 37 g/l BHI (BD Biosciences)  
DYT medium (Double Yeast Tryptone) 10 g/l yeast extract, 5 g/l NaCl, 16 g/l tryptone  
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Table 2.5: Media supplements 
Antibiotic Stock solution Final concentration 
Carbenicillin 100 mg/ml in H2O 100 µg/ml  
Chloramphenicol 30 mg/ml in ethanol 30 µg/ml  
Kanamycin 50 mg/ml in H2O 50 µg/ml  
Rifampicin 20 mg/ml in methanol 1mg/ml 
Triclosan 20 mg/ml in ethanol  20 µg/ml  
 
2.1.3 Antibodies, enzymes, kits and size standards 
All applied antibodies, enzymes and kits used for this study are listed in Table 2.6, 2.7 and 
2.8. 
 
Table 2.6: Antibodies 
Antibody Dilution Manufacturer 
Primary antibodies   
Anti-FLAG 1:10000 Sigma 
Anti-H-NS 1:100000 Davids Biotechnology 
Anti-InvA 3A2 1:4000 Dersch & Isberg, 1999 
Anti-RovA 1:2000 Davids Biotechnology 
Anti-RovC 1:1000 Davids Biotechnology 
Anti-RovM 1:4000 Davids Biotechnology 
   
Secondary antibodies   
Anti-digoxygenin alkaline phosphatase 1:8000 Roche 
Anti-mouse immunoglobulin, HRP-linked 1:8000 Cell signaling 
Anti-rabbit immunoglobulin, HRP-linked 1:8000 Cell signaling 
 
Table 2.7: Enzymes 
Enzyme Manufacturer 
Alkaline phosphatase, calf intestinal (CIP) NEB 
Antarctic phosphatase NEB 
Benzonase Merck 
DNaseI Roche 
Lysozyme Sigma 
Mango TaqTM DNA polymerase Bioline 
Phusion® High-fidelity DNA polymerase NEB 
Restriction enzymes NEB 
RiboLock RNase inhibitor Thermo Scientific 
T4 DNA ligase Promega 
T4 Polynucleotide kinase (PNK) Thermo Scientific 
 
Table 2.8: Commercial kits 
Kit Manufacturer 
Dig-luminescent detection Roche 
Mango-Mix Bioline 
NucleoSpin® Gel and PCR Clean-up Macherey-Nagel 
NucleoSpin® Plasmid Macherey-Nagel 
QIAquickTM Gel extraction Qiagen 
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QIAquickTM PCR Purification Qiagen 
QIAquickTM Plasmid Midiprep Qiagen 
QIAquickTM Plasmid Miniprep Qiagen 
SenisiFastTMSYBR® No-ROX Bioline 
SV Total RNA Isolation Promega 
Transcript AidTM T7 High Yield Transcription kit Fermentas 
RNA Clean & Concentrator™-5 Zymo Research 
  
 
All size standards used for this study are listed in Table 2.9. 
 
Table 2.9: Molecular size standards 
Size standard Manufacturer 
Gene ruler DNA Ladder mix Thermo Scientific 
PageRuler Prestained Protein Ladder Thermo Scientific 
RNA Molecular Weight Marker I, Dig-labeled Roche 
 
2.1.4 Chemicals and buffers 
All chemicals and buffers, if not otherwise specified, were obtained from the following 
companies: Applichem, BD Biosciences, Biochrom, BioRad Biozol Diagnostics, Difco, 
Fluka, Gerbu, J.T. Baker, Macherey und Nagel, Merck, NEB, Oxoid, Omnilab, PEQLAB, 
Roche, Roth, Serva, Sigma-Aldrich, T. H. Geyer, Thermo Scientific and VWR 
International. 
 
2.1.5 Technical equipment and software 
The technical equipment and material used in this study was manufactured by the 
following companies: Amersham Biosciences, Biomentra, BioRad, Brand, Eppendorf, GE 
Healthcare, Heidolph, Hirschmann, IBS Integra, Greiner, Millipore, Metrohm, Peqlab, 
Pierce, Sarstedt, Sartorius, Schleicher/Schüll, Schott, Sigma, Stratagene and Whatman. 
 ApE (A plasmid Editor), Excel:Mac (Microsoft Office 2011) and GraphPad Prism 
were used for data processing and Adobe Photoshop CS5 extended (Version 12.1 Adobe 
Systems inc.) and Adobe Illustrator CS5 (Version 15.1.0 Adobe Systems inc.) were used 
for graph editing. Additionally, Word:Mac and PowerPoint:Mac (Microsoft Office 2011) 
were used. For the analysis of sequences the NCBI (National Centre for Biotechnology 
Information) or Kegg (Kyoto Encyclopedia of Genes and Genomes) databases were used. 
Protein alignments were performed using the Phyre2 (Protein Homology/analogY 
Recognition Engine V 2.0) database (http://www.sbg.bio.ic.ac.uk/phyre2/phyre2_ output/ 
3debc240fe95cd11/summary.html) and ExPASy (https://web.expasy.org/cgi-bin/ 
protparam/protparam). 
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2.2 Microbiological Methods 
2.2.1 Cultivation and storage of bacteria 
For bacterial overnight cultures a single colony was picked from an agar plate under 
sterile conditions. Antibiotics were added in a 1:1000 ratio for selection if required. 
Bacterial cultures were incubated in a shaker at 25°C (Y. pseudotuberculosis) or 37°C 
(E. coli) at 200 rpm. Main cultures were inoculated with a defined volume of overnight 
culture and were incubated in a shaker at the desired temperature. 
 In order to culture bacteria on solid medium, bacteria were stroke on agar plates 
(containing the proper antibiotic) and grown for one or two days. The grown plates were 
stored at 4°C for a maximum of four weeks. To store bacteria for a longer period of time, 
glycerol stock cultures were prepared. For this 1.25 ml of bacterial overnight culture and 
0.75 ml of 80% glycerol were mixed and stored at – 80°C. 
 
2.2.2 Sterilization methods 
Liquid and solid media were heat-sterilized in an autoclave for 20 minutes at 121°C at 
1 bar overpressure in an autoclave. Heat-sensitive media were sterile filtered using filters 
with a pore diameter of 0.2 µm. Glassware was heat-sterilized in a compartment dryer at 
180°C. Lab benches and other material was disinfected using 70% ethanol or 1 to 7% 
Pursept. 
 
2.2.3 Determination of the bacterial cell number 
The optical density of a bacterial culture was measured in order to quantify the bacterial 
cell number. For this, 1 ml bacterial culture was filled into a UV-microcuvette and 
measured against sterile LB medium as blank. High-density cultures (high OD) were 
diluted 1:10 in LB before the measurement.  
 
2.3 Molecular biological methods for DNA analysis 
2.3.1 DNA amplification (PCR) and DNA gel electrophoresis 
DNA fragments were specifically amplified via polymerase chain reaction (Saiki et al., 
1988). Standard PCR reaction setups require a DNA template, desoxynucleotides, a DNA 
polymerase, and a pair of primers. Primers are synthesized oligonucleotides that are 
homologous to the region upstream and downstream of the DNA fragment of interest. 
PCR is based on three repetitive steps, which are repeated 29 to 35 times: First, double-
stranded DNA-molecules are denatured by heat at 95°C to provide single-stranded DNA. 
Second, for primer annealing the mixture is cooled down to 40°C to 60°C (depending on 
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the GC-amount of the oligonucleotides). Forward and reverse primer are complementary 
to the target DNA sequence. In the final step, new DNA fragments are synthesized by the 
DNA polymerase, starting from the end of the primers in 5’ to 3’ direction at the optimal 
temperature for the polymerase. For amplification of cloning inserts, the Phusion® High-
Fidelity DNA polymerase (Thermo Fischer Scientific, USA) was used. This DNA 
polymerase harbors a 3’-5’ exonuclease proofreading activity, minimizing the error rate. 
For control colony PCRs, the MangoMixTM (Bioline, Germany), containing the MangoTaq 
polymerase was used to identify positive clones. As template a single colony was picked 
with a sterile pipette tip and was directly added to the 15 µl PCR reaction mixture. 
 
Example of a Phusion PCR reaction 
Template DNA   1 ng to 200 ng 
5 x HF-buffer    10 µl 
Phusion polymerase (2 U/µl)  0.5 µl 
10 mM dNTP mixture   1 µl 
10 µM Oligonucleotide  0.75 µl 
H2Odest.    add up to 50 µl 
 
Example of a colony PCR reaction mixture 
Template    single colony 
2x MangoMixTM   7.2 µl 
10 µM Oligonucleotide  0.45 µl 
H2Odest.    6.9 µl 
 
A typical PCR reaction cycle used in this study is listed below. Cycles 2 to 4 were 
repeated up to 35 times. 
 
Step     temperature  time 
1. Denaturation (initial)  95°C   5 min 
2. Denaturation   95°C   30 sec 
3. Annealing    variable  30 sec 
4. Elongation    72°C   variable 
5. Elongation (final)   72°C   5-10 min 
6. Cool of the samples to 14°C 
 
PCR products were mixed with 6x loading dye and were loaded onto an agarose gel 
(ranging from 0.8% to 2.5% of agarose, depending on the size of the fragment). DNA 
29 - 35 cycles 
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fragments were separated in an electric field by applying 120 V for 40 to 75 minutes in 1x 
TAE buffer (40 mM Tris acetate; 1 mM EDTA pH 8.0). Afterwards, the gel was stained in 
ethidium bromide for 10 to 20 minutes. Ethidium bromide is an intercalating agent that 
incorporates sequence-unspecifically in between the bases of neighboring DNA molecules 
and fluoresces under UV-light. 
 
2.3.2 DNA purification from agarose gels 
For the isolation of DNA fragments from agarose gels, DNA-fragments were excised from 
the gel with a scalpel using 315 nm UV-light, after electrophoretic separation. In contrast 
to the usually used 226 nm UV-light, the 315 nm UV-light minimizes damages in the DNA. 
Then, DNA fragments were purified using the “QIAquick Gel Extraction Kit” (QIAGEN, 
Germany) or the “NucleoSpin® Gel and PCR Clean-up kit” (Macherey-Nagel, Germany) as 
recommended by the manufacturer. The kit contains silica-membranes, allowing DNA-
binding under high-salt conditions. DNA-elution was performed in nuclease-free water 
(low-salt conditions) and the DNA was stored at -20°C until use. 
 
2.3.3 Isolation of plasmid DNA 
Plasmid DNA was isolated from bacterial cells using the “QIAGEN Plasmid Mini Kit”, the 
“QIAGEN Plasmid Midi Kit” (QIAGEN, Germany) or the “Nucleo Spin® Plasmid kit” 
(Macherey-Nagel, Germany), according to the manufacturer’s instructions. For this, 
bacteria harboring the plasmid of interest were grown over night in LB-medium containing 
the required antibiotic. Finally, DNA was eluted in the desired volume of nuclease-free 
water. 
 
2.3.4 DNA purification 
DNA purification was performed after PCR reactions and restriction digestions to remove 
dNTPs, enzymes, and salts, using the “PCR Purification Kit” (QIAGEN, Germany) or the 
“NucleoSpin® Gel and PCR Clean-up kit“ (Macherey-Nagel, Germany).  
 
2.3.5 Determination of DNA concentration 
DNA concentrations were determined by measuring the absorbance with a NanoDrop 
photospectrometer. The wavelength of maximal absorption for DNA is 260 nm, so the A260 
was measured. DNA purity was determined by measuring the A260/A280, as a ratio lower 
than 1.8 indicates protein contamination in the sample. 
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2.4 Molecular cloning 
2.4.1 Cloning of DNA fragments via restriction sites and DNA restriction 
For molecular cloning of DNA fragments into a desired vector, primers comprising 
restriction sites for restriction endonucleases at their 5’ ends are required for PCR. These 
restriction sites merely make up a small part of the homologous sequence, so that the 
primer specificity is not impaired. In this study, restriction endonucleases (NEB, USA) that 
recognize specific palindromic sequences 4 to 8 nucleotide long were used. The 
endonucleases produce sticky or blunt ends that can be re-ligated. 
PCR products were purified (section 2.3.4.) prior to the restriction digestion. For 
restriction, insert and vector were digested with the same restriction endonucleases in a 
buffer offering optimal working conditions for the enzymes. In order to digest DNA 
fragments with two different enzymes at once, the suitable buffer was chosen according to 
the manufacturer’s recommendation. 
 
Example of a restriction digest 
DNA (2 - 3 µg)  x µl 
10 x Reaction buffer  5 µl 
Enzyme 1 (1 U/µl)  1 µl 
Enzyme 2 (1 U/µl)  1 µl 
100 x BSA   0.5 µl 
H2Odest    add up to 50 µl 
 
The restriction digest was incubated at 37°C for 1.5 hours and was purified afterwards, 
using the QIAGEN “PCR Purification Kit” or the “NucleoSpin® Gel and PCR Clean-up kit“. 
To prevent self-ligation, vectors were eluted in 30 µl of nuclease-free water and were 
dephosphorylated by adding of 1.5 µl of Antarctic Phosphatase and 3.5 µl of Antarctic 
Phosphatase buffer for two hours at 37°C. The dephosphorylation step leads to hydrolysis 
of the 5’ phosphate group of the vector, which is needed for ligases, thus preventing self-
ligation. 
 
2.4.2 Ligation of DNA fragments 
The final step for the construction of a plasmid is the integration of the insert into the 
desired vector. The enzyme T4 DNA ligase catalyzes the ligation reaction (Promega, 
USA). DNA ligases are capable of covalently fixing either sticky or blunt ends of DNA 
fragments resulting from restriction digestion. Phosphodiester-bonds are formed between 
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neighboring 3’-hydroxy and 5’-phosphate ends of double-stranded DNA-molecules. A 
standard ligation reaction (10 µl) contains the following components: 
Vector    1 µl 
Insert    7 µl 
T4 DNA ligase  1 µl 
10 x ligation buffer  1 µl 
 
The ligation reaction was incubated for 2-3 hours at RT or at 17°C overnight. 
 
2.4.3 Plasmid construction 
All plasmids constructed during this study, the corresponding oligonucleotides, and 
restriction sites are listed in the table 2.10. 
 
Table 2.10 Plasmid construction 
Plasmid Description Primer pair    
III920/III921 (upstream) 
pVK10 pAKH3, ori R6K ∆rovC, CmR III922/III845 (downstream) 
  III920/III845 (3-step PCR) 
pVK25 pBAD30, ori p15A, 5’UTR-rovC (-39)b, CbR V993/V995 
  VI699/VI723 (upstream) 
pVK30 pAKH3, ori R6K, CmR YPK_3563, 3xFLAG-tag, 
SAGASA-linker 
VI724/VI700 (donwstream) 
pVK43 pBAD18-lacZ, 5’UTR-rovC, ori ColE1, AmpR VII244/VII395 
  VI699/VI700 (3-step PCR) 
pVK46 pZA24, ori p15A, rovC+, KanR VII533/VII534 
  PS156/III287 (upstream) 
pVK47 pZA24, ori p15A, rovC+ K163E, KanR III286/PS157 (downstream)   
VII553/VII534 (2-step PCR) 
  PS130/III287 (upstream) 
pVK48 pZA24, ori p15A, rovC+ K175E, KanR III286/PS131 (downstream) 
  VII553/VII534 (2-step PCR) 
  PS160/III287 (upstream) 
pVK49 pZA24, ori p15A, rovC+ K211E/K215E, KanR III286/PS161 (downstream) 
  VII553/VII534 (2-step PCR) 
  PS158/III287 (upstream) 
pVK50 pZA24, ori p15A, rovC+ R202E, KanR III286/PS159 (downstream) 
  VII553/VII534 (2-step PCR) 
  PS150/III287 (upstream) 
pVK51 pZA24, ori p15A, rovC+ R225E, KanR III286/PS151 (downstream) 
  VII553/VII534 (2-step PCR) 
  PS114/III287 (upstream) 
pVK52 pZA24, ori p15A, rovC+ S219E/A220E, KanR III286/PS115 (downstream) 
  VII553/VII534 (2-step PCR) 
pVK56 pZA24, ori p15A, rovC+ R85E/K87E, KanR VII533/VIII294 (upstream) 
VIII293/VII534 (downstream) 
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VII533IVII534 (2-step PCR) 
pVK57 pZA24, ori p15A, rovC+ G187E/K190E, KanR VII533/VIII296 (upstream) 
VIII295/VII534 (downstream) 
VII533IVII534 (2-step PCR) 
pVK58 pZA24, ori p15A, rovC+ R229E, KanR VII533/VIII298 (upstream) 
VIII297/VII534 (downstream) 
VII533IVII534 (2-step PCR) 
pVK59 pZA24, ori p15A, rovC+ K56E, KanR VII533/VIII300 (upstream) 
VIII299/VII534 (downstream) 
VII533IVII534 (2-step PCR) 
 
The complementation plasmid pVK25 was constructed by amplifying the rovC gene with 
primer pair V993/V995, using Y. pseudotuberculosis chromosomal DNA as template. The 
PCR fragment was digested with SalI and HindIII. The translational rovC’-‘lacZ fusion 
pVK43, harboring the complete rovC 5’UTR, was constructed by amplification of the rovC 
5’UTR and the first codons of the coding sequence using primers VII244/VII395. 
Subsequently, the fragment was digested with NheI /EcoRI and ligated into the NheI 
/EcoRI site of the plasmid pBAD18-lacZ. In order to create an inducible rovC 
overexpression plasmid, the amplified rovC gene, including the rovC 5’UTR, was fused 
behind the araC gene of the arabinose inducible promoter of the pBAD30 vector. For 
construction of the complementation plasmid pVK46, the rovC gene was amplified with 
primer pair VII533/VII534 and plasmid pSSE11 as template. The amplified rovC gene was 
digested with KpnI and SmaI and was ligated into the KpnI/SmaI site of the arabinose 
inducible plasmid pZA24. The complementation plasmids pVK47, pKV48, pVK49, 
pVK50, pVK51, pVK52, pVK56, pVK57, pVK58 and pVK59 were constructed in two 
steps, to integrate different RovC amino acid substitutions by PCR. The primer pairs used 
to generate the upstream and downstream fragments are listed in table 2.10. Via the PS 
primer pairs (kindly provided by Pooja Sadana) and primers VIII293 to VIII300, specific 
amino acids in the rovC wild type sequence were exchanged. Primer pair VII533/VII534 
were used to amplify the complete rovC gene using the upstream and downstream 
fragments as templates. The PCR products were digested with KpnI and SmaI and were 
integrated into the KpnI/SmaI site of pZA24. Construction of the mutagenesis plasmids 
pVK10 and pVK30 is described in section 2.5.1. 
 
2.4.4 DNA sequencing 
Sequencing of plasmids was performed at the GMAK, the Department of Genome 
Analysis, at the Helmholtz Center for Infection Research in Germany or by Seqlab, 
Germany. 
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2.4.5 Bacterial transformation 
Many bacteria possess a natural competence to take up free DNA into the cell with low 
efficiency. Treating the cells either physically or chemically can increase the 
transformation rate. Transformation was used to introduce exogenous DNA molecules into 
bacterial cells. For this, a plasmid carrying the gene of interest was transformed into a 
bacterial strain. The plasmid is replicated in the bacteria as well as the introduced gene. 
For the selection of positively transformed bacteria, agar plates containing the required 
antibiotic were used. 
 
Preparation of electrocompetent bacteria 
For the preparation of electrocompetent bacteria, the desired amount of BHI medium was 
inoculated either 1:50 (Y. pseudotuberculosis) or 1:100 (E. coli) with an overnight culture 
of the respective bacteria. Cells were grown for 3.5 h at 25°C (Y. pseudotuberculosis) or 
37°C (E. coli) at 200 rpm to an OD600 between 0.5-0.8. Next, the bacteria were incubated 
on ice for 10 to 30 minutes and afterwards the cells were harvested by centrifugation at 
6000 rpm for 5 minutes at 4°C. The bacterial pellet was washed two times with 10 ml ice-
cold water (E. coli) or transformation buffer (Y. pseudotuberculosis) and centrifuged as 
described above. Subsequently, the E. coli pellet was resuspended in the appropriate 
amount of ice-cold 10% glycerol. Competent E. coli cells were stored in 40 µl aliquots at -
20°C. The Yersinia pellet was resuspended in the appropriate volume of transformation 
buffer and 40 µl aliquots of competent cells were directly used for transformation. 
 
Transformation via electroporation 
For transformation, an aliquot of competent cells was thawed on ice, plasmid DNA was 
added to the bacteria and mixed carefully. In case of ligation reactions, the ligation was 
dialyzed for 20 minutes on a filter membrane for salt exchange, prior to transformation. 
Then, the bacteria with the DNA were transferred into a pre-chilled electroporation 
cuvette. Subsequently, the cuvette was exposed to a voltage pulse (25 µF, 2500 V, 200 
Ω, 5 msec). Following the electroporation, the bacteria were directly mixed with 1 ml BHI 
medium and incubated at 25°C for 2 hours (Y. pseudotuberculosis) or 1 hour at 37°C 
(E. coli). After phenotypic expression, the bacteria were pelleted by centrifugation at 
9000 rpm for 2 minutes. The pellet was resuspended in 100 µl medium and plated on an 
agar plate containing the desired antibiotic for selection.  
 
Y. pseudotuberculosis transformation buffer: 272 mM sucrose, 15% glycerol 
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2.5 Mutagenesis of Y. pseudotuberculosis 
For the deletion of specific genes of Y. pseudotuberculosis or integration of gene 
modifications (e.g. FALG-tags), suicide plasmids derived from the plasmid pAKH3 were 
introduced into the respective Yersinia strain and integrated via homologous 
recombination. Construction of plasmids, introduction into Y. pseudotuberculosis and 
verification of correct mutants was performed as described below. 
 
2.5.1 Construction of mutagenesis plasmids 
For the construction of mutagenesis plasmids, a PCR fragment harboring a 
chloramphenicol resistance gene flanked by the upstream and downstream regions of the 
gene of interest was generated. First, the chloramphenicol gene (1014 bp) was amplified 
with primer pair I661/I662 using the plasmid pKD3 as template. Second, the upstream and 
downstream region of the target gene, both approximately 500 bp in length, were 
amplified by PCR with Y. pseudotuberculosis chromosomal DNA as template. For this, the 
reverse primer of the upstream fragment harbored a 20 bp overhang at its 5’-end that was 
homologous to the first nucleotides of the chloramphenicol gene, while the forward primer 
of the downstream fragment had a 20 bp homologous region to the last nucleotides of the 
chloramphenicol gene. Both PCR fragments were separated on a 2% agarose gel and 
excised and purified as described in sections (2.3.2 and 2.3.4). Finally, a 3-step PCR was 
performed, using the upstream and downstream fragments of the respective gene as well 
as the chloramphenicol gene as template. The forward primer of the upstream fragment 
and the reverse primer of the downstream fragment, both creating a SacI restriction site, 
were used as primer pair for this PCR reaction. Subsequently, the resulting 2000 bp PCR 
fragment was purified and cut with SacI and was integrated into the SacI site of the 
pAKH3 plasmid.  
Mutagenesis plasmids for the integration of gene modifications such as N-terminal 
or C-terminal tags were generated using G-blocks (IDT, USA) as templates. In this study a 
G-block containing the sequence of a 3xFLAG-tag, a SAGASA-linker and an ATG start 
codon was used to integrate a 3xFLAG-tag at a desired genomic region. For N-terminal 
3xFLAG-tagging of the target gene, the upstream and downstream fragments, each 500 
bp in length, were amplified by PCR using Y. pseudotuberculosis chromosomal DNA as 
template. For this, an upstream fragment was generated with a forward primer 500 bp 
upstream of the genomic region of interest and a reverse primer harboring a homologous 
region to the 3xFLAG-tag encoded on the G-block at the 5’-end. A downstream fragment 
was generated with a forward primer complementary to the 3xFLAG-tag. Then, a 3-step 
PCR was performed with the forward primer of the upstream fragment and the reverse 
primer of the downstream fragment and the 3xFLAG-tag encoding G-block as well as the 
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upstream and downstream fragments as templates. The resulting PCR-fragment was 
digested with SacI and was ligated into the SacI site of the pAKH3 plasmid. All 
mutagenesis plasmids were verified by sequencing as described in section 2.4.4. 
 
 
2.5.2 Bacterial conjugation 
Bacterial conjugation is a method used to transfer genetic material from one prokaryotic 
cell to another via direct cytosolic contact (Sana et al., 2014). The pAKH3 plasmid with the 
suicide R6K-ori was used in this study. The E. coli strain S17-1λpir harbors the 
chromosomally encoded pir-protein that is required for independent replication of this 
plasmid. Y. pseudotuberculosis can take up plasmids via conjugation but is unable to 
replicate them since they do not encode the pir-protein. Consequently, only those bacteria 
that have integrated the plasmid into their chromosome are able to express the antibiotic 
resistance cassette encoded on the plasmid. Bacterial conjugation was used in this study 
in order to delete a gene of interest in the Y. pseudotuberculosis chromosome. 
 For conjugation, 10 ml of BHI media were inoculated 1:50 with a fresh overnight 
culture of the desired Y. pseudotuberculosis strain and 5 ml LBRoth (containing the 
required antibiotic) were inoculated 1:100 with an E. coli S17-1λpir overnight culture, 
carrying the mutagenesis plasmid. The Y. pseudotuberculosis culture was grown for 3.5 
hours at 25°C and the E. coli culture for 3 hours at 37°C. In order to allow pili-formation, 
the E. coli culture was incubated for additional 30 minutes at 37°C without shaking. Then, 
a filter paper (0.22 µm, Milipore, USA) was placed on a sterile funnel and vacuum was 
applied. Next, 1 ml of the donor strain (E. coli strain S17-1λpir carrying the plasmid) was 
carefully harvested on the filter paper. In order to remove the antibiotic, the bacteria on the 
filter were washed with 2 ml of the growth media. Finally, 4 ml of the desired 
Y. pseudotuberculosis recipient strain were added on top of the E. coli strain and the filter 
was incubated on a pre-warmed LBBD plate at 25°C to allow conjugation. After 3 to 5 
hours or overnight incubation on the filter, the bacteria were harvested. For this, the filter 
was placed in a falcon tube and 1 ml of BHI media was added and vortexed. Then, the 
bacteria were transferred into an Eppendorf tube and 100 µl were directly spread on an 
agar plate containing the Yersinia-selective antibiotic triclosan. The remaining bacteria 
were spun down and the pellet was resuspended in approximately 100 µl media and 
plated onto another agar plate. Both plates were incubated at 25°C for 48 hours. 
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2.5.3 Mutant verification and selection 
The Y. pseudotuberculosis colonies that grew on selective media were picked and plated 
again on plates containing the selective antibiotic. Then, the cells were patched on LBBD 
plates supplemented with 10% sucrose (and chloramphenicol) to select for colonies that 
have lost the mutagenesis plasmid. The plasmid harbors the sacB gene that is induced by 
sucrose and leads to the production of a toxic substance (Gay et al., 1985). Consequently, 
only bacteria that have lost the plasmid could survive on these plates. Then, the colonies 
were plated on LBBD plate containing either just LB or chloramphenicol and carbenicillin. 
Colonies that grew only on LB/chloramphenicol and not on carbenicillin were 
subsequently checked for correct insertion of the DNA fragment of interest by PCR. The 
Y. pseudotuberculosis strain YP318 (∆csrA/∆rovC) was constructed using the strain YP53 
(∆csrA) and plasmid pVK10. YP338 (∆rovM/∆rovC) was generated using YP72 (∆rovM) 
and plasmid pVK10. Strain YP360 (3xFLAG-tag_YPK_3563) was generated using the 
YPIII wild type strain and plasmid pVK30.   
 
2.6 Molecular biological methods for RNA analysis 
2.6.1 RNA purification 
For RNA isolation, bacterial cultures were grown under the desired conditions. Then, 2 ml 
of the bacteria were pelleted by centrifugation for 1 minutes at 12000 rpm. The pellets 
were resuspended in 0.4 volume parts of stop solution and immediately snap-frozen in 
liquid nitrogen. This is a crucial step to inactivate exogenous ribonucleases. After a 
second centrifugation step for 1 min at 12000 rpm, the supernatant was decanted and the 
pellet was resuspended in 200 µl lysozyme solution (50 mg lysozyme/ml TE-buffer). For 
cell lysis, the samples were incubated for 5 to 20 minutes at room temperature. The 
following steps were performed using the “SV Total RNA Isolation System” (Promega, 
USA) according to the manufacturer’s instructions. 
 
2.6.2 Determination of RNA purity 
Photometric measurement of RNA concentrations is based on the principle that the 
aromatic ring systems of purine- and pyrimidine-bases show an absorption maximum at 
260 nm. To determine the RNA concentration of a sample, the absorbance was measured 
at 260 nm by a NanoDrop. The purity was assessed by measuring the ratio of 260 nm and 
280 nm. Pure RNA has a A260/A280 ratio of 2.0. 
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2.6.3 Northern blot analysis of mRNA transcripts 
Northern blot was performed to analyze specific RNA transcripts. For this, the isolated 
RNA was separated on agarose gels as the negatively charged RNA migrates to the 
anode in an electric field. Prior to lading, the RNA was mixed with loading dye, heated for 
10 minutes at 70°C, cooled down on ice for 2 minutes (to reduce the formation of 
secondary structures) and loaded onto a 1.2% MOPS agarose gel. Usually, 10 µg of RNA 
were loaded and gelelectrophoresis was performed at 120 V for 80 minutes in 1x MOPS 
buffer. The digoxygenin-labeled ‘RNA Molecular Weight Marker I’ was loaded in a 
separate well for size discrimination. The 16S and 23S rRNAs were imaged using the gel 
documentation system (BioRad, USA) to estimate the quality of the RNA and as a loading 
control. 
 Subsequently, the separated RNA was transferred onto a positively charged nylon 
membrane by vacuum blotting for 90 minutes at a pressure of 5 bar in 10x SSC buffer. 
The RNA was linked to the membrane by exposure to UV-light using the UV-cross-linker 
(Stratagene, USA) 3 times at 120.000 microjules. Pre-hybridization, hybridization, 
membrane washing and immunological detection were performed using the “DIG 
Luminescent Detection Kit” (Roche, USA) according to the manufacturer’s instructions. 
The rovC Northern blot probe was synthesized by PCR using the Taq polymerase (NEB), 
DIG-labeled dNTPs and primer pair III286/IV91. The PCR reaction (100 µl in total) 
contained the following ingredients: 
 
10 x ThermoPol buffer  10 µl  
10x DIG DNA labeling Mix  10 µl 
Chromosomal DNA   3 µl 
MgCl2     5 µl 
Primer A (10 µM)   1 µl 
Primer B (10µM)   1 µl 
Taq polymerase (1U/µl)  1 µl 
H2Odest     69 µl 
 
The RNA transcripts hybridized with the DIG-labeled DNA probes were detected via 
chemiluminescence using CDP-Star (Roche, Germany). The membrane was incubated 
with the chemiluminescent substrate and subsequently exposed to X-ray films CL-
Xposure (Thermo Scientific, Germany).  
 
RNA loading dye: 0.03% bromphenol blue, 4 mM EDTA, 0.1 mg/ml EtBr, 2.7% formaldehyde, 31% 
formamide, 20% glycerol in 4x MOPS buffer 
20x MOPS buffer: 200 mM MOPS, 50 mM sodium acetate, 10 mM EDTA 
20x SSC buffer: 3M NaCl, 0.3 M sodiumcitrate pH 7.0 
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2.6.4 RNA stability assay  
To determine the stability of specific mRNA transcripts in different Y. pseudotuberculosis 
strains, transcription was stopped and the mRNA transcript levels were monitored. 
Transcription was stopped by addition of rifampicin that inhibits the activity of the DNA-
dependent RNA polymerase. 
 Bacterial cultures were grown in 20 to 30 ml LB medium to the desired growth 
phase, rifampicin in a final concentration of 1 mg/ml was added to stop transcription, and 
1.8 ml sample were taken and mixed with 0.2 ml stop-solution and snap-frozen in liquid 
nitrogen after 0, 2.5, 5, and 7.5 minutes after addition of rifampicin. The samples were 
purified as described in section 2.6.1. 
 In order to determine the RNA decay, the total amount of RNA in each sample was 
determined. For this the Northern blots were imaged using the ChemiDoc XRS+ imaging 
system (BioRad, USA). To further determine the half-life of the RNAs, the Northern blots 
were quantified via the ImageJ image processing software (Schneider et al., 2012). Then 
the mRNA amounts were calculated and normalized to the 16S rRNA and 23S rRNA 
amounts and were plotted on a half-logarithmic scale. The half-life of the transcripts was 
determined by applying a regression line. Each stability assay was performed at least in 
triplicates. 
 
Rifampicin: 20 mg/ml in methanol 
Stop solution: 5% phenol, 95% ethanol 
 
2.6.5 In vitro transcription-translation assay 
In order to analyze the effect of a certain protein of interest on translation efficiency, in 
vitro transcription-translation assays can be performed. To carry out the assay, a DNA 
fragment harboring a T7 promoter, the sequence of the gene of interest, and a terminator 
sequence was amplified by PCR using primer pair V773/VII836 and plasmid pVK01 as 
template. For PCR purification, 150 µl RNase-free water and 400 µl phenol-chloroform-
isoamylalcohol (PCI) for precipitation were added. By centrifugation at 12000 rpm for 5 
minutes at RT, the homogenate was separated into an aqueous and an organic phase. 
The upper (aqueous) phase was transferred to a new microcentifuge tube and 405 µl of 
100% ethanol and 45 µl of 3 M NaAc (pH 5.2) were added. The RNA was precipitated at  -
20°C for at least 30 minutes. Subsequently, the RNA was pelleted by centrifugation at 
12000 rpm for 30 minutes at 4°C and was then washed in 75% ethanol by centrifugation 
at 4°C for 15 minutes at 12000 rpm. The RNA pellet was dried and resuspended in 100 µl 
RNase-free water and stored at -20°C until use. The reaction was performed using the 
“PURExpress® In Vitro Protein Synthesis” kit (NEB), according to the manufacturer’s 
instructions. 
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Example reaction setup: 
Solution A    10 µl 
Solution B    7.5 µl 
Template RNA (2.5 µg)/ H2Odest. 2.5 µl 
CsrA protein/H2Odest.   5 µl 
 
100 nM of purified CsrA protein (see section 2.7.7) were incubated with the reaction 
mixture for 2 hours at 37°C. As controls, one reaction setup was incubated without protein 
and another reaction was incubated without DNA template. Subsequently, 5 µl of 4x SDS 
sample buffer were added to the samples. After boiling for 10 minutes at 95°C, the 
samples were separated on a 15% SDS gel and transferred onto a PVDF membrane (see 
section 2.7.3). Translated RovC protein was detected using the monoclonal RovC 
antibody. In order to check that equal amounts of protein sample were loaded into each 
well, the proteins on the membrane were stained with Ponceau S solution (Serva) after 
Western blotting. 
 
Ponceau S solution: 0.2% Ponceau S, 3% TCA 
 
2.6.6 qRT-PCR analysis 
In order to investigate the influence of specific factors on RNA transcript levels 
quantitative real time PCR was performed. All mRNA is reverse transcribed into 
complementary DNA (cDNA) and during the following PCR reaction of the target gene, a 
fluorescent dye (SYBR® Green) accumulates and is monitored during each PCR cycle 
that allows relative quantification (Bustin et al., 2005). For isolation of total RNA, the “SV 
total RNA isolation Kit” (Promega) was used (see section 2.6.1). To assure that the 
prepared RNA does not contain contaminating DNA a DNase digestion (240 µl in total) 
was performed. 
 
Example DNase digestion: 
RNA (50 µg)    200 µl 
Turbo-DNase (Ambion)  2 µl 
10x DNase buffer   24 µl 
Ribolock    0.5 µl 
H2Odest.    13.5 µl 
 
The DNase reaction mixture was incubated for 1 h at 37°C. Then the volume was 
adjusted to 300 µl and 300 µl phenol-chloroform-isoamylalcohol (PCI) were added and the 
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sample was vortexed for 15 seconds. The sample was separated into an organic and 
aqueous phase by centrifugation for 10 minutes at 14000 rpm and 4°C. The upper 
aqueous phase was transferred into a new collection tube and again 300 µl PCI were 
added. The sample was vortexed for 30 seconds and spun down for 3 minutes at 14000 
rpm and 4°C. Again, the aqueous phase was transferred into a fresh collection tube and 
the previous steps were repeated. Next, 1/10 volume (30 µl) of 3 M NaAc, pH 4.5 and 2.5 
volumes (750 µl) of 100% ethanol was added and the sample was mixed well. To 
precipitate the RNA, the sample was incubated for at least 1 h at -20°C. Subsequently, 
the RNA was pelleted by centrifugation for 20 minutes at 13000 rpm and 4°C and washed 
with 70% ethanol (500 µl) once. Finally, the pellet was dried and resuspended in 50 µl of 
RNase-free H2O. The samples were checked for DNA contamination by PCR. 
 For RT-PCR analysis the “SensiFast SYBR no-Rox One-step Kit” (Bioline) was 
used. A master mix was prepared for each primer pair in regard to a final reaction volume 
of 12.5 µl. The sopB gene was used as reference gene as it exhibits identical expression 
levels in the wild type and the tested mutants.  
 
Example qRT-PCR reaction mix (1 reaction) 
2x SensiFast SYBR no-ROX One-step mix  6.25 µl 
Primer Mix      1 µl 
RiboSafe RNase inhibitor    0.25 µl 
Reverse transcriptase    0.125 µl 
RNase-free H2O     2.375 µl 
RNA (25 ng/µl)     2.5 µl 
 
10 µl of each master mix were transferred to the qRT-PCR reaction tubes and 2.5 µl of 
RNA sample was added. For each primer pair a no-template control reaction containing 
RNase-free instead of RNA water instead of RNA sample and a control without the 
reverse transcriptase were prepared as control reactions. Reverse transcription and 
detection of the fluorescent labeled cDNA was carried out in the Rotor-Gene Q real-time 
PCR cycler (Qiagen, Germany) with the following 3-step cycling program: 
 
1. Reverse transcription  
1 x 45°C for 20 minutes 
2. Polymerase activation  
1x 95°C for 5 minutes 
3. 3-step cycling (40 cycles) 
Denaturation  95°C for 10 seconds 
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2mean CT wildtype geneX – mean CT mutant geneX 
 
2 mean CT wildtype sopB – mean CT mutant sopB 
 
Annealing   58°C for 20 seconds 
Elongation  72°C for 10 seconds 
Final Elongation   72°C for 10 minutes 
 
Gene specific primers are listed in table 2.11. 
 
 
Table 2.11: Oligonucleotides used for qRT-PCR 
Oligonucleotide Sequence (5'>3') Function 
III393 CCGACGTAAAGCCGCGATAC sopB (fw) 
III394 CCTCGTTCATAAGCACTCGTC sopB (rev) 
V647 ATGTATTTACGGCGTCTTTACGATC YPK_3548 (fw) 
V648 TTAGATGCTATCCGGCTGGTGG YPK_3548 (rev) 
V649 GCTCACCTTACGTGCCAGCGT YPK_3552 (fw) 
V650 CCGCATTATCGATCCACCCTATG YPK_3552 (rev) 
V651 CGGCCCAACTGGATGTGCTC YPK_3559 (fw) 
V652 CATGCAGATGGCGGCTTTGC YPK_3559 (rev) 
V653 CATCTTCGACATTATTTTTAACTGTC YPK_3566 (fw) 
V654 GTTCACAATGCAGTTGGTAACTC YPK_3566 (rev) 
VII248 CTAATGGAGGGGGTATACCCGATG YPK_3567 (fw) 
VII249 CTGAACGGTTACTTAATTTTAGTGACC YPK_3567 (rev) 
VII250 CGCGTGTTCAGAATGATTTTCCCAC YPK_3568 (fw) 
VII251 CCCGTGCAATATAGGTCTTCTTGGG YPK_3568 (rev) 
   
To determine the cycle threshold (CT) was set to 0.005 to determine the cycle threshold of 
the analyzed genes. The CT value defines the number of cycles that is required for a 
fluorescent signal to exceed the background fluorescence and indicates the expression of 
a gene. Relative transcript levels were calculated using the following formula, assuming 
an optimal primer efficiency of 2 (one duplication per cycle). 
 
 
Relative expression= 
  
 
 
2.7 Biochemical methods 
2.7.1 Preparation of whole cell extracts 
Whole cell extracts were analyzed for monitoring the amount of certain proteins under 
specific conditions and/or in different strains. The extracts were prepared from liquid 
overnight cultures. For this, the OD600 was measured and 1 ml of the bacterial culture was 
spun down at 13000 rpm for 1 minute at room temperature (RT). The pellet was 
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resuspended in the appropriate volume of 4x SDS sample buffer with an OD600 equivalent 
of 1. Next, the protein samples were denatured at 95°C for 5 minutes. The samples were 
stored at -20°C until use. Depending on the protein, 5 to 10 µl whole cell extract were 
applied to SDS-gels for separation. Whole cell extracts for western blotting were prepared 
from three independent cultures.  
 
4x SDS sample buffer: 1 M Tris-HCl, 20% Glyerin, 3% SDS, 8% β-mercaptoethanol, bromophenol blue, 
ddH2O 
 
2.7.2 SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is a biochemical 
technique for the separation of proteins in an electric field. The anionic detergent SDS 
gives proteins a negative charge and denatures them. Then the proteins are separated 
while running through the polyacrylamide-gel matrix from the (-) electrode to the 
(+) electrode. Proteins are separated by size since small proteins run faster through the 
matrix than larger proteins.  
 The samples were diluted in 4x SDS sample buffer and loaded onto the gel. The 
PageRulerTM Prestained Protein Ladder (Fermentas) was used for size determination of 
the proteins. In the electrophoresis chamber 25 mA per gel were applied. Subsequently, 
the gels were either stained with Coomassie brilliant blue or used for western blot 
analysis. 
 
Coomassie brilliant blue staining: 
Gels were stained for 30 to 60 minutes in Coomassie brilliant blue solution on a shaker. 
Coomassie-Brilliant-Blue G250 is a dye that stains the proteins by binding unspecifically to 
cationic and unpolar side chains of amino acids. The gel was washed with water until the 
protein bands were visible against the non-colored background.  
 
Coomassie brilliant blue: 60 mg/l Coomassie Brilliant Blue G250, 35 mM HCl 
 
2.7.3 Western blot analysis 
Western blot analysis is a technique used to transfer proteins from a gel onto a 
hydrophobic PVDF membrane via electro-blotting. Protein-specific antibodies are used for 
immunological detection, which in turn are recognized by secondary antibodies coupled to 
either alkaline phosphatase (AP) or horseradish peroxidase (HRP). This enzyme converts 
a chemical compound into a luminescent signal that can be detected by an imaging 
system. Western blotting was performed for 1 hour at 100 V. Subsequently, the 
membrane was blocked for 1 hour at room temperature or over night at 4°C on a shaker 
in TBST-M. Then, the membrane was incubated with the primary antibody (directed 
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against the protein of interest) in TBST-M for 1 hour while shaking. The membrane was 
washed three times for 10 min in TBST to remove residual antibody. Next, the membrane 
was incubated with the secondary antibody (directed against the primary antibody) diluted 
in TBST for 1 hour. Finally, the membrane was washed three times for 10 min in TBST 
and developed by use of the “Western Lightning ECL II Kit”. The signal was documented 
using the ChemiDoc XRS+ (BioRad, USA) or via exposure to X-ray films CL-Xposure 
(Thermo Scientific, USA). 
 
TBST: 20 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.05% TWEEN-20 
TBST-M: 20 mM Tris/HCl pH 7.5, 150 mM NaCl, 0.05% TWEEN, 12,5% non-fat dry milk 
 
2.7.4 Purification of unspecific antibodies 
Purification of unspecific antiserum is often required when an antibody detects various 
unspecific signals besides the signal of interest. For purification, a 20 ml bacterial culture 
inoculated with a mutant strain lacking the desired protein was incubated over night. Then 
the culture was pelleted at 8000 rpm for 10 minutes at RT and the pellet was washed 
once with 20 ml of 0.9% NaCl. Subsequently, the pellet was resuspended in 5 ml transblot 
buffer and incubated for 5 minutes at RT on a shaker, followed by centrifugation for 5 
minutes at 8000 rpm and RT. Next, the pellet was resuspended in 1 ml transblot buffer, 
centrifuged again and 1 ml chloroform was added. The pellet was vortexed for 15 seconds 
and centrifuged once more. Then, the white substance on the surface was transferred into 
a new collection tube and washed twice with 0.9% NaCl. Finally, the pellet was incubated 
with 200 µl of antiserum for 10 minutes at 37°C. Following another centrifugation step, the 
supernatant containing the serum was transferred into a new collection tube and was 
stored at 4°C. 
 
Transblot buffer: 15.6 mM Tris-HCl pH8.3, 120 mM glycerol, 20% methanol, 0.002% SDS 
 
2.7.5 β-galactosidase activity assay 
The lacZ reporter system is a biochemical method to analyze gene expression. The lacZ 
gene encodes the enzyme β-galactosidase, which recognizes the synthetic compound o-
nitrophenyl-β-D-galactosidase (ONPG) as a substrate and cleaves it into β-galactosidase 
and the yellow-colored substrate o-nitrophenyl. The intensity of the color correlates to the 
enzyme concentration and this correlates with the activity of the gene of interest. In order 
to perform a β-galactosidase assay, Y. pseudotuberculosis strains carrying the lacZ 
reporter fusion of interest, were grown overnight for 16 hours at 25°C. Next day, the 
overnight cultures were diluted 1:10 in LBBD medium and the OD600 was measured. 
Subsequently, 200 µl of cells were taken directly from the cuvette and filled into glass 
tubes. For cell lysis 50 µl of 0.1% SDS and 50 µl of chloroform were added, mixed 
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properly and incubated at room temperature (RT) for 10 minutes. Then, 1.8 ml 1x Z-buffer 
were added and the reaction was started by adding 400 µl of ONPG. When the samples 
were colored to a sufficient extent, the reaction was stopped by addition of 1 ml of 1 M 
NaCO3 and the reaction time was documented. 200 µl were transferred to a microwell 
plate and the absorbance was measured at 415 nm in an Elisa reader (BioRad, USA). 
The β-galactosidase activity was calculated using the following formula: 
 
 
β-galactosidase activity =   
 
OD415  optical density of sample after reaction 
6.75  extinction coefficient of cleaved ONPG in µmol/min/mg protein 
OD600  optical density of bacterial culture 
V  used culture volume in ml 
t  reaction time in minutes 
 
1x Z-buffer: 8.53 g Na2HPO4, 5.5 g NaH2PO4 * 8 H2O, 0.75 g KCl, 0.246 g MgSO4 * 7 H2O, pH 7 
 
2.7.6 Protein stability assay 
To investigate the degradation of proteins over a certain period of time, protein stability 
assays can be carried out in vivo. For this Y. pseudotuberculosis cultures were grown 
over night in 20 ml LB medium (with the required antibiotic) at 25°C and 200 rpm. Next 
day, protein expression of the cultures was induced by addition of 0.1% arabinose. The 
cultures were incubated for 5 hours at 25°C and 200 rpm, and then protein expression 
was stopped by adding chloramphenicol (200 µg/µl) to the media. Samples were taken 
after the following time points: 0, 30, 60, 90, 120, and 180 minutes. Two ml culture were 
taken at each time point, one ml to determine the optical density of the culture and one 
was prepared for SDS-PAGE and Western blotting (see section 2.7.1).  
 
2.7.7 Protein secretion assay 
Secretion systems are complex systems used by bacteria in order to secrete or 
translocate proteins into neighboring cells. For analysis of protein secretion, 25 ml of LBBD 
medium were inoculated 1:50 from a Y. pseudotuberculosis overnight culture of the 
desired strain. The cultures were grown for 6 hours at 25°C to early stationary phase 
(OD600 = 2). Then the cells were adjusted to an equal OD600 and 18 ml were spun down 
for 10 minutes at 9000 rpm. Next, the supernatant was filtered using a 0.2 µm filter 
(Millipore, USA) and 2 ml (1/10 volume) of 100% TCA (trichloracetic acid) were added for 
protein precipitation. After incubation for 20 to 30 minutes on ice, the proteins were spun 
down by centrifugation at 4°C for 10 minutes at 12500 rpm. The pellet was resuspended 
in 2 ml acetone-SDS solution (1.75 ml 100% acetone and 0.25 ml 2% SDS) and incubated 
OD415nm *6.75 
OD600nm*t*V 
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on ice for 20 minutes. Following another centrifugation step, the pellet was washed in 500 
µl 100% acetone and was centrifuged again. Finally, the pellet was dried, resuspended in 
50 µl 4xSDS sample buffer and boiled for 10 minutes at 95°C. The samples were loaded 
onto 15% SDS polyacrylamide gels and secreted 3xFLAG-Hcp protein was detected via 
Western blot using a monoclonal anti FLAG antibody. 
 
2.7.8 Cell viability assay 
The number of viable cells in the bacterial cultures used for the protein secretion assay 
was determined in order to exclude that detected proteins in the supernatant are a result 
of cell lysis. Cell viability can be monitored by quantification of the ATP present in the 
culture, as ATP is an indicator of metabolically active bacteria. For this, the “BacTiter-
Glo™ Microbial Cell Viability Assay” kit (Promega, USA) was used. 100 µl of the desired 
bacterial culture were transferred to a 96 well plate in duplicates and was mixed with an 
equal volume of BacTiter-Glo™ Reagent and incubated in the dark for 5 minutes. Growth 
media (LBBD) without bacteria was used as control. Then the luminescence units were 
recorded using the Varioscan Flash and SkanIt RE software (Thermo Scientific). 
 
2.7.9 Overexpression of proteins 
Heterologous protein expression is a method used to express recombinant proteins in 
bacteria fast and efficiently. The gene of interest is introduced into an expression vector 
and modified with a hexa-histidin-tag (6 histidin residues), either at the C- or N- terminal 
end. Proteins modified with a His-tag can be purified via Nickel-NTA-affinity 
chromatography. The expression vectors have an inducible promoter. In this study, the 
expression vector pET28(a)+ was used for overexpression of CsrA (pAKH172). 0.5 mM 
IPTG (Isopropyl-β-D-thiogalactopyranosid) was used to induce transcription of the 
inducible promoter. The inducible T7 promoter is recognized by the T7 polymerase 
encoded in the chromosome of the E. coli strain BL21λDE3. 
 For CsrA overexpression, 100 ml of DYT growth medium containing the respective 
antibiotic, were inoculated 1:100 from an overnight culture and incubated for 2 hours at 
37°C. At an OD600 ranging from 0.6 to 0.8, protein expression was induced by adding 0.5 
M IPTG for 3 hours at 37°C. The cells were harvested by centrifugation at 6000 rpm at 
4°C and pellets were stored at -20°C until use. 
 The frozen cell pellet containing the protein of interest was resuspended in 10 ml 
ice-cold lysis buffer supplemented with 1 EDTA-free protease tablet and 4 µl of 
benzonase. Subsequently, the cells were lysed with a French pressure cell 
(G. Heinemann, Germany). The bacterial lysates were cleared by centrifugation at 14000 
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rpm for 30 minutes at 4°C. The supernatant containing the protein extract was transferred 
to a falcon tube and purified via Ni-NTA affinity chromatography (2.7.10). 
 
2.7.10 Protein purification via Ni-NTA affinity chromatography 
Ni-NTA affinity chromatography is a technique used to purify proteins containing 6x His-
tags. Separation of a target protein from a protein mixture is dependent on the binding 
properties of the target protein towards the ligand (nickel), which is immobilized to a NTA-
matrix (nitrilo-triacetate). Target proteins coupled to 6x His-tags are able to bind to the 
ligand via their tags. After removing unbound proteins by several washing steps, the target 
protein is eluted by displacing through the additional binding partner imidazole.  
Gravity flow columns were loaded with 500 µl Ni-NTA-Superflow (Qiagen, Hilden) and 
were equilibrated with 10 ml lysis buffer. Afterwards, the protein extract was applied to the 
column to allow binding of the fusion protein. Unbound proteins were removed by washing 
the Ni-NTA matrix two times with 10 ml washing buffer. Elution buffer was added to elute 
the target protein. Six fractions containing 500 µl were collected in microcentrifuge tubes. 
The protein purification was verified by SDS-PAGE and protein concentrations were 
determined as described in section 2.6.9. 
 
CsrA lysis buffer: 0.1 M Tris-HCl, 0.3 M NaCl, 20 mM imidazole 
CsrA wash buffer: 0.1 M Tris-HCl, 0.3 M NaCl, 40 mM imidazole 
CsrA elution buffer: 0.1 M Tris-HCl, 0.3 M NaCl, 250 mM imidazole 
 
2.7.11 Determination of protein concentration 
To determine the protein concentration the Bradford assay was applied. The dye 
Coomassie-Brilliant-Blue G250 was used to form colored dye-protein complexes. In an 
acidic environment, it binds unspecifically to cationic and unpolar hydrophobic side chains 
of amino acids. Complex formation leads to a shift of the absorption maximum of the dye 
from λ = 465 nm to λ = 595 nm. By measuring the extinction of bovine serum albumin 
(BSA) of known concentrations (20 – 1000 μg/ml in H2O dest.), a calibration curve was 
determined and was used to calculate the protein concentration. 250 µl Bradford reagent 
were mixed with 5 µl of protein sample or the protein buffer as blank. The OD was 
measured at 595 nm and the protein concentration was calculated by means of a 
calibration curve. Another method to determine protein concentrations is the 
measurement by a nanodrop at 280 nm using the default settings – E 0.1% (1 mg/ml). 
Spectrophotometric determination of protein concentration depends on Beer Lambert ́s 
law, which gives the relation between the absorption of light and the amount of absorbing 
substance present. Protein concentrations obtained by measurement at the Nanodrop 
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were divided by the absorbance (0.1% = 1 g/l), which was obtained from EXPASY and is 
calculated as mass extinction coefficient/molecular weight (Wilkins et al., 1999). 
  
2.7.12 Electrophoretic mobility assays (EMSA) with RNA 
Electrophoretic mobility shift assay is a method used to analyze interactions between DNA 
or RNA and proteins. Migration of DNA/RNA in the gel matrix differs visibly from migration 
of DNA-protein or RNA-protein complexes. For RNA band shifts, CsrA protein was 
overexpressed and purified as described in sections 2.7.7 and 2.7.8 and was dialyzed in 
1x band shift buffer. The genomic region of interest was amplified by PCR and 
subsequently in vitro transcribed according to the “TranscriptAidTM T7 High Yield 
Transcription Kit” (Fermentas). The in vitro transcription was conducted for 2 hours at 
37°C. 
 
Example reaction of an in vitro transcription (20 µl): 
5x TranscriptAidTM reaction buffer  4 µl 
ATP/CTP/GTP/UTP mix   8 µl 
Template DNA    6 µl 
TranscriptAidTM enzyme mix   2 µl 
 
2 µl of DNase I were added to the in vitro transcription mix for 15 minutes at 37°C to 
digest the DNA template. The DNase was inactivated by adding 2 µl of 0.5 M EDTA to the 
in vitro transcription mix for 10 minutes at 65°C. For RNA purification, 150 µl RNase-free 
water was added and 400 µl phenol-chloroform-isoamylalcohol (PCI) for precipitation. The 
homogenate was separated into an aqueous and an organic phase by centrifugation at 
12000 rpm for 5 minutes at RT. The upper (aqueous) phase was transferred to a new 
microcentifuge tube and 400 µl chloroform-isoamylalcohol (CI) were added and the 
sample was mixed. Following another centrifugation step, the upper phase was 
transferred into a new microcentifuge tube and 405 µl of 100% ethanol and 45 µl of 3 M 
NaAc (pH 5.2) were added. The RNA was precipitated at  -80°C for at least 30 minutes. 
Subsequently, the RNA was pelleted by centrifugation at 12000 rpm for 30 minutes at 4°C 
and was then washed in 75% ethanol by centrifugation at 4°C for 15 minutes at 12000 
rpm. The RNA pellet was dried and resuspended in 100 µl RNase-free water and stored 
at -20°C until use. 
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5’ Dephosphorylation of RNA: 
In order to radioactively label RNA fragments, the unlabeled 5’ phosphate has to be 
removed. For this, the RNA samples were incubated for 30 minutes at 800 rpm with calf 
intestinal alkaline phosphatase (CIP). 
 
Example setup for dephosphorylation (50 µl): 
10x CutSmart buffer    5 µl 
RNA (1 µg)    20 µl 
CIP (10 U)    1 µl 
H2Odest.    24 µl 
 
After incubation, the RNA samples were purified as described above in this section. All 
samples were eluted in 20 µl RNase-free water and the RNA concentration and purity was 
determined (section 2.6.2). 
 Next, the labeling reaction was prepared in 1.5 ml safe-seal microcentrifuge tubes. 
For 5’ labeling, the dephosphorylated RNA samples were incubated for 1 hour at 37°C 
with radioactive γ-P32-Adenosine 5’triphosphate (ATP) (SRP-301; Hartmann Analytik, 
Braunschweig). The 5’ phosphorylation reaction is catalyzed by the enzyme 
polynucleotide kinase (PNK). 
 
Example labeling reaction (10 µl) 
10x PNK buffer A   1 µl 
RNA (200 ng)    x µl 
PNK (10 U)    1 µl 
γ-P32-ATP (10 µCi)   3 µl 
H2Odest.    x µl 
 
The reaction was stopped by addition of 40 µl STE buffer. Subsequently, the labeled RNA 
samples were purified using the “RNA Clean & Concentrator™-5” kit (Zymo Research, 
USA) according to the manufacturer’s instructions. The samples were eluted in 20 µl 
RNase-free water. 
 The protein concentration was determined (as described in section 2.7.11) prior to 
each band shift experiment. Protein dilutions were prepared in 1x band shift buffer, 
yielding final concentrations ranging from 0.5 to 250 nM protein. The RNA concentration 
was adjusted to a final concentration of 2 nM per reaction in 1x band shift buffer. 
Subsequently, the RNA was denatured at 70°C for 10 minutes and cooled down on ice for 
5 minutes. For binding, 5 µl of RNA were mixed with 5 µl of protein and incubated on ice 
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for 20 minutes. Afterwards, the samples were loaded onto a 4% TBE gel and separated 
for 45 minutes at 80 V in 1x TBE running buffer. Then the gels were dried for 60 min on a 
gel-dryer at 80°C and were cooled down for additional 30 minutes. Subsequently, the 
samples on the gels were exposed to a phosphor screen overnight. The radiogram was 
detected using the Typhoon™ FLA 9000 (GE Healthcare). 
 
RNA bandshift buffer: 20 mM Na2HPO4 pH 8.0, 20 mM NaH2PO4 pH 8.0, 100 mM KCl, 2 mM DTT, 5% 
glycerol 
STE buffer (pH 7.5): 100 mM NaCl, 20 mM Tris-HCl pH 8.0, 10 mM EDTA pH 8.0 
1x TBE: 10.8 g Tris, 5.5 g boric acid, 4 ml 0.5 M EDTA pH 8.0 
 
2.7.13 Electrophoretic mobility shift assay (EMSA) with DNA 
In order to monitor DNA-protein interactions, all purified RovC proteins (kindly provided by 
Pooja Sadana) were diluted in 1x band shift buffer, yielding final concentrations from 1.95 
to 250 nM (67 to 288 ng). The genomic region of interest was amplified by PCR and 
purified afterwards. The DNA concentration was determined as described in section 2.3.5. 
The DNA concentration was adjusted to a final concentration of 130 fmol per reaction. 12 
µl of DNA were incubated with 8 µl of protein for 30 minutes at RT. Samples were loaded 
onto a 4% TBE gels and separated for 1 hour at 90 V in 1x TBE running buffer. DNA-
protein complexes in the gel were stained in ethidium bromide and visualized under UV-
light. 
 
1x DNA band shift buffer: 10 mM HEPES pH 7.4, 40 mM NaCl, 5 mM DTT, 5% glycerol, 1 mM MgCl2, 0.1 
mg/ml BSA 
4% TBE gel: 0.5 ml 10x TBE, 1 ml 40% polyacrylamide, 240 µl rhinohide, 16 µl TEMED, 66 µl 10% APS, 8.2 
ml H2Odest. 
 
2.7.14 DNase I Footprint assay 
To determine the exact binding region of RovC in the T6SS4 promoter region, a DNase I 
footprint assay was performed. In order to do so the T6SS4 upstream region was 
amplified with primer VI826 (sense) DIG-labeled and primer IV735 (antisense) using 
plasmid pSSE64 as template. The DIG-labeled T6SS4 DNA was incubated with 
increasing concentrations of purified RovC protein (concentrations ranging from 255 ng to 
3 µg) for 30 minutes at RT in band shift buffer (see section 2.7.11). The reaction mixture 
was incubated with an appropriate DNase I concentration (1:8 dilution) for exactly 20 
seconds and stopped by addition of 50 µl DNase I stop solution. For DNA extraction 50 µl 
PCI were added and the samples were vortexed for 20 seconds. Then the samples were 
centrifuged for 10 min at 13000 rpm at 4°C. The aqueous phase was transferred to a new 
collection tube and 25 µl of ammonium acetate were added and mixed with the samples. 
Next, 2 µl glycogen and 300 µl 100% ethanol were added and the samples were 
incubated at -20°C for precipitation for at least 30 min. Subsequently, the DNA was 
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pelleted by centrifugation for 20 minutes at 13000 rpm and 4°C and washed in 500 µl 70% 
ethanol. After drying, the pellets were resuspended in 5 µl stop solution and boiled for 3 
minutes at 85°C. 
 
Sequencing reaction: 
For the sequencing reaction, a DNA template (plasmid pSSE64) harboring the complete 
sequence of interest was used. PCR reaction tubes containing 4 µl of each ddNTP (G, A, 
T and C) were prepared and the following master mix was added (final volume 17.5 µl): 
 
Plasmid DNA (1 µg)    x µl 
DIG-labeled primer (15.3 nmol)  1µl 
Reaction buffer (usb kit)   2 µl 
Thermo sequence DNA polymerase  2 µl 
H2Odest.     x µl 
 
2 µl of the master mix were added to the ddNTPs, mixed well and transferred into a 
Thermocycler (40 cycles): 
 
1. Initial denaturation  95°C for 3 minutes 
2. Denaturation   95°C for 30 seconds 
3. Annealing   60°C for 40 seconds 
4. Elongation   72°C for 40 seconds 
5. Final Elongation  72°C for 4 minutes 
 
Finally, 4 µl of stop solution were added and mixed and the reactions were boiled at 75°C 
for 2 minutes prior to loading. 
 
Sequencing gel: 
The samples and the sequencing reaction were separated on a 6% urea gel: 
7 M urea   42 g 
10 TBE   10 ml 
40% acrylamide  15 ml 
10% APS   500 µl 
TEMED   50 µl 
H2Odest.   Fill up to 100 ml 
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After loading, the samples were separated for 2.5 h at 3000 V and 60 W in 1x TBE buffer. 
Subsequently, the gel was transferred to a positively charged nylon membrane via 
capillary blotting for 1.5 hours at RT and the samples were UV-linked to the membrane by 
cross-linking. Then the samples were detected using CDP-Star (Roche, Germany) 
according to the manufacturer’s instructions. Finally, the membrane was incubated with 
the chemiluminescent substrate and subsequently exposed to X-ray films CL-Xposure 
(Thermo Scientific, Germany).  
 
DNaseI stop solution: 15 mM EDTA, 10 µl/ml yeast carrier tRNA 
Stop solution: 95% formamide, 20 mM EDTA, 0.05% bromphenol blue, 0.05% xylene cyanol 
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3 Results 
The initial colonization of the host gastrointestinal tract of the host by 
Y. pseudotuberculosis is mediated mainly by the outer-membrane protein invasin. This 
protein allows tight binding of Yersinia to the M-cells and eventually leads to uptake of the 
bacteria (Marra & Isberg, 1997). The expression of this crucial virulence factor is 
dependent on temperature and strictly controlled by the transcriptional regulator RovA. 
RovA and, consequently, invasin are part of a complex regulatory network consisting of 
the LysR-type regulator RovM, the nucleoid-associated protein H-NS, the cAMP receptor 
protein Crp, the TCS BarA/UvrY and the post-transcriptional Csr (carbon storage 
regulator) system. This regulatory network responds to different environmental cues such 
as temperature and nutrient availability (Heroven et al., 2012). Recently, microarray data 
revealed a link between the global carbon storage regulator system and the type VI 
secretion system operon 4 (T6SS4) of Y. pseudotuberculosis (Bücker et al., 2014). CsrA 
negatively regulated all genes belonging to the T6SS4 operon. In addition, it was reported 
that the newly discovered T6SS4 regulator RovC is also controlled by CsrA (Bücker et al., 
2014; Seekircher, 2014).   
 
3.1 RovC is a novel CsrA-controlled regulator of Y. pseudotuberculosis 
Previous studies identified the new regulator RovC (YPK_3567) in Y. pseudotuberculosis 
to be a repressor of the small non-coding RNA CsrC. RovC is a protein exclusively 
present in the closely related strains Y. pseudotuberculosis and Y. pestis (Seekircher, 
2014). Recent data show that RovC has its highest expression at 25°C in stationary 
growth phase and that synthesis of this protein is controlled by global virulence 
determinants such as Crp and CsrA, linking RovC to early-stage virulence gene 
expression. In addition, previous studies revealed that RovC positively affects the 
expression of the T6SS4 (Seekircher, 2014; Knittel, 2015). In order to examine the effect 
of RovC on T6SS4 expression and to investigate the role of CsrA in rovC and T6SS4 
regulation further experiments were performed in this work. 
 
3.1.1 CsrA represses expression of the T6SS4 of Y. pseudotuberculosis 
CsrA controls a great number of genes in Yersinia and was recently implicated in the 
regulation of the T6SS4 operon of the Y. pseudotuberculosis strain YPIII (Seekircher, 
2014). In order to test the effect of CsrA on the expression of the T6SS operon 4, three 
genes were selected (YPK_3552, YPK_3559 and YPK_3566) and analyzed by qRT-PCR 
using total RNA from the Y. pseudotuberculosis wild type strain YPIII and the ∆csrA 
mutant strain. To see whether CsrA specifically affects T6SS4 expression, genes located 
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upstream and downstream of the operon (YPK_3548, YPK_3567 and YPK_3568) were 
also monitored by qRT-PCR. YPK_3567 encodes the newly identified T6SS4 regulator 
RovC and, therefore, it was interesting to analyze a possible CsrA-mediated regulation of 
RovC. Expression of the three genes belonging to the T6SS4 was strongly upregulated in 
the absence of CsrA, confirming the results obtained from previous studies. An even more 
pronounced CsrA-dependency was observed for the rovC gene that is strongly repressed 
by CsrA (Figure 3.1 A). To further validate these results, expression of a translational 
T6SS4’-‘lacZ reporter fusion between the wild type and the ∆csrA mutant strain was 
compared. Expression of the T6SS4’-‘lacZ reporter fusion was significantly upregulated in 
the ∆csrA strain in comparison to the wild type. This effect could be fully compensated by 
in trans complementation with a CsrA+ overexpression plasmid (Figure 3.1 B). 
Consequently, the β-galactosidase reporter assay showed that CsrA represses the 
expression of the T6SS4 operon and confirms the obtained qRT-PCR data. 
 
Figure 3.1: Expression of the T6SS4 operon and rovC is repressed by CsrA. 
(A) To verify the results from the microarray, one-step qRT-PCR was performed with primer pairs specific for 
selected genes of the T6SS4 operon and genes upstream and downstream of the T6SS cluster. RNA was 
isolated from at least three independent cultures of the Y. pseudotuberculosis wild type strain (YPIII) and the 
ΔcsrA mutant strain (YP53). Gene expression levels were normalized to the sopB reference transcript for the 
wild type and the ΔcsrA strain respectively, and are given as relative expression of each gene in relation to 
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sopB. The data represent the mean ± standard deviation of three independent experiments carried out in 
duplicate. (B) Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) was monitored in the wild 
type strain (YPIII) and the ΔcsrA mutant strain (YP53) in order to confirm the qRT-PCR results. Both strains 
were transformed with the empty vector pAKH85 (pV) and complemented with the csrA+ plasmid pAKH56 
(pcsrA+). β-galactosidase activity (µmol/mgmin) was measured in strains grown over night for 16 hours at 
25°C in LB medium. The data represent the mean ± standard deviation of three independent experiments, 
carried out in triplicates. Data were analyzed by Student’s t-test. Asterisks indicate results differing 
significantly from each other (****P<0.0001; *P<0.05). 
  
3.1.1.1 CsrA-mediated regulation of the T6SS4 operon occurs via RovC 
The qRT-PCR indicated that not only expression of the T6SS4 but also expression of 
RovC strongly depends on the presence of CsrA. Since RovC was previously described to 
positively affect T6SS4 expression, the role of RovC was further analyzed. Moreover, the 
importance of both regulators (RovC and CsrA) regarding T6SS4 expression was 
assessed. For this, expression of the translational T6SS4’-‘lacZ reporter fusion was 
monitored in the Y. pseudotuberculosis wild type strain, the ∆csrA mutant, the ∆rovC 
mutant and the ∆csrA/∆rovC double mutant strain. Expression of the reporter fusion was 
again strongly elevated in the ∆csrA strain compared to the wild type. In the ∆rovC mutant 
strain, expression of the reporter fusion was significantly downregulated in contrast to the 
wild type and this effect could not be restored by deletion of csrA. The ∆csrA∆rovC double 
mutant strain did not exert the same strong induction of T6SS4’-‘lacZ expression as 
observed in the ∆csrA single mutant (Figure 3.2). In conclusion, activation of T6SS4’-‘lacZ 
expression requires the presence of functional RovC protein. Expression of RovC seems 
to be repressed by CsrA and RovC in turn has an activating function in T6SS4 regulation. 
 
Figure 3.2: CsrA represses the expression of the T6SS via rovC.  
To analyze the role of rovC in T6SS4 regulation, expression of a translational T6SS4’-‘lacZ reporter fusion 
(pSSE64) was measured in the Y. pseudotuberculosis wild type strain (YPIII), the ΔcsrA mutant strain (YP53), 
the ΔrovC mutant strain (YP148) and the ΔcsrA/ΔrovC double mutant strain (YP318). β-galactosidase activity 
(µmol/mgmin) was measured in strains grown over night for 16 hours at 25°C in LB medium. The data 
represent the mean ± standard deviation of three independent experiments, carried out in triplicates. Data 
were analyzed by Student’s t-test. Asterisks indicate results differing significantly from each other 
(****P<0.0001). 
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3.1.1.2 RovC strongly induces expression of the T6SS4 
A positive effect of RovC on the T6SS4 operon was already described in a previous study 
(Seekircher, 2014). qRT-PCR data of that work showed significant downregulation of the 
tested T6SS4 genes in a strain lacking the rovC gene (Seekircher, 2014). The putative 
inducing effect of RovC on T6SS4’-‘lacZ expression observed above was analyzed in 
more detail by monitoring the reporter fusion in the wild type and the rovC deficient strain. 
Upon overexpression or complementation with a RovC+ plasmid under the control of its 
natural promoter, both strains showed significantly elevated T6SS4’-‘lacZ expression 
levels in the β-galactosidase assay (Figure 3.3). This confirms that RovC is a novel 
activator of T6SS4 expression in Y. pseudotuberculosis. 
 
Figure 3.3: RovC overexpression induces expression of the T6SS4. 
Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) was monitored in the 
Y. pseudotuberculosis wild type strain (YPIII) and the ΔrovC mutant strain (YP148). Both strains were 
transformed with the empty vector pACYC184 (pV) and complemented with the rovC+ plasmid pSSE11 
(provC::rovC+). β-galactosidase activity (µmol/mgmin) was measured in strains grown over night for 16 hours 
at 25°C in LB medium. The data represent the mean ± standard deviation of three independent experiments, 
carried out in triplicates. Data were analyzed by Student’s t-test. Asterisks indicate results differing 
significantly from each other (****P<0.0001; ***P<0.001). 
 
3.1.2 CsrA represses transcription of rovC 
Recent studies revealed a connection between RovC and the Csr system and indicated a 
repressive effect on rovC expression mediated by the global regulators Crp and CsrA 
(Seekircher, 2014; Knittel, 2015). Although CsrA is known to be a post-transcriptional 
regulator, the effect of CsrA on transcription of rovC was investigated. Firstly, the rovC 
transcript levels in the Y. pseudotuberculosis wild type and the csrA mutant were 
compared by Northern blotting. The rovC transcript levels were highly increased in the 
∆csrA mutant strain in comparison to the wild type (Figure 3.4 A). In addition, the 
expression of a transcriptional rovC’-‘lacZ reporter fusion was monitored in the wild type 
and the ∆csrA mutant strain. The rovC’-‘lacZ reporter fusion harbored the complete 
upstream region of the rovC gene ranging from -579 nt to +1 nt relative to the 
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transcriptional start site (Figure 3.4. B). The reporter fusion exhibited significantly higher 
expression levels in the csrA deficient strain compared to the wild type. Further, rovC 
expression could be complemented upon CsrA overexpression (Figure 3.4. C). Since 
CsrA is a post-transcriptional regulator that controls stability and/or translation of mRNAs 
(Romeo et al., 2013), the observed effect has to occur indirectly via another regulator. 
 
Figure 3.4: CsrA significantly represses transcription of rovC. 
(A) The rovC transcript levels were analyzed in the Y. pseudotuberculosis wild type strain (YPIII) and the 
ΔcsrA mutant strain (YP53) by Northern blotting. Strains were grown in LB medium over night for 16 hours. 
Total RNA was isolated and separated on a 1.2% MOPS gel, transferred onto a nylon membrane and probed 
with a digoxigenin (DIG)-labeled rovC encoding PCR-fragment. 16S and 23S rRNAs were used as loading 
control. The ΔrovC mutant strain (YP148) was used as negative control. (B) Schematic representation of the 
transcriptional rovC-lacZ reporter fusion, representing the rovC upstream region (-579 to the TSS (+1)) 
encoded on the reporter plasmid and the RBS of the lacZ reporter gene. (C) Expression of a transcriptional 
rovC-lacZ reporter fusion (pAKH189) was measured in the Y. pseudotuberculosis wild type strain (YPIII) and 
the ΔcsrA mutant strain (YP53). Both strains were transformed with the empty vector pAKH85 (pV) and 
complemented with the csrA+ plasmid pAKH56 (pcsrA+). β-galactosidase activity (µmol/mgmin) was 
measured in strains grown over night for 16 hours at 25°C in LB medium. The data represent the mean ± 
standard deviation of three independent experiments, carried out in triplicates. Data were analyzed by 
Student’s t-test. Asterisks indicate results differing significantly from each other (****P<0.0001). 
  
3.1.3 Post-transcriptional effects of CsrA on rovC expression 
Since post-transcriptional regulation by the Csr system was described for various 
transcripts in other bacteria, analysis of CsrA-dependent regulation of rovC on the post-
transcriptional level was another aim of this work. The transcriptional start site (TSS) of 
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the rovC gene was mapped in previous studies by in vitro transcriptome analysis and 
validated by primer extension. The rovC TSS was found to be located 39 nucleotides 
upstream of the rovC coding region (Nuss et al., 2015; Knittel, 2015). 
 In order to exclude the negative regulatory effects CsrA exerts on rovC 
transcription, all experiments investigating the post-transcriptional regulation of rovC were 
performed in the ∆rovC strain transformed with an inducible pPBAD::rovC+ plasmid (see 
Figure 3.5 A). This plasmid harbors the complete rovC 5’UTR, but not the CsrA-controlled 
rovC promoter- and upstream region. Hence, by using this plasmid, post-transcriptional 
effects could be monitored exclusively. To analyze the post-transcriptional effect of CsrA 
on rovC expression, the amounts of RovC protein synthesized from the inducible 
pPBAD::rovC+ plasmid, were compared between the ∆rovC mutant and the ∆csrA/∆rovC 
double mutant strain. Surprisingly, CsrA exerted a positive effect on RovC protein 
synthesis as more RovC protein was detectable in the ∆rovC pPBAD::rovC+ strain 
compared to the csrA deficient strain (Figure 3.5 B). This effect was confirmed by 
monitoring the expression of a translational rovC’-‘lacZ reporter fusion in the wild type and 
the csrA mutant strain. Expression levels in the wild type were significantly elevated in 
comparison to the ∆csrA deficient strain and could be complemented to wild type levels 
upon overexpression (Figure 3.5 C). Consequently, CsrA exhibits a positive effect on 
RovC expression on the post-transcriptional level.  
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Figure 3.5: RovC protein synthesis is induced in the presence of CsrA. 
(A) Schematic representation of the inducible RovC+ plasmid. The plasmid harbors the arabinose inducible 
Para promoter, the complete rovC 5’UTR (-39 to +1 relative to the transcriptional start site) and the rovC coding 
sequence. (B) RovC protein amounts were monitored in the Y. pseudotuberculosis ΔrovC mutant strain 
(YP154) and the ΔcsrAΔrovC double mutant strain (YP318). Both strains were transformed with the empty 
vector pBAD30 (pV) or the inducible rovC+ overexpression plasmid pVK25 (pPBAD::rovC+). The promoter was 
induced by addition of 0.1% arabinose. Whole cell extracts were prepared from strains grown over night at 
25°C for 16 hours, separated on 15% SDS gels and transferred onto a PVDF membrane. Proteins were 
detected by immunoblotting using a monoclonal RovC antibody. The ∆rovC mutant strain served as negative 
control and a detected unspecific band was used as loading control. (C) Expression of a translational rovC’-
‘lacZ reporter fusion (pVK43) was monitored in the Y. pseudotuberculosis wild type strain (YPIII) and the 
ΔcsrA mutant strain (YP53). Both strains were transformed with the empty vector pAKH85 (pV) and 
complemented with the csrA+ plasmid pAKH56 (pcsrA+). β-galactosidase activity (µmol/mgmin) was 
measured in strains grown over night for 16 hours at 25°C in LB medium. The data represent the mean ± 
standard deviation of three independent experiments, carried out in triplicates. Data were analyzed by 
Student’s t-test. Asterisks indicate results differing significantly from each other (****P<0.0001). 
  
 To further investigate post-transcriptional regulation of rovC by CsrA, the rovC 
5’UTR was analyzed in more detail. CsrA homodimers preferentially bind to 5'- 
A/UCANGGANGU/A-3' (N = any nucleotide) RNA consensus sequences. These 
consensus sequences are generally located in the 5’UTR of the target transcript and 
contain GGA-motifs with an ideal spacing of 10 to 63 nucleotides (Schubert et al., 2007). 
Interestingly, three putative CsrA binding motifs (GGA-motifs) were found to be located 
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nt to +1 nt), one in close proximity to the TSS (+1) and the other in the Shine-Dalgarno 
sequence. In addition, a third GGA-motif is located within the beginning of the rovC coding 
sequence (+32 nt relative to the RovCAUG) (Figure 3.6. A).  
 In order to see whether CsrA binds to the rovC mRNA transcript, electrophoretic 
mobility shift assays (EMSAs) were performed. In vitro transcribed rovC RNA fragments of 
varying length were generated, harboring either all three GGA-motifs, two GGA-motifs or 
a substitution of GGA by UUC (see Figure 3.6. A). CsrA-6xHis protein was overexpressed 
in the E. coli strain BL21λDE3 and purified via its C-terminal His6-tag by Ni-NTA affinity 
chromatography (see Figure S1). For EMSA analysis, the different rovC transcripts, with 
hns RNA as negative control, were incubated with increasing amounts of purified CsrA 
protein. The bandshift assays showed that all rovC fragments were bound by CsrA, 
although with differing binding affinities (Figure 3.6 B). CsrA exerted the strongest binding 
affinity to rovC RNA fragment II, which contains the two 5’UTR GGA-motifs, since all free 
RNA molecules were bound by CsrA at a concentration of about 25 nM. Initial binding of 
CsrA to this fragment was already observed at the second lowest protein concentration 
(0.75 nM). RNA fragment I showed a slightly weaker CsrA binding affinity than fragment II, 
whereas for fragments III, IV and V, all harboring at least one substitution within a GGA 
motif, binding was noticeably decreased. These three fragments harbored the GGA-motif 
located in the rovC coding sequence leading to unspecific interactions with CsrA. As an 
additional negative control, a rovC mRNA fragment lacking all three GGA-motifs was 
tested for CsrA binding using high protein concentrations ranging from 0.5 to 250 nM. 
Even at the highest protein concentration applied, no CsrA binding was observed (Figure 
3.6 C), indicating that CsrA specifically interacts with the binding motif located within the 
rovC 5’UTR. In addition, EMSA analysis indicated that CsrA preferentially interacts with 
the two GGA-motifs located in the rovC 5’UTR but to a lower extend also with the GGA-
motif within the rovC coding sequence. 
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Figure 3.6: CsrA directly interacts with specific GGA-motifs within the rovC mRNA transcript. 
(A) Schematic representation of the in vitro transcribed rovC mRNA fragments. The three GGA-motifs within 
the RNA fragments are highlighted in blue, the transcriptional start site is labeled with +1 and the end of the 
fragment with +77. The ribosomal binding site and the beginning of the rovC coding sequence are underlined. 
Fragments containing varying length of the rovC mRNA are labeled with roman numerals ranging from I to VI. 
All substitutions of GGA-motifs within the fragments are indicated as ‘uuc’. The fragments either range from +1 
to +77 or +1 to +71, depicted by grey lines below the rovC mRNA sequence. (B) and (C) EMSAs with RNA 
fragments I to V show direct binding of CsrA protein to the rovC transcript. The hns RNA fragment was used 
as negative control, since it is not bound even when the highest CsrA concentration is applied. To test CsrA 
binding, the RNAs were incubated with increasing concentrations of purified CsrA ranging from 0 to 50 nM (B) 
or 0 to 250 nM (C). 
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The RNA-binding studies showed that CsrA directly binds to the GGA-motifs located 
within the 5’UTR of the rovC mRNA transcript, indicating direct CsrA-mediated control of 
rovC expression on the post-transcriptional level. Therefore, the effect of CsrA on rovC 
transcript stability and/or translation initiation was investigated. 
 To address the question whether CsrA influences rovC mRNA degradation, RNA 
stability was compared between the Y. pseudotuberculosis wild type strain and the ∆csrA 
mutant strain. In order to exclude endogenous rovC transcripts, rovC was ectopically 
expressed under the control of the inducible pBAD promoter in the ∆rovC and 
∆csrA/∆rovC double mutant. The strains were grown for 6 hours at 25°C to early 
stationary phase and transcription was stopped by addition of rifampicin. At time point 0, 
equal amounts of rovC transcript were present in both strains (Figure 3.7 A). However, the 
rovC transcript was degraded more rapidly in the csrA deficient strain. Quantification of 
the RNA amounts in both strains confirmed that the rovC mRNA is destabilized in the 
absence of CsrA (Figure 3.7 B). In the ∆csrA mutant the rovC transcript was degraded 
approximately 1 minute and 17 seconds faster compared to in the wild type. 
Consequently, it can be assumed that binding of CsrA protein to the rovC 5’UTR is 
required to stabilize the rovC mRNA transcript. 
 
Figure 3.7: The rovC mRNA transcript is stabilized by CsrA. 
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(A) RNA stability assay for comparison of the mRNA half-life in dependence on CsrA. For this, strains ΔrovC 
(YP148) and ΔcsrA/ΔrovC (YP318) were complemented with the arabinose inducible rovC+ overexpression 
plasmid pVK25 (pPBAD::rovC+). Cultures were inoculated 1:50 (ΔrovC) and 1:20 (ΔcsrA/ΔrovC) from fresh over 
night cultures and grown for 6 hours at 25°C. The pBAD promoter was induced by addition of 0.1% arabinose. 
Transcription was stopped by adding rifampicin to a final concentration of 1 mg/ml. Samples were taken 
directly after rifampicin addition (0 min) and after 2.5, 5, or 7.5 minutes. Total RNA was isolated and separated 
on a 1.2% MOPS gel, transferred onto a nylon membrane and probed with a digoxigenin (DIG)-labeled rovC 
encoding PCR-fragment. 16S and 23S rRNAs were used as loading control. (B) The Northern blots were 
documented, and the relative band intensity was calculated in relation to the 16S and 23S rRNAs. The graph 
represents the remaining percentage (y-axis) of rovC mRNA over time (x-axis) on a half-logarithmic scale. The 
half-life of the rovC mRNA was calculated via exponential regression. Asterisks indicate results differing 
significantly from each other (*P<0.05). 
 
 Then it was investigated, whether CsrA plays a role in the initiation of rovC mRNA 
translation. Therefore, an in vitro transcription-translation approach was performed by 
incubating a template rovC DNA fragment with and without CsrA protein. A DNA fragment 
harboring the 5’UTR and the complete rovC coding sequence was used for the reaction 
(Figure 3.8. A). The samples were incubated for 2 hours at 37°C to allow the translation of 
RovC protein. Equal amounts of RovC protein were synthesized independent of CsrA 
presence (Figure 3.8. B), indicating that CsrA does not affect translation initiation of rovC. 
 
Figure 3.8: rovC translation initiation is not affected by CsrA. 
(A) Schematic representation of the rovC DNA-fragment used for the in vitro transcription-translation assay. 
The fragment harbors a T7 promoter, the complete 5’UTR (-39 to +1 relative to the transcriptional start site) 
and the coding sequence of the rovC gene and a terminator sequence. (B) To analyze the effect of CsrA on 
rovC translation, an in vitro transcription-translation assay was performed. The rovC DNA fragment was 
amplified by PCR and purified. The DNA fragment was incubated with and without 100 nM CsrA protein and 
incubated at 37°C for 2 hours. As negative control, a reaction mixture without template was incubated with 
100 nM CsrA. Subsequently, the samples were separated on a 15% SDS gel and transferred to a PVDF 
membrane. RovC protein was detected using a polyclonal RovC antibody. Ponceau S Red stained bands on 
the membrane were used as loading control. 
 
3.2 Control of T6SS4 expression by different regulators 
Type VI secretion systems have been extensively studied in V. cholerae and 
P. aeruginosa, where, to date, much is known about the utilization of their T6SS for 
interbacterial competition (Hood et al., 2010; MacIntyre et al., 2010). However, it remains 
to be investigated whether type VI secretion systems of pathogenic yersiniae are involved 
in killing of bacterial competitors. For Yersinia species, previous studies mainly focused on 
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factors controlling the expression of T6S systems. The identified factors are predominantly 
transcriptional regulators that control expression of the Y. pseudotuberculosis T6SS 
operon 4, including the response regulator OmpR that responds to osmotic stress, and the 
virulence regulator RovM which depends on available nutrients (Gueguen et al., 2013; 
Song et al., 2015). Apart from transcriptional activators, some T6SS repressors such as 
the gene silencer protein H-NS, which represses two T6SS clusters in Salmonella, are 
described (Brunet et al., 2015).  
 While the first part of this work focused on the effect of CsrA on the newly 
identified T6SS4 activator RovC and on CsrA-mediated regulation of rovC expression, this 
part shows how the T6SS4 and RovC are regulated. For this, described T6SS4 regulators 
were chosen and their effect on T6SS4 and RovC expression was assessed.   
 
3.2.1 Regulation of the T6S system by the transcriptional regulator RovM 
Recently, Song et al., (2015) showed that the virulence regulator RovM is important for 
the activation of the T6SS4 of Y. pseudotuberculosis. Expression of a translational 
T6SS4’-‘lacZ reporter fusion was significantly downregulated in a rovM-deficient strain and 
could be complemented upon RovM overexpression. RovM expression is induced upon 
nutrient restriction and hardly detectable at elevated temperatures (37°C) (Heroven & 
Dersch, 2006). Moreover, expression of rovM was shown to be regulated by the Csr 
system, as CsrA exerts an indirect positive effect on RovM synthesis (Heroven et al., 
2008). A previous study showed that the expression levels of RovC are highest at 25°C in 
stationary growth phase (Knittel, 2015) and these results imply that RovM and RovC are 
expressed under the same conditions and controlled by CsrA. Therefore, the question 
arose whether RovC and RovM control each other’s expression and whether loss of one 
protein can be complemented by the other with regard to T6SS4 activation. 
First, this study addressed the question how RovM affects the expression of the 
T6SS4 and its regulator RovC in the Y. pseudotuberculosis strain YPIII. For this, the 
expression of a T6SS4’-‘lacZ and a rovC’-‘lacZ reporter fusion were monitored in the wild 
type and the ∆rovM mutant strain both complemented with a rovM+ overexpression 
plasmid (Figure 3.9 A and B). Expression of the T6SS4’-‘lacZ fusion was slightly 
decreased in the rovM-deficient strain, but significantly increased upon overexpression of 
RovM (Figure 3.9 A). In contrast to this, deletion or overexpression of RovM did not affect 
expression of the rovC’-‘lacZ reporter fusion. To ensure that synthesis of RovM is not 
regulated by RovC, the RovM protein amounts were assessed by Western blot in the wild 
type, the ∆rovM and the ∆rovC mutant strain (Figure 3.9 C). Surprisingly, RovM synthesis 
was slightly decreased in the absence of rovC, indicating a positive influence of RovM by 
RovC. Therefore, the next objective of this work was to analyze RovC dependent 
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expression of RovM. In order to do so, expression of a translational rovM’-‘lacZ reporter 
fusion was monitored in the wild type and the rovC mutant strain. Complementation of 
both strains with an inducible rovC+ plasmid showed increased expression of the reporter 
fusion (Figure 3.10). However, this effect is rather small as no differences in the 
expression levels between wild type and rovM mutant were observed when the strains 
were transformed with the empty vector.  
Taken together, RovM activates T6SS4 but not rovC expression (Figure 3.9 
A and B) while, in turn, RovC only slightly induces expression of rovM (Figure 3.10) but 
strongly activates the expression of the T6SS4 operon (Figure 3.3). 
 
 
 
Figure 3.9: RovM induces T6SS4 expression but not rovC. 
Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) (A) and a translational rovC’-‘lacZ 
reporter fusion (pVK03) (B) were monitored in the Y. pseudotuberculosis wild type strain (YPIII) and the 
ΔrovM mutant strain (YP72). Both strains were transformed with the empty vector pIV2 (pV) or complemented 
with the rovM+ overexpression plasmid pAKH64 (provM+). β-galactosidase activity (µmol/mgmin) was 
measured in strains grown over night for 16 hours at 25°C in LB medium. The data represent the mean ± 
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standard deviation of three independent experiments, carried out in triplicates. Data were analyzed by 
Student’s t-test. Asterisks indicate results differing significantly from each other (****P<0.0001; **P<0.01). (C) 
RovM protein amounts were monitored in the wild type strain (YPIII), the ΔrovM mutant strain (YP72) and the 
ΔrovC mutant strain (YP154), transformed with the empty vector pIV2 (pV) or the rovM+ overexpression 
plasmid pAKH64 (provM+). Whole cell extracts were prepared from cultures grown over night for 16 hours at 
25°C in LB medium, separated on 15% SDS gels and transferred onto a PVDF membrane. Proteins were 
detected by immunoblotting with a polyclonal RovM antibody and H-NS protein amounts were detected as 
loading control. The ΔrovM mutant strain was used as negative control. 
 
 
 
Figure 3.10: RovC overexpression induces rovM expression. 
Expression of translational rovM’-‘lacZ reporter fusion (pAKH63) was measured in the Y. pseudotuberculosis 
wild type strain (YPIII) and the ΔrovC mutant strain (YP154). Strains were transformed with the empty vector 
pBAD30 (pV) or complemented with the inducible rovC+ plasmid pVK25 (pPBAD::rovC+). β-galactosidase 
activity (µmol/mgmin) was measured in strains grown over night for 16 hours at 25°C in LB medium. The 
promoter was induced by addition of 0.1% arabinose. The data represent the mean ± standard deviation of 
three independent experiments, carried out in triplicates. Data were analyzed by Student’s t-test. Asterisks 
indicate results differing significantly from each other (****P<0.0001). 
 
The data presented above show that both regulators, RovC and RovM, exert a positive 
effect on T6SS4 gene expression. Therefore, the importance of both regulators regarding 
T6SS4 activation was analyzed in an epistasis study, monitoring T6SS4’-‘lacZ expression. 
In order to do so, the Y. pseudotuberculosis wild type, the ∆rovM mutant, the ∆rovC 
mutant and a ∆rovM/∆rovC double mutant strain were either complemented with a rovC+ 
or rovM+ overexpression plasmid. Then, expression of a translational T6SS4’-‘lacZ 
reporter fusion was monitored in these strains. Complementation with RovC in the tested 
strains resulted in a strong induction of the T6SS4’-‘lacZ fusion in comparison to the 
strains transformed with the empty vector (Figure 3.11 A). For expression control of the 
introduced rovC+ plasmid, Western blot samples were prepared, showing equal amounts 
of RovC protein in all strains (Figure 3.11 B). However, hardly any RovC protein was 
detectable in the wild type, and no RovC protein could be visualized in the strains 
transformed with the rovM+ plasmid (Figure 3.11 C). This is consistent with the data 
presented above, where no positive regulatory effect of RovM on rovC expression was 
observed. In contrast to the effect observed upon rovC overexpression, introduction of a 
rovM+ plasmid led to an induction of the T6SS4’-‘lacZ reporter fusion in the wild type and 
the ∆rovM mutant strain. Both, the rovC-deficient strain and ∆rovM/∆rovC double mutant 
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strain could not induce expression of the reporter fusion when complemented with the 
rovM+ plasmid (Figure 3.11 D). This led to the assumption that RovC is an essential 
activator of the T6SS4 operon as it cannot be complemented by RovM, whereas loss of 
rovM can be complemented by rovC. Analysis of the RovM protein amounts supports the 
data presented above, as equal RovM amounts were detectable in all strains and no 
regulatory effect of RovM on rovC expression was observed (Figure 3.11 E and F).   
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Figure 3.11: RovM-dependent T6SS4 expression requires the presence of RovC. 
Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) ((A) and (D)) was monitored in the 
Y. pseudotuberculosis wild type strain (YPIII), the ΔrovM mutant strain (YP72), the ΔrovC mutant strain 
(YP154) and the ΔrovM/ΔrovC double mutant strain (YP338). The strains were transformed with the empty 
vector pZA24 (pV) or the inducible rovC+ plasmid pVK46 (pPara::rovC+) (A), (B), (E). In addition, strains 
transformed with the empty vector pIV2 (pV) or the rovM+ plasmid pAKH64 (provM+) were analyzed (C), (D), 
(F). (A) and (D): β-galactosidase activity (µmol/mgmin) was measured in strains grown over night for 16 
hours at 25°C in LB medium. The Para promoter was induced by addition of 0.1% arabinose. The data 
represent the mean ± standard deviation of three independent experiments, carried out in triplicates. Data 
were analyzed by Student’s t-test. Asterisks indicate results differing significantly from each other 
(****P<0.0001). The RovC protein amounts ((B) and (C)) and the RovM protein amounts ((E) and (F)) were 
detected in the Y. pseudotuberculosis wild type strain (YPIII), the ΔrovM mutant strain (YP72), the ΔrovC 
mutant strain (YP154) and the ΔrovM/ΔrovC double mutant strain (YP338). Whole cell extracts were prepared 
from cultures grown over night for 16 hours at 25°C in LB medium, separated on 15% SDS gels and 
transferred onto a PVDF membrane. Proteins were detected by immunoblotting using a polyclonal RovC ((B) 
and (C)) antibody or a polyclonal RovM antibody ((E) and (F)). The ∆rovC mutant strain ((B) and (C)) and the 
∆rovM mutant strain ((E) and (F)) was used as negative control. 
 
3.2.2 RovA affects expression of the T6SS4 
The transcriptional regulator RovA is negatively controlled by the LysR-type protein RovM 
and part of the regulatory cascade controlling the expression of invasin (Heroven & 
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Dersch, 2006). RovA of Y. pestis, which lacks the inv gene, was reported to control other 
factors involved in the virulence of this pathogen such as the psa locus and a T6SS locus. 
This T6SS locus (YPO0499 to YPO0516) of Y. pestis CO92 is strongly downregulated in 
the rovA mutant background and is highly homologous to the Y. pseudotuberculosis 
T6SS4 cluster (YPK_3548 to YP_3566) (Cathelyn et al., 2006; Yang et al., 2018).  
Due to this, the effect of RovA on the expression of T6SS4’-‘lacZ reporter fusion 
was monitored. RovA exerts a positive effect on the reporter fusion as the expression is 
slightly reduced in the ∆rovA mutant strain compared to the wild type (Figure 3.12 A). 
However, complementation of the rovA deficient strain with a rovA+ overexpression 
plasmid could not be complemented to the expression levels of the wild type, but on the 
contrary reduced the expression even further. RovA protein amounts were compared in a 
Western blot to ensure that equal amounts of RovA protein are synthesized upon 
complementation. Additionally, invasin as a direct target of RovA was detected showing 
similar protein amounts in the complemented wild type and ∆rovA mutant (Figure 3.12 C). 
Nevertheless, these results point out that the overall expression levels of the T6SS4’-‘lacZ 
reporter fusion are very low, making it rather difficult to monitor a precise effect. 
Consequently, a more strongly expressed reporter fusion or a different RovA+ 
complementation plasmid would be needed to investigate whether RovA in 
Y. pseudotuberculosis has a similar effect on the T6SS4 as observed in Y. pestis.  
In case of the rovC’-‘lacZ reporter fusion, the expression is neither altered in 
presence or absence of rovA nor upon complementation with a rovA+ plasmid 
(Figure 3.12 B). Hence, expression of the T6SS4 activator RovC is not controlled by 
RovA. 
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Figure 3.12: RovA affects expression of the T6SS4. 
Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) (A) and a translational rovC’-‘lacZ 
reporter fusion (pVK03) (B) was monitored in the Y. pseudotuberculosis wild type strain YPIII and the ∆rovA 
mutant strain (YP107). Strains were transformed with the rovA+ overexpression plasmid pFS45 (provA+). β-
galactosidase activity (µmol/mgmin) was measured in strains grown over night for 16 hours at 25°C in LB 
medium. The data represent the mean ± standard deviation of three independent experiments, carried out in 
triplicates. Data were analyzed by Student’s t test. Asterisks indicate results differing significantly from each 
other (****P<0.0001; **P<0.01). (C) The RovA and invasin amounts were analyzed in the 
Y. pseudotuberculosis wild type strain YPIII and the ∆rovA mutant strain, complemented with rovA+ 
overexpression plasmid pFS45 (provA+). Whole cell extracts were prepared from cultures grown over night for 
16 hours at 25°C in LB medium, separated on 15% SDS gels and the proteins were detected by 
immunoblotting using a monoclonal RovA and invasin antibodies. H-NS protein amounts were detected as 
loading control and the ∆rovA mutant strain was used as negative control. 
 
3.2.3 The two component system OmpR/EnvZ represses T6SS4 expression 
The two-component system (TCS) OmpR/EnvZ responds to alterations of the osmolarity 
conditions within the bacterial environment (Forst & Roberts, 1994). Recent studies 
revealed that the response regulator OmpR controls expression of the 
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Y. pseudotuberculosis T6SS4 upon its phosphorylation. These studies report that OmpR 
directly interacts with three different sites within the T6SS4 upstream region. OmpR 
binding to two of the binding sites was described to exert a positive effect on the T6SS4 
expression, while binding to a third site represses transcription of the T6SS operon 
(Zhang et al., 2013; Gueguen et al., 2013). Therefore, this study aimed to investigate the 
effect of this TCS on expression of the T6SS4 and the two regulators RovC and RovM in 
the Y. pseudotuberculosis strain YPIII and the isogenic ∆ompR/∆envZ mutant strain. 
Expression of both T6SS4 activators was unaltered when comparing expression levels of 
a translational rovM’-‘lacZ (Figure 3.13 A) and a rovC’-‘lacZ (Figure 3.13 B) reporter fusion 
between the wild type strain and the ∆ompR/∆envZ deficient strain. In contrast to the data 
published by Gueguen et al. (2013), which shows a positive regulation of the T6SS4 by 
OmpR, expression of the T6SS4 reporter fusion in this study was upregulated in the 
ompR/envZ mutant strain, demonstrating a negative effect of the TCS on T6SS4 
expression.  
 
 
 
Figure 3.13: The TCS OmpR/EnvZ represses expression of the T6SS4. 
Expression of a translational rovM’-‘lacZ (pAKH63) (A), a rovC’-‘lacZ (pVK03) (B) and a T6SS4’-‘lacZ 
(pSSE64) (C) reporter fusion was measured in the Y. pseudotuberculosis wild type strain (YPIII) and the 
∆ompR/∆envZ mutant strain (YP300). β-galactosidase activity (µmol/mgmin) was measured in strains grown 
over night for 16 hours at 25°C in LB medium. The data represent the mean ± standard deviation of three 
independent experiments, carried out in triplicates. Data were analyzed by Student’s t-test. Asterisks indicate 
results differing significantly from each other (***P<0.001; n.s.: not significant). 
 
0.0
0.5
1.0
1.5
n.s.
0
1
2
3
0.0
0.2
0.4
0.6
0.8 ***
A B
C
-g
al
ac
to
si
da
se
 a
ct
iv
ity
 
(µ
m
ol
/(m
g*
m
in
))
-g
al
ac
to
si
da
se
 a
ct
iv
ity
 
(µ
m
ol
/(m
g*
m
in
))
-g
al
ac
to
si
da
se
 a
ct
iv
ity
 
(µ
m
ol
/(m
g*
m
in
))
rovM’-’lacZ
wt ∆ompR/envZ wt ∆ompR/envZ
wt ∆ompR/envZ
rovC’-’lacZ
T6SS4’-’lacZ
RESULTS 
 
 70 
3.2.4 H-NS-dependent T6SS4 expression 
The next regulator analyzed in this work regarding its involvement in T6SS4 regulation is 
the gene silencer protein H-NS. Generally, H-NS represses transcription of target genes 
by direct binding to curved double-stranded DNA sequences (Atlung & Ingmer, 1997), 
especially to DNA molecules exhibiting a high AT-content as shown, for example, in 
Y. pseudotuberculosis (Heroven et al., 2004). Therefore, the effect of H-NS on the 
expression of the T6SS4 and RovC was monitored in the wild type strain. As a deletion of 
hns is lethal for Yersinia, the wild type carrying a dominant-negative hns’ plasmid, 
harboring only the N-terminal oligomerization domain, was used to mimic an hns deletion 
strain. Expression of the T6SS4’-‘lacZ reporter fusion was slightly induced in the wild type 
strain transformed with the dominant-negative hns’ version but also upon overexpression 
of H-NS (Figure 3.14 A). Due to relatively high standard deviations and low expression 
levels of the reporter fusion, the effect observed in the hns’ strain is rather negligible, 
especially, as the effect is most probably caused by the plasmid. Thus, H-NS is not 
involved or plays only a minor role in T6SS4 gene silencing. Matching this data, 
expression of the rovC’-‘lacZ reporter fusion was also not altered upon deletion or 
overexpression of H-NS (Figure 3.14 B). 
 
Figure 3.14: H-NS does not control T6SS4 and rovC expression. 
Expression of a translational T6SS4’-‘lacZ (pSSE64) (A) and rovC’-‘lacZ (pSSE32) (B) reporter fusion was 
monitored in the Y. pseudotuberculosis wild type strain (YPIII). The strains were transformed with the empty 
vector pK18 (pV1) and complemented with plasmid pAKH30, encoding a dominant negative N-terminal H-NS 
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fragment (phns’). In addition, strains were transformed with the empty vector pAKH85 (pV2) and 
complemented with the hns+ overexpression plasmid pAKH74 (phns+). β-galactosidase activity (µmol/mgmin) 
was measured in strains grown over night for 16 hours at 25°C in LB medium. The data represent the mean ± 
standard deviation of three independent experiments, carried out in triplicates. Data were analyzed by 
Student’s t-test. 
 
3.3 RovC is a new and crucial regulator of the T6SS4 operon in 
Y. pseudotuberculosis  
Expression of the Y. pseudotuberculosis T6SS4 operon was already reported to be 
controlled by a number of regulatory proteins such as the virulence regulator RovM and 
the response regulator OmpR. Generally, most T6SS4 regulators are associated with 
nutrient availability and stress conditions (Song et al., 2015; Gueguen et al., 2013; Zhang 
et al., 2013). The present work identified RovC as a new T6SS4 regulator which strongly 
induces expression of the operon (see section 3.1.1.2). In addition, this study showed that 
presence of RovC is essential in order to induce T6SS4 expression, as complementation 
of a rovC deficient strain with RovM was not sufficient to induce expression of a T6SS4’-
‘lacZ reporter fusion (see section 3.2.1). As many of the recently described T6SS4 
regulators are DNA-binding proteins that directly interact with different sites within the 
T6SS4 upstream region (see Figure 1.7), the next aim of this work was to investigate 
whether RovC also interacts with the promoter of the operon.  
 
3.3.1 RovC directly interacts with the promoter region of the T6SS4 
Previously, expression of selected genes of the T6SS4 operon, when compared between 
the wild type and ∆rovC mutant strains were found to be significantly downregulated in the 
absence of rovC (Seekircher, 2014). In addition, this work demonstrated that the presence 
of RovC is essential to induce expression of the T6SS4 operon. Recently, the crystal 
structure of the RovC protein was solved and revealed a hexameric form (see Figure 1.8) 
with a C-terminal helix-turn-helix motif (Sadana, 2017). The crystal structure confirms the 
results obtained from a secondary structure alignment (Phyre2) predicting that the C-
terminus of the RovC protein shows homology to a DNA-binding domain (Knittel, 2015).  
 Overexpression and purification of RovC, as well as cleavage of the His-SUMO-
tag was performed by Pooja Sadana, who kindly provided the protein for DNA EMSA 
analysis. In order to examine whether RovC binds to the T6SS4 upstream region, DNA 
EMSAs were performed with fragments harboring different parts of the upstream region 
in-between the T6SS4 operon and the rovC gene. For this, distinctive DNA fragments 
were amplified by PCR to cover the complete upstream region and parts of the coding 
region of the operon to localize the RovC-binding region. The nucleotide sequence and 
the primers used to generate the fragments are indicated below (Figure 3.15 A). Different 
concentrations of purified RovC protein were incubated with the respective DNA 
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fragments (I-V) and DNA-binding was examined. RovC binding was observed for 
fragments I, II and IV starting at a protein concentration of about 100 to 200 ng, whereas 
fragments III and V did not interact with RovC (Figure 3.15 B). Due to this, the RovC 
binding region was determined to be located within an approximately 100 bp stretch 
upstream of the T6SS4 promoter (Figure 3.15 A: red dashed line). 
 
 
(ng) RovC protein75056242231617810056320
T6SS4 DNA
control DNA
DNA-RovC complex
T6SS4 DNA
control DNA
DNA-RovC complex
I
II
ATGTCACTCATattattgtccatccgttttaaaatcaaaaatagcttgctattccttgctattcgctggttgaggctaaccttatgtggaatttaaaagt 
 
 
caagtacatgatttataacctccctgtttgtatattttataatcatcctgatttacatacctgttataggttatagctattctctgttgtgataggttatagctattat 
 
 
gtctttatttttttcttatttaagaaataacctaggacaaaaaacagtagtagggataaacttattcgcagattttttcacccttcatacatttattaaatttacat 
 
 
aaccattagcacgatgacgtggatgaatagccaaaataagaggacatagatATGAGAAAGAAGCTATATAATGACTTCGCGT 
 
 
GGGAATGCCTGAGGCGAAATCCACAATATATTAGCGATTGGGAATTATTTATGAAAAATACTCTTACTAA 
 
 
TGGAGGGGGTATACCCGATGATTCTGAATTAATCCAATCAGAGCTGG 
+1 
+1 
I, II,  
III, V 
I, IV 
V IV III 
II 
T6SS4 rovC  
+1 +1 
-10  -35 
I 
II 
III 
IV 
V 
RovC binding region 
B
T6SS4 DNA
control DNA
III
A
-10 -35
RESULTS 
 
 73 
 
Figure 3.15: RovC directly interacts with the promoter region of the T6SS4 operon. 
(A) Schematic representation of the T6SS4 and rovC upstream region with all DNA fragments used for the 
EMSA. The fragments harboring varying lengths of the upstream region are shown below the fragment and 
are labeled with roman numbers (I to V). The RovC binding region is marked in red (dashed line) and the 
transcriptional start sites of the T6SS4 operon and the rovC gene are indicated with +1 and a broken arrow. 
The -10 and -35 regions of the T6SS4 promoter are indicated below the fragment. The DNA sequence 
beneath the schematic representation depicts the beginning and end of each fragment and the DNA-binding 
region of RovC is indicated within the DNA sequence (red dashed lines). Primers for amplification of the 
fragments are indicated as arrows. (B) EMSAs with purified RovC protein. 130 fmol of DNA were incubated 
with increasing amounts of RovC protein (0 ng to 750 ng) for 30 minutes at RT. Samples were separated on 
4% polyacrylamide gels, incubated in ethidium bromide and the DNA was visualized using UV-light. A csiD 
DNA fragment from E. coli was used as negative control.  
 
 The EMSA analysis confirmed that RovC is a DNA-binding protein that directly 
binds to the upstream region of the T6SS4 operon. To determine the exact binding site of 
RovC and the DNA sequence that is bound, a DNase I footprint assay was performed. 
The plasmid pSSE64, harboring the complete upstream region of the T6SS4 operon, 
served as template for the sequencing reaction, synthesized with a DIG-labeled primer. 
The DNA fragment was amplified with a DIG-labeled forward primer and an unlabeled 
reverse primer generating the exact DNA-binding region determined by the EMSA. The 
DNase I concentration was adjusted to a 1:8 dilution to achieve optimal digestion of the 
applied DNA fragment. The DIG-labeled DNA fragment was incubated with increasing 
concentrations of RovC protein and subsequently digested with the optimized DNase I 
concentration. By comparing the DNase I protected region with the sequencing reaction, 
the RovC binding site was determined (Figure 3.16 A). The RovC binding site 
encompassed a DNA stretch of about 42 nucleotides located directly upstream of the -10 
and -35 region of the T6SS4 promoter (Figure 3.16 B). 
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Figure 3.16: RovC directly binds to a region close to the -10 and -35 region of the T6SS4 promoter. 
(A) A DNase I footprinting assay was performed to narrow down the RovC binding site. The protected region 
is indicated on the right-hand side. T6SS4 DNA and a sequencing reaction were amplified with a DIG-labeled 
primer using the plasmid pSSE64 as template. T6SS4 DNA was incubated with increasing concentrations of 
RovC protein (0 ng to 3000 ng) for 30 minutes at room temperature and was subsequently digested with an 
appropriate concentration of DNase I for 30 seconds. The DNA-protein samples and the sequencing reaction 
were separated on a 6% urea gel, transferred onto a nylon membrane and visualized with a digoxigenin 
antibody. (B) Schematic representation of the RovC DNA-binding site indicated as a red line. RovC binds to 
the T6SS4 promoter in a region approximately -76 to -34 bp upstream of the T6SS4 transcriptional start site 
(labeled with +1 and a broken arrow). The exact binding sequence is given below. 
 
3.3.2 Analysis of the DNA-binding mechanism of RovC 
The aforementioned results indicated that RovC is a DNA-binding protein that specifically 
interacts with the T6SS4 promoter region. Due to the ring shaped hexameric structure of 
RovC with an overall size of 173 kDa (Sadana, 2017), the question arose, where, 
precisely, the DNA-binding occurs. As binding of T6SS4 DNA could either occur in the 
center of the hexamer or on its suface RovC protein variants harboring specific amino 
acids substitutions were generated and kindly provided by Pooja Sadana. Either one, two 
or in one case three amino acid were substituted to glutamic acid (E), alanine (A), 
methionine (M) or proline (P). For example, substituion of amino acids to glutamic acid 
gives the amino acid a negative charge, which is unfavorable for binding to negativley 
charged DNA fragments. Therefore, the importance of specific amino acids for DNA-
binding could be studied. The analyzed amino acids were either located in the center of 
the RovC hexamer or on its surface (see Figure 1.8 A). All RovC proteins carrying the 
differet amino acid substitutions were analyzed by DNA EMSA (this study) or Microscale 
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thermophoresis (MST) (Sadana, 2017) for DNA-binding. Analysis of the RovC proteins 
harboring amino acid substituions within the center of the protein revealed that these 
proteins were still able to bind to the T6SS4 DNA fragement (Figure 3.17 B to F). 
However, some amino acid substitutions resulted in an impaired DNA-binding affinity 
compared to the wild type RovC protein (Figure 3.17 A). Substitution of the lysine residues 
at positions 211 and 215 to glutamic acid resulted in a rather weak affinity for the T6SS4 
fragment or even unspecific binding (Figure 3.17 E). Also, subsitution of lysine 181, 
glutamic acid 182 and 183 to alanine clearly reduced the DNA-binding affinity (Figure 3.17 
F). In contrast to this, substituion of lysine 175 (Figure 3.17 B), glycine 187 and lysine 190 
(Figure 3.17 C) or lysine 56 (Figure 3.17 D) to glutamic acids resulted in no reduction of 
DNA-binding. 
   
 
Figure 3.17: Amino acid substitutions within the center of the RovC hexamer only slightly infuence 
DNA-binding. 
DNA EMSAs with purified RovC proteins harboring varying amino acid substitutions. (A) Wild type RovC 
protein, (B) RovC K175E, (C) RovC G187E/K190E, (D) RovC K56E, (E) RovC K211E/K215E and (F) RovC 
K181A/E182A/E183A. 130 fmol of DNA were incubated with increasing amounts of RovC protein (0 ng to 
281 ng) for 30 minutes at room temperature. Samples were separated on 4% TBE gels, incubated in ethidium 
bromide and the DNA was visualized using UV-light. A csiD DNA fragment from E. coli was used as negative 
control.  
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In contrast to that, all substitutions of amino acids positioned on the surface of the RovC 
hexamer completely abolished binding of the mutant proteins to DNA (Figure 3.18). 
Independent of the amount of substituted amino acids, exchange to glutamic acid (Figure 
3.18 A, C, D, E, F, G and I), proline (Figure 3.18 B) or methionine (Figure 3.18 H) resulted 
in loss of the DNA-binding ability. 
 
Figure 3.18: Amino acid substitutions on the surface of the RovC hexamer prevent DNA-binding. 
DNA EMSAs with purified RovC proteins harboring varying amino acid substitutions. (A) RovC S219E/A220E, 
(B) RovC I150P, (C) RovC R85E/K87E, (D) RovC K233E, (E) RovC R229E, (F) RovC R225E, (G) RovC 
R202E and (H) RovC K233A/K234A. 130 fmol of DNA were incubated with increasing amounts of RovC 
protein (0 ng to 281 ng) for 30 minutes at room temperature. Samples were separated on 4% TBE gels, 
incubated in ethidium bromide and the DNA was visualized using UV-light. A csiD DNA fragment from E. coli 
was used as negative control.  
 
In summary, amino acid substitutions within the center of the hexameric RovC protein only 
slightly affect binding of RovC to the T6SS4 promoter, however, no DNA-binding could be 
observed for all tested substitutions located on the surface of RovC. Consequently, 
T6SS4 DNA-binding occurs on the surface of the RovC protein. 
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3.3.2.1 DNA-binding of RovC is essential to induce T6SS4 expression 
The DNA-binding studies showed that specific amino acids on the surface of RovC are 
important for RovC-DNA interactions. Therefore, it was examined whether DNA-binding of 
RovC is essential to induce expression of the T6SS4 operon. For this, specific amino 
acids that are either located on the surface of RovC or in the center of the protein were 
chosen, mutated and, the gene cloned under the control of the inducible Para promoter. All 
RovC proteins were overexpressed in the Y. pseudotuberculosis wild type strain YPIII, 
carrying a translational T6SS4’-’lacZ reporter fusion, and β-galactosidase activity was 
monitored. T6SS4’-‘lacZ expression in the wild type transformed with the empty vector or 
a wild type RovC+ overexpression plasmid were measured as controls. The RovC proteins 
harboring amino acid substituions within the center of the hexamer significantly induced 
expression of the reporter fusion (K175E, K211E/K215E, G187E/K190E and K56E) 
(Figure 3.19 A). In contrast to this, the RovC proteins carrying amino acid substitutions 
located on the surface of RovC did not induce expression of the T6SS4’-’lacZ reporter 
fusion in comparision to the empty vector (R202E, R225E, S219E/A220E and R229E) 
(Figure 3.19 A). Substitution of serine 219 and alanine 220 to glutamic acid, however, lead 
to a minor increase in T6SS4’-‘lacZ expression, although this was not comparable to 
those RovC proteins with substitutions within the center. 
 In order to ensure that all tested RovC protein variants are expressed in Yersinia 
and that the expression effects observed do not result from loss of protein synthesis, 
Western blot samples were prepared and the protein was detected using a RovC 
antibody. Detection of RovC protein by Western blot showed that all RovC proteins are 
expressed in vivo and no false effects were monitored in the expression assay (Figure 
3.19 B). Thus, DNA-binding of the different RovC variants is crucial to exert a positive 
effect on T6SS4 expression in Y. pseudotuberculosis. 
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Figure 3.19: T6SS4 expression in dependence on RovC proteins harboring different amino acid 
substitutions. 
(A) Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) was measured in the 
Y. pseudotuberculosis wild type strain YPIII. YPIII strains carrying the T6SS4’-‘lacZ reporter fusion were 
transformed with the empty vector pZA24 (pV) and complemented with the arabinose inducible rovC+ 
overexpression plasmids pVK46 (provC+), pVK48 (provC+K175E), pVK49 (provC+K211E/K215E), pVK50 
(provC+R202E), pVK51 (provC+R225E), pVK52 (provC+S219E/A220E), pVK57 (provC+G187E/K190E), pVK58 
(provC+R229E) and pVK59 (provC+K56E). β-galactosidase activity (µmol/mgmin) was measured after strains 
were grown over night for 12 hours at 25°C in LB medium. Then, expression of the Para promoter was induced 
by addition of 0.1% arabinose to the medium for 4 h. The data represent the mean ± standard deviation of two 
independent experiments, carried out in triplicates. Data were analyzed by the Student’s t-test. Asterisks 
indicate results differing significantly from each other (****P<0.0001, *** P<0.001; n.s.: not significant). B 
Western blot to monitor the amount of synthesized RovC protein. Whole cell extracts were prepared from 
overnight cultures grown for 16 hours at 25°C in LBBD medium, separated on 15% SDS gels and transferred 
onto a PVDF membrane. Proteins were detected by immunoblotting with a monoclonal antibody directed 
against RovC. H-NS protein amounts were detected as loading control and the ∆rovC mutant strain served as 
negative control.  
 
3.3.2.2 Amino acid substitutions within RovC do not alter protein stability 
The in vivo analysis of the different RovC protein variants indicated that amino acid 
alterations that affect DNA-binding result in a loss of T6SS4 induction. Verification of 
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protein expression revealed that depending on the amino acid substitution, varying 
amounts of RovC protein are synthesized. Substitution of lysine residues 211 and 215 to 
glutamic acid, for example, resulted in considerably elevated protein synthesis, whereas 
substitution of arginine 225 to glutamic acid led to noticeably reduced protein amounts 
(Figure 3.19 B). Due to this, it was examined whether these amino acid substitutions alter 
RovC protein stability. All RovC variants tested above for induction of T6SS4 expression 
were monitored in the Y. pseudotuberculosis wild type strain YPIII in a protein stability 
assay. Protein synthesis was stopped by addition of chloramphenicol and samples were 
taken at different time points. The protein stability assay showed that although the 
amounts of RovC differ between each RovC variant, no significant variation in protein 
stability was observed (Figure 3.20 A to I). Thus, RovC is a rather stable protein that is not 
degraded by proteases for at least three hours and substitution of amino acids did not 
alter the stability of RovC.  
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Figure 3.20: RovC protein stability is not altered by amino acid substitutions within the hexamer.  
RovC protein stability was compared between proteins harboring different amino acid substitutions in the 
Y. pseudotuberculosis wild type strain YPIII. The strain was transformed with the arabinose inducible rovC+ 
overexpression plasmids (A) pVK46 (provC+), (B) pVK48 (provC+K175E), (C) pVK49 (provC+K211E/K215E), 
(D) pVK50 (provC+R202E), (E) pVK51 (provC+R225E), (F) pVK52 (provC+S219E/A220E), (G) pVK57 
(provC+G187E/K190E), (H) pVK58 (provC+R229E) and (I) pVK59 (provC+K56E). Strains were grown for 12 
hours at 25°C in LB medium. Then, expression of the Para promoter was induced by addition of 0.1% 
arabinose to the medium for 4 hours. Protein synthesis was stopped by addition of chloramphenicol to a final 
concentration of 200 µg/ml. Whole cell extracts were prepared directly after chloramphenicol addition (0 min) 
and after 30, 60, 90, 120, 150, and 180 min, samples were separated on 15% SDS gels and transferred onto 
PVDF membranes. RovC protein was detected using a polyclonal RovC antibody. The ∆rovC mutant strain 
served as negative control and an unspecific band was used as loading control. 
 
Further, it was examined whether RovC autoregulates its own expression by 
interacting with the rovC promoter region. Regulatory feedback-loops are well-known 
control systems for transcriptional regulation. For instance, the transcriptional regulators 
RovM and RovA were described to be autoregulated (Heroven et al., 2004; Heroven & 
Dersch, 2006). Alteration of the autoregulation could explain synthesis of different protein 
amounts in the bacterial cell. To analyze this, expression of a translational rovC’-‘lacZ 
reporter fusion was monitored in the wild type strain and the ∆rovC mutant strain either 
carrying an empty vector or a rovC+ overexpression plasmid. Comparison of rovC’-‘lacZ 
expression between both strains revealed that RovC is not autoregulated, as expression 
of the reporter fusion did not differ upon overexpression of RovC (Figure 3.21). 
Consequently, neither autoregulation nor protein stability can explain the varying amounts 
of synthesized RovC protein upon substitution of specific amino acids. 
 
 
Figure 3.21: RovC is not autoregulated. 
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Expression of a translational rovC’-‘lacZ reporter fusion (pSSE32) was monitored in the Y. pseudotuberculosis 
wild type strain (YPIII) and the ∆rovC mutant strain (YP154). Both strains were transformed with the empty 
vector pACYC184 (pV) and complemented with the rovC+ overexpression plasmid pSSE11 (provC::rovC+). β-
galactosidase activity (µmol/mgmin) was measured in strains grown over night for 16 hours at 25°C in LB 
medium. The data represent the mean ± standard deviation of three independent experiments, carried out in 
triplicates. Data were analyzed by Student’s t-test. 
 
3.3.3 Overexpression of RovC results in synthesis of a functional T6SS4 
The previous results of this study demonstrated that RovC is a novel regulator of the 
T6SS4 operon of Y. pseudotuberculosis and that the presence of RovC is essential in 
order to induce expression of the operon. Various studies have reported that functionality 
of type VI secretion systems can be determined by the ability to export Hcp into the 
supernatant (Bönemann et al., 2009). Therefore, RovC-dependent Hcp secretion by the 
T6SS4 was assessed. A Y. pseudotuberculosis strain (YP360) carrying a chromosomally-
integrated 3xFLAG tag fused to the N-terminal part of the T6SS4 tail tube protein Hcp was 
generated in order to detect secreted Hcp protein in the supernatant. Hcp secretion was 
monitored in the wild type strain YPIII and the chromosomally 3xFLAG-tagged strain, 
either transformed with the empty vector or with a RovC overexpression plasmid. 
Secreted FLAG-tagged Hcp was only detected in the 3xFLAG-hcp strain when RovC was 
overexpressed from a plasmid (Figure 3.22 A).  
 
Figure 3.22: Hcp effector translocation is triggered upon RovC overexpression. 
(A) Secretion of the T6SS4 effector protein Hcp was monitored in the Y. pseudotuberculosis wild type strain 
YPIII. In order to detect secreted Hcp protein in the supernatant, a 3xFLAG-tag was fused to the N-terminus of 
Hcp (YPK_3563) (YP360). The strain was transformed with the empty vector pACYC184 (pV) or 
complemented with the rovC+ overexpression plasmid pSSE11 (provC::rovC+). Cultures were grown to early 
stationary phase for 6 hours in LB at 25°C. The cells were pelleted and the protein-containing supernatant 
was filtered and precipitated with TCA. Precipitated proteins and pellet samples were resuspended in equal 
amounts of sample buffer, separated on 15% polyacrylamide gels, transferred onto PVDF membranes and 
visualized using a monoclonal FLAG antibody. (B) In order to exclude cell lysis upon overexpression of RovC, 
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a cell viability assay was performed using the BacTiter-Glo™ Microbial Cell Viability Assay” kit. The relative 
luminescence units were recorded and the cell viability was assessed. 
 
Expression of the 3xFLAG-tagged Hcp protein was confirmed by detecting Hcp in the 
pellet of YP360, either transformed with the empty vector or the RovC+ plasmid. Hcp 
protein was also synthesized without overexpression of RovC, but in lower amounts and is 
not delivered into the supernatant (Figure 3.22 A). In addition, cell viability of all strains 
was assessed to guarantee that the Hcp protein in the supernatant is not a result of cell 
lysis. The cell viability assays did not show any lysis of the cells as the relative 
luminescence units measured for the bacteria are clearly higher in comparison to the 
media control sample (blank) (Figure 3.22 B). Therefore, overexpression of RovC results 
in secretion of Hcp into the supernatant and indicates that the Y. pseudotuberculosis 
T6SS4 is functional. 
 In order to identify functional components of the Y. pseudotuberculosis T6SS4, 
Hcp secretion was examined for ClpV dependency. The AAA+ ATPase ClpV was reported 
to be involved in energizing the T6SS mediated secretion process by catalyzing TssBC 
depolymerization. Further, ClpV was expected to be the major energy source for T6S 
systems and AAA+ ATPases were assumed to provide energy for protein secretion in 
general (Mougous et al., 2006; Bönemann et al., 2009; Cianfanelli et al., 2016). Therefore, 
RovC-dependent Hcp translocation into the supernatant was monitored in the 
Y. pseudotuberculosis strain YP360 (wt 3xFLAG-hcp) and the isogenic ∆clpV mutant 
strain YP351 (∆clpV 3xFLAG-hcp). Secreted Hcp protein was detected in the supernatant 
of both, the wild type and the clpV deficient strain and depended on the presence of RovC 
(Figure 3.23). Consequently, deletion of the ClpV ATPase is not sufficient to prevent 
secretion of Hcp and indicates that another energizing source must trigger protein 
secretion. 
 
Figure 3.23: Deletion of the ATPase ClpV is not sufficient to prevent Hcp export into the supernatant. 
Secretion of the T6SS4 effector protein Hcp was monitored in the Y. pseudotuberculosis wild type strain 
YP360 (3xFLAG-YPK_3563) and the ∆clpV mutant strain (YP351). The strains were transformed with the 
empty vector pACYC184 (pV) or complemented with the rovC+ overexpression plasmid pSSE11 
(provC::rovC+). Cultures were grown to early stationary phase for 6 hours in LB at 25°C. The cells were 
pelleted and the protein-containing supernatant was filtered and precipitated with TCA. Precipitated proteins 
were resuspended in equal amounts of sample buffer, separated on 15% polyacrylamide gels, transferred 
onto PVDF membranes and visualized using a monoclonal FLAG antibody. 
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4 Discussion 
Pathogenic bacteria are constantly exposed to rapidly changing environments, for 
example, when switching between an environmental lifestyle and host colonization. This 
change requires a fast adjustment of the bacterial metabolism to the nutrient availability of 
the new environment as well as a rapid shift of the gene expression profile to virulence 
factors important to establish a successful infection. In Y. pseudotuberculosis, the set of 
virulence genes involved in the infection process differs between the initial phase and the 
ongoing phase of infection. Even within the host, Yersinia is confronted with drastic 
environmental changes that demand vast alterations in the bacterial gene expression 
pattern. Therefore, Y. pseudotuberculosis has evolved sophisticated regulatory 
mechanisms that control gene expression at the transcriptional, post-transcriptional and 
post-translational level. The Csr system, for example, is a global regulatory system that is 
involved in the adaptation of bacteria during host infection (Heroven & Dersch, 2014; 
Heroven et al., 2012; Lucchetti-Miganeh et al., 2008). Expression of the early virulence 
genes, including the transcriptional regulators RovM and RovA and the internalization 
factor invasin of Y. pseudotuberculosis is tightly controlled by the RNA-binding protein 
CsrA of the Csr system. Recent data indicate that the newly discovered regulator RovC is 
also involved in the CsrA-RovM-RovA cascade and that CsrA tightly controls expression 
of rovC. The rovC gene is genetically linked to the T6SS4 of Y. pseudotuberculosis as it is 
located directly downstream of the operon. Indeed, the hexameric RovC protein was 
implicated in the positive regulation of the type VI secretion system 4 (T6SS4) of 
Y. pseudotuberculosis (Seekircher, 2014; Knittel, 2015). In the present study, regulation of 
RovC was discovered to be controlled by CsrA at the transcriptional and post-
transcriptional level. Furthermore, RovC was shown to be a crucial activator of the T6SS4 
by directly interacting with its promoter region of the T6SS4. 
 
 
4.1 Expression control of the T6SS4 and its activator RovC 
The T6SS4 of Y. pseudotuberculosis is almost exclusively expressed at 25°C in stationary 
growth phase (Zhang et al., 2011) and further activating signals or conditions remain to be 
discovered. This study revealed that RovC is a novel regulator that activates expression of 
the T6SS4 under the above-mentioned conditions. However, under laboratory growth 
conditions, the overall amount of RovC in the cell seems to be very low, since hardly any 
rovC mRNA or RovC protein could be detected by Northern blot or Western blot in the 
Y. pseudotuberculosis wild type strain YPIII. Previous studies already indicated that 
synthesis of RovC is highest at 25°C in stationary growth phase but barely observable in 
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exponential growth phase (Seekircher, 2014; Knittel, 2015). In accordance with this, the 
T6SS4 homologous T6SS (y3658–y3677) of the Y. pestis strain KIM10 was reported to be 
integrated in the membrane fractions of cells grown at 25°C in stationary growth phase 
(Pieper et al., 2009). These results imply that RovC and consequently the T6SS4 are 
expressed under the same growth conditions as described for the early virulence genes of 
Y. pseudotuberculosis. In fact, previous studies could demonstrate a connection of RovC 
with the CsrA-RovM-RovA-invasin cascade (Heroven & Dersch, 2006; Seekircher, 2014; 
Knittel, 2015; Rabsch, 2018). This indicates that the T6SS4 of Y. pseudotuberculosis is 
connected to the early virulence genes via RovC.  
 However, Y. pseudotuberculosis possesses four different T6S systems which 
might suggest a specialization of each T6SS to diverse regulatory mechanisms and/or 
targets under different environmental conditions (Boyer et al., 2009). For instance, data 
from our group indicate that, in contrast to T6SS cluster 4, which is activated at 25°C, 
T6SS cluster 1 has its highest expression at 37°C (Rabsch, 2018). Thus, the T6SS4 is 
most probably important for survival outside the host and for competition with 
environmental bacteria, whereas T6SS1 might be essential during host colonization or in 
order to colonize a specific niche. For Y. pestis CO92 it was reported that the T6SS 
homologous to the Y. pseudotuberculosis T6SS4, is also strongly repressed at 37°C and 
induced at 26°C. Thus, it can be hypothesized that harboring multiple T6SS clusters is 
advantageous for the requirements under different conditions (Robinson et al., 2009). 
 Furthermore, expression of RovC appears to be specific for Y. pseudotuberculosis 
since RovC-dependent T6SS4 expression could only be observed in E. coli when RovC 
was overexpressed under the artificial pBAD promoter but not under its natural promoter 
(Figure S2). In agreement with this, no RovC protein could be detected in E. coli (data not 
shown), implicating that RovC is not only a Yersinia-specific protein but also requires 
a Yersinia-specific activator. Additionally, overexpression of RovC in the 
Y. pseudotuberculosis wild type strain YPIII resulted in a noticeable growth defect of those 
cells carrying the overexpression plasmid in comparison to the ones carrying the empty 
vector. Especially cells transformed with the rovC+ plasmid harboring the rovC promoter 
exhibited a significant defect in growth. YPIII carrying the arabinose inducible pPBAD::rovC+ 
version showed only slightly reduced growth in comparison to the empty vector control 
(Figure S3). This effect most probably results from the addition of arabinose to the growth 
media that can be used by the bacteria as an additional carbon source (Poncet et al., 
2009; Schleif, 2010). Moreover, induction of rovC expression with arabinose after 2 h 
resulted in lower amounts of RovC protein in the pPBAD::rovC+ bacteria in contrast to those 
carrying the rovC::rovC+ vector, which might explain the observed growth differences. In 
this work, RovC was shown to a major activator of T6SS4 expression. 
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Assembly/disassembly of T6SSs is an energetically unfavorable process as it dramatically 
impairs bacterial fitness and growth. Consequently, tight control of rovC expression and 
thus of the T6SS4 is most likely favorable for Yersinia. Due to this, the present work 
describes CsrA dependent regulation of rovC at both, the transcriptional and post-
transcriptional level. 
 
4.1.1 Transcription of rovC is strongly repressed by CsrA 
CsrA is part of the global post-transcriptional Csr system that controls various essential 
cellular processes such as the central carbon metabolism, motility and biofilm formation 
(Heroven et al., 2012). Furthermore, CsrA is crucial for the adaptation of numerous 
bacteria to drastic environmental alterations by affecting a number of stress-related and 
physiological processes (Timmermans & Van Melderen, 2010). Additionally, CsrA was 
shown to be an essential virulence determinant required to successfully infect mice, as 
deletion of csrA results in loss of virulence of Y. pseudotuberculosis (Nuss et al., 2017; 
Heroven et al., 2012; Kusmierek & Dersch, 2018; Heroven et al., 2008).  
Preceeding studies could demonstrate that the Csr system not only controls the 
expression of the early virulence genes in Y. pseudotuberculosis, but also a type VI 
secretion system. One work investigated the contribution of metabolic processes to 
virulence by analyzing the role of the global virulence regulators CsrA, Crp and RovA. 
Their approach revealed changes of the carbon core metabolism in the absence of these 
regulators and showed that deletion of csrA strongly upregulated the expression of all 
genes belonging to the T6SS cluster 4 (Bücker et al., 2014). In addition to this, other 
studies discovered that expression of rovC is strongly increased in the absence of csrA 
(Seekircher, 2014; Knittel, 2015). Accordingly, the present work validated that expression 
of selected genes of the T6SS4 operon and rovC are strongly upregulated in the csrA 
deficient strain in comparison to the wild type (Figure 3.1). RovC was discovered in a 
genetic screening approach of a preceeding study that already implied rovC transcription 
to be CsrA-dependent (Seekircher, 2014). Thus, the data obtained in this study perfectly 
confirm the previously observed effects. In addition, the present study could show that 
CsrA-dependent repression of the T6SS4 cluster occurs via the new regulator RovC and 
that overexpression of RovC significantly induces expression of the translational T6SS4’-
‘lacZ reporter fusion (Figures 3.2 and 3.3). These findings are also in agreement with 
qRT-PCR data, showing a significant decrease in T6SS4 gene expression in a ∆rovC 
strain (Seekircher, 2014).  
 Due to the results of this study, it can be assumed that CsrA represses RovC 
synthesis and consequently the T6SS4 operon at the transcriptional level (Figure 3.4 A 
and C). As CsrA is known to be a post-transcriptional regulator that controls mRNA 
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stability and/or translation by directly interacting with unpaired regions within target 
transcripts, the repressive effect of CsrA on rovC transcription has to occur indirectly 
(Romeo, 1998; Babitzke & Romeo, 2007; Mercante et al., 2009; Schubert et al., 2007). 
Since unpaired regions are characteristic for secondary structures of RNA molecules but 
not for double stranded DNA duplexes, CsrA-dependent repression of rovC transcription 
is most probably mediated via another regulator. Thus, CsrA could either repress a so far 
unknown transcriptional activator or positively affect a transcriptional repressor of RovC.  
To date, no transcriptional regulators that control rovC transcription have been 
identified. Recent data from our group, however, suggest that this regulator might be the 
cAMP receptor protein Crp. cAMP-Crp complexes control transcription of target genes by 
directly binding to their promoter sequence under glucose-limiting conditions (Gunasekera 
et al., 1992; Zheng et al., 2004; Kolb et al., 1993). Previous studies report a tight 
connection between Crp and the Csr system, as both control the expression of virulence 
genes in response to nutrients. Crp was shown to repress transcription of the small 
ncRNA CsrB, whereas it exerts a positive effect on CsrC transcription (Heroven et al., 
2012). It was shown that CsrA exerts a positive effect on Crp expression and that 
transcription of rovC is strongly repressed by Crp (Rabsch, 2018). These results confirm 
the data presented in previous studies, showing that Crp represses transcription of rovC 
(Seekircher, 2014; Knittel, 2015). However, no direct interaction between Crp and the 
rovC promoter region could be observed. Consequently, another regulator has to be 
involved in repression of rovC transcription. Therefore, the discovery of the direct 
transcriptional regulator of RovC will be of interest in future experiments. 
 
4.1.2 Post-transcriptional regulation of rovC is mediated by CsrA 
The present work demonstrated that the global regulator CsrA indirectly represses 
expression of rovC at the level of transcription. Surprisingly, the data presented in this 
study clearly indicate that CsrA exerts a dual function regarding the control of rovC 
expression, as analysis of a translational rovC’-‘lacZ reporter fusion revealed that CsrA 
positively affects rovC expression post-transcriptionally (Figure 3.5).It is possible that 
CsrA affects mRNA stability and/or translation efficiency of rovC. In agreement with this, 
CsrA is a RNA-binding protein that is well-known to affect translation and/or stability of 
target mRNAs (Romeo, 1998; Schubert et al., 2007). In fact, mapping of the rovC 
transcriptional start site revealed that the rovC 5’UTR has an overall length of 39 
nucleotides and harbors two GGA-motifs that could act as putative CsrA binding sites 
(Nuss et al., 2015; Knittel, 2015). One GGA-motif is located close to the transcriptional 
start site and the other within the Shine-Dalgarno sequence. Additionally, a third GGA-
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motif is present in the beginning of the rovC coding sequence (see Figure 3.6). and direct 
interaction of CsrA with the rovC mRNA transcript was documented (Figure 3.6 B). Target 
recognition by CsrA preferentially involves binding to typical features of RNA secondary 
structures, such as unpaired nucleotides within short hairpin structures that harbor GGA-
motifs (Heroven et al., 2012). Although, the rovC mRNA harbors three GGA-motifs that 
could function as possible binding sites for CsrA, the data presented here strongly 
suggest that CsrA preferentially binds to the two GGA-motifs located in the rovC 5’UTR, 
since the highest binding affinities were observed for the fragment harboring only these 
two motifs (Figure 3.6; Fragment II). Furthermore, these GGA-motifs exhibit a distance of 
approximately 18 nt, which has been reported previously as a nearly ideal spacing for the 
CsrA homodimer to interact with two sites within target RNAs (Mercante et al., 2009). For 
computational prediction of the mRNA secondary structure of the rovC transcript, 
harboring the two GGA-motifs located in the 5’UTR, the RNA fold software Mfold was 
used (Figure S4) (Zuker, 2003). Interestingly, only the GGA-motif closest to the 5’UTR 
would be accessible, as the RNA folding predicts a base-paired SD-sequence. The CsrA 
protein can form a bridge complex and thus interact with two binding sites that are as 
close as 10 nt and as distant as 63 nt as described for glgCAP 5’-leader. The glgC 
transcript also contains one GGA motif situated within the SD sequence and another 
located 28 nt upstream (Mercante et al., 2009). Moreover, a similar mechanism is 
proposed for binding of the CsrA homolog RsmE to the hcnA 5’UTR in P. fluorescence 
(Schubert et al., 2007). These models suggest that CsrA initially binds to a GGA-motif that 
presents a high affinity binding site, which results in a conformational change of the RNA 
secondary structure and eventually allows binding to a second lower affinity binding site. 
Thus, the mechanism could be similar for the rovC transcript and explain binding of CsrA 
to the two binding sites located in the rovC 5’UTR. The GGA-motif located at the 5’ end of 
the rovC 5’UTR could represent a high affinity binding site according to Schubert et al. 
(2007) and through structural rearrangements the second binding site within the SD 
sequence could be bound. This further indicates a stabilizing effect of CsrA on the rovC 
mRNA transcript (Figure 3.7). It can be concluded that binding of CsrA to the rovC mRNA 
stabilizes the mRNA and could protect the transcript from cleavage by RNases. A similar 
mechanism is described for the sRNA RsmZ of P. aeruginosa, which is protected from 
RNase E mediated degradation through binding of RsmE (Duss et al., 2014). Generally, in 
most of the above-mentioned cases, binding of CsrA or its homologues RsmA or RmsE, 
exerts a repressive effect on translation of the bound RNA. Positive effects of CsrA on 
mRNA stability/translation as observed for rovC were described for only a few genes, as 
for example flhDC of E. coli. FlhDC synthesis is positively affected by CsrA through direct 
binding of CsrA to the flhDC transcript, thus stabilizing it (Wei et al., 2001). Binding of 
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CsrA to the flhDC leader transcript protects the mRNA from degradation by RNase E by 
blocking its cleavage sites (AU-rich sequences) (Yakhnin et al., 2013). Therefore, binding 
of CsrA to the rovC transcript might also protect the RNA from cleavage by RNases. 
Whether CsrA binding to the rovC leader transcript protects the mRNA from RNase E-
mediated degradation or by that of another RNase needs to be examined in future 
experiments. The major virulence regulator LcrF represents another example for positive 
post-transcriptional regulation by CsrA (Kusmierek, 2018). Synthesis of LcrF is 
significantly reduced in the absence of CsrA and in vitro translation of lcrF revealed that 
CsrA is indispensable for the increase of the lcrF translation efficiency. A weak interaction 
between CsrA and the lcrF 5’UTR and SD sequence was reported. However, this 
interaction was not strong enough to prevent binding of the ribosome (Hoßmann, 2017; 
Kusmierek, 2018). In case of the rovC mRNA transcript, a similar mechanism might be 
applicable. Taken together, this work demonstrated that CsrA positively affects RovC 
expression at the post-transcriptional level by directly binding and stabilizing the rovC 5’ 
leader transcript.  
 
4.2 T6SS4 expression in Y. pseudotuberculosis is dependent on various 
regulators 
T6SSs have been extensively studied in particular in V. cholerae and P. aeruginosa as 
well as in many other bacterial species. They have been shown to be involved in 
interbacterial competition by translocating toxic effector proteins into other prokaryotic 
cells (Hood et al., 2010; MacIntyre et al., 2010; Speare et al., 2018; Salomon et al., 2013; 
Sana et al., 2016). While the focus lies mostly on understanding their mode of action, 
rather little is known about the regulation of T6SSs (Lazzaro et al., 2017). Regulation of 
T6S systems is probably best described for V. cholerae, where T6SS expression was 
shown to be controlled by a complex regulatory network that involves various global 
regulators and signaling pathways (Kitaoka et al., 2011; Joshi et al., 2017). Due to its 
aqueous life style, V. cholerae is frequently associated with chitinous surfaces. Thus, the 
main T6SS cluster is activated through TfoX via the chitin utilization cascade in concert 
with the natural competence factor QstR (Vezzulli et al., 2010; Dalia et al., 2014; 
Borgeaud et al., 2015 ; Joshi et al., 2017). In addition, the V. cholerae T6SS is controlled 
by quorum sensing. At low cell density the T6SS is repressed via a phosphorelay 
cascade, leading to the activation of the sRNAs Qrr 1-4 by phosphorylated LuxO. sRNA 
binding results in destabilization of the mRNAs of the main T6SS cluster. The Qrr sRNAs 
also inhibit HapR, the activator of the auxiliary clusters 1 and 2. At high cell density, Qrr-
mediated inhibition of the T6SS is alleviated  (Shao & Bassler, 2014; Joshi et al., 2017). 
An additional repressor of the V. cholerae T6SS is the global H-NS-like regulator TsrA 
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(Zheng et al., 2010 ; Joshi et al., 2017). However, nothing of the above-mentioned is 
known for T6SS regulation by related factors in Y. pseudotuberculosis. Although, in 
comparison to V. cholerae, rather little is known about the function of T6SSs in 
Y. pseudotuberculosis, a number of recent studies identified new T6SS regulators. Among 
these are the response regulator OmpR of the TCS OmpR/EnvZ and the virulence 
regulator RovM (Zhang et al., 2013; Gueguen et al., 2013; Song et al., 2015). 
 
4.2.1 Early virulence regulators RovM and RovA control T6SS4 expression 
The novel virulence regulator RovC and the T6SS4 operon of Y. pseudotuberculosis 
display their highest expression levels at 25°C in stationary growth phase. The LysR-type 
transcriptional regulator RovM has also been reported to be expressed under these 
conditions and was recently shown to positively affect expression of the T6SS4 (Song et 
al., 2015; Heroven & Dersch, 2006). As the present study demonstrates RovC to be a 
crucial activator of the T6SS4 operon (Figure 3.3), it was interesting to investigate the role 
and importance of both regulatory proteins, RovC and RovM, regarding T6SS4 activation. 
In this context, it was shown that RovM had no effect on rovC expression (Figure 3.9) and 
that it directly controls T6SS4 expression not via RovC. However, this work showed that 
expression of rovM is activated by RovC (Figure 3.10). 
 Furthermore, the data presented in this work support the observation that both 
regulators, RovC and RovM, exhibit a strong positive effect on T6SS4 expression. 
Surprisingly, expression of T6SS4 genes in a ∆rovMrovC double mutant strain could only 
be induced when RovC was overexpressed but not when a rovM+ overexpression plasmid 
was used (Figure 3.11). These results strongly indicate that RovC is a crucial and 
necessary activator of the T6SS4 operon essential for induction of T6SS4 expression. 
RovM, in contrast, exerts a positive effect and activates expression of the operon but does 
not seem to be essential for the activation of T6SS4 expression.  
 RovA is primarily known to activate transcription of the internalization factor invasin 
in Y. pseudotuberculosis, although recently, RovA was shown to control expression of the 
T6SS4 operon in the Y. pestis strain CO92 (Nagel et al., 2001; Cathelyn et al., 2006). 
Interestingly, this T6SS cluster (YPO0499 to YPO0516) of Y. pestis, which is strongly 
downregulated in a rovA mutant strain, is the one homologous to the T6SS4 cluster in the 
Y. pseudotuberculosis strain YPIII. Similar to the effect observed in Y. pestis, it could be 
shown that expression of the T6SS4’-‘lacZ reporter fusion was significantly downregulated 
in the absence of rovA. RovA recognizes AT-rich sequences within the promoter of its 
target gene, which can also be found within the T6SS4 promoter region (Heroven et al., 
2004). Consequently, low amounts of RovA could activate transcription of the T6SS4, 
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whereas high amounts of RovA in the cell could occupy a low affinity binding site resulting 
in repression of T6SS4 transcription. This is in agreement with the data obtained from a 
microarray analysis in Y. pseudotuberculosis, showing that all T6SS4 genes are 
upregulated in the absence of rovA (Bücker et al., 2014). 
 
4.2.2 Control of T6SS4 expression by the TCS OmpR/EnvZ 
The two-component signal transduction system OmpR/EnvZ responds to 
extracytoplasmic/envelope stress, such as osmotic changes and is thus important for 
adaptation to environmental alterations (Mizuno & Mizushima, 1990; Gerken & Misra, 
2010; Batchelor et al., 2005). It has also been reported to be involved in virulence of 
Y. pestis as it enables the bacteria to rapidly respond to osmotic, pH and oxidative stress 
variations (Reboul et al., 2014). Recently, two studies implicated that OmpR is a 
transcriptional regulator of the T6SS4 in Y. pseudotuberculosis that directly binds to the 
T6SS4 promoter and activates its expression. These studies report three different OmpR 
binding sites located in the T6SS4 upstream region. Two of these binding sites are 
located within the rovC upstream region and rovC coding sequence (see Figure 1.7) 
(Gueguen et al., 2013; Zhang et al., 2013). Presence of OmpR binding sites within the 
rovC upstream and coding region might indicate that OmpR also participates in the control 
of rovC expression. Due to this, the present study investigated the role of the OmpR/EnvZ 
TCS in the regulation of the T6SS4 and its activators rovC and rovM. However, monitoring 
of reporter fusions in the Y. pseudotuberculosis wild type in comparison to the 
∆ompR/envZ mutant strain did not match the results observed by Gueguen et al. (2013) 
and Zhang et al. (2013). In the contrary, expression of the T6SS4’-‘lacZ reporter fusion 
was significantly upregulated in the ompR/envZ deficient strain, suggesting a negative 
influence of this TCS on T6SS4 expression (Figure 3.13). Discrepancies between the 
results obtained by Gueguen et al. (2013), and this work could be explained by different 
experimental set-ups, such as the use of different strains. Gueguen et al. (2013) used the 
Y. pseudotuberculosis strain IP31758 and both strains, YPIII and IP31758, exhibit various 
strain-specific differences, such as absence of a a certain gene or mutations within a gene 
rendering it non-functional. For example, the phoP gene of the PhoP/PhoQ TCS is non-
functional in the YPIII strain and the CNFy toxin is only present in the strains YPIII and 
IP2666, due to a rather huge phylogenetic distance (Seecharran et al., 2017; Pisano et 
al., 2014; Lockman et al., 2002). Consequently, genes that are involved in T6SS control 
might also differ between the two strains.  
 For OmpR, three different binding sites within the T6SS4 upstream region of 
the Y. pseudotuberculosis strain YPIII were reported, of which two positively affect T6SS4 
transcription and one negatively (Zhang et al. 2011). Deletion of the binding site that 
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represses T6SS4 transcription (O2) resulted in increased expression of the T6SS4 
reporter fusion in the wild type (Zhang et al., 2013). Moreover, in contrast to the other 
studies, the reporter fusion monitored in this work did not harbor the first OmpR binding 
site (O1) that exerted a positive effect on T6SS4 transcription (Zhang et al., 2011; Zhang 
et al., 2013). In conclusion, it can be assumed that OmpR in the Y. pseudotuberculosis 
wild type strain YPIII preferentially binds to the repressive binding site rather than to the 
one exhibiting a positive effect. Upon overexpression of OmpR, its binding to the inducing 
binding sites might increase over the repressive one and cause an overall positive effect 
on T6SS4 expression. Since the present study compared the wild type to an ∆ompR/envZ 
mutant strain, only the negative effect of OmpR could be measured. In addition, the 
reporter gene assay should be repeated under low osmolarity conditions that are known to 
activate OmpR-dependent transcription of the porin OmpF (Yoshida et al., 2006). In 
contrast to the T6SS4’-‘lacZ reporter fusion, expression of the rovC’-‘lacZ and rovM’-‘lacZ 
reporter fusions did not alter between wild type and the ∆ompR/envZ strain, indicating that 
OmpR specifically regulates expression of the T6SS4 but not its regulators RovC and 
RovM (Figure 3.13). 
 Another transcriptional regulator that was reported to be involved in T6SS 
regulation is the histone-like nucleoid structuring protein H-NS. Generally, H-NS represses 
transcription of target genes by directly binding to AT-rich sequences in the promoter 
region (Beloin & Dormann, 2003, Fang & Rimsky, 2008). Silencing of T6SS gene clusters 
has already been described for other Gram-negative bacteria such as Salmonella 
Thyphimurium, Vibrio parahaemolyticus and Edwardsiella piscicida (Salomon et al., 2014; 
Cui et al., 2016; Brunet et al., 2015). Thus, the present study aimed at investigating 
whether H-NS also constitutes a T6SS4 regulator in Y. pseudotuberculosis. The influence 
of H-NS on T6SS4 expression and on the T6SS4 regulator RovC was analyzed in a 
reporter gene assay, either using a dominant-negative H-NS version, mimicking a ∆hns 
strain, or upon overexpression of H-NS (Figure 3.14). However, neither expression of the 
T6SS4 nor of RovC seems to be controlled by H-NS, indicating that another 
transcriptional repressor is responsible for the relatively low amounts of RovC and 
consequently the T6SS4 under standard growth conditions. 
 
4.3 RovC is an essential activator of the Y. pseudotuberculosis T6SS4 
Transcriptional regulators generally up- or downregulate transcription by interacting with a 
specific sequence within the promoter of a gene, thus allowing target-specific gene 
transcription (Browning & Busby, 2004). Some transcription factors, known as global 
regulators, are described to control a large number of genes, whereas others regulate 
only a single gene. Transcriptional activators mostly enhance the affinity of the RNA 
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polymerase to bind to a specific promoter sequence. These activators can bind either 
upstream of the -35 region, close to the -35 region or in-between the -10 and -35 region 
and promote transcription by recruiting the RNA polymerase through interaction with 
different subunits (Browning & Busby, 2004; Visweswariah & Busby, 2015).  
In the past, numerous transcriptional regulators that activate expression of the 
T6SS4 were discovered and found to be involved in various stress-related processes. The 
alternate σ factor RpoS, for example, was shown to directly activate T6SS4 transcription 
and, furthermore, the T6SS4 was found to be involved in RpoS-dependent stress 
resistance such as to osmotic and acid stress (Guan et al., 2015). Moreover, recent 
studies revealed that the T6SS4 mediates oxidative stress resistance through direct 
transcriptional activation by the oxidative stress regulator OxyR and by the transcriptional 
activator ZntR in order to control ROS levels inside the cell (Wang et al., 2015; Wang et 
al., 2017). Another regulator that connects the Y. pseudotuberculosis T6SS4 to osmotic 
stress resistance is the response regulator OmpR of the OmpR/EnvZ TCS. However, the 
described effect could not be confirmed in this study.  
The present work could also demonstrate that RovM, which is a strong T6SS4 
activator (Song et al., 2015), plays a minor role in the activation of the operon in contrast 
to RovC. Therefore, the newly-discovered T6SS4 regulator RovC seems to be essential 
for T6SS4 induction and was investigated for DNA-binding in this work. 
 
4.3.1 RovC is a transcriptional activator of the T6SS4 
Type VI secretion system expression is controlled at multiple levels by transcriptional, 
post-transcriptional and post-translational regulation, with transcriptional regulation being 
probably the most abundant mechanism (Leung et al., 2011). The present work could 
clearly demonstrate that RovC constitutes an important activator of the T6SS4 of 
Y. pseudotuberculosis and that presence of RovC is essential to induce expression of the 
operon. Thus, it was interesting to examine whether RovC functions as a direct activator 
of the T6SS4 operon through interaction with the T6SS4 promoter. DNA-binding studies 
revealed that RovC directly binds to a sequence upstream of the T6SS4 promoter region, 
which could be further narrowed down to an approximately 42 bp sequence located 
upstream of the -35 region of the T6SS4 promoter (see Figure 3.15 and 3.16). Binding of 
transcription factors in close proximity to the -35 region of the target gene promoter is well 
described for transcriptional activators. Therefore, different mechanisms of RovC-
dependent T6SS4 promoter activation could be applicable, with RovC probably 
representing a Class II transcriptional activator (Browning & Busby, 2004).  
 In accordance with this, a bioinformatics approach revealed that numerous T6SS 
clusters of, for example, V. cholerae, P. aeruginosa or A. hydrophila, possess promoter 
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sequences that are recognized by the alternate sigma factor σ54. This sigma factor is 
known to recruit the RNA polymerase to the promoter and requires a functional bacterial 
enhancer binding protein (bEBP) with ATP binding and hydrolysis activities (Bernard et 
al., 2011; Silverman et al., 2012; Kitaoka et al., 2011; Leung et al., 2011). Although, the 
RovC structure does not specifically embody typical Walker motifs, essential elements for 
ATP binding and hydrolysis as, for example, described for the V. cholerae VasH protein, it 
is still possible that RovC might function in a similar manner (Kitaoka et al., 2011). Similar 
to VasH, both proteins harbor a C-terminal DNA-binding region represented by a helix-
turn-helix motif (Sadana, 2017). In addition, the Y. pseudotuberculosis and Y. pestis T6SS 
gene clusters were described to harbor σ54-dependent promoter sequences in their T6SS 
upstream regions. The presence of σ54-dependent promoter sequences in Yersinia is 
divergent in comparison to other human or animal pathogens such as E. coli and 
Salmonella and leads to the assumption that these T6SS clusters in Yersinia are rather 
linked to the environmental lifestyle or to flea colonization than to human hosts (Bernard et 
al., 2011). This is in agreement with the data reported in previous studies and the present 
work, showing that RovC as well as the T6SS4 exhibit highest expression levels at 25°C 
in stationary growth phase (Seekircher, 2014; Knittel, 2015).  
 Most recently, the protein structure of RovC was solved by crystallization and 
SAXS (Small Angle X-Ray Scattering). RovC assembles as a hexamer in solution and 
forms a ring-like structure. Interestingly, hexamer formation seems to be critically 
important since mutations that disrupt the hexameric interface resulted in insoluble or 
highly unstable proteins (Sadana, 2017). Further analysis of the structure revealed two 
different but possible DNA-binding mechanisms for RovC-DNA interaction. Either DNA 
could be binding to the surface of the RovC hexamer or DNA-binding could occur within 
the center of the protein. Hence, the present study investigated DNA-binding by 
monitoring different RovC variants harboring different amino acid substitutions, either on 
the surface or in the center of the hexamer. In most cases, the DNA-binding ability of the 
different RovC variants was assessed by exchange of the amino acid of interest for the 
negatively charged glutamic acid. In case the amino acid is involved in DNA-binding, the 
negative charge should prevent interaction with the already negatively charged DNA 
molecule. As a control, MALS experiments were performed showing that the amino acid 
substitutions did not disrupt the RovC hexamer (Sadana, 2017). The present study could 
clearly demonstrate that T6SS4 DNA-binding occurs at the surface of the RovC hexamer, 
since all amino acids substituted in that area completely abolished DNA-binding, even 
when high protein concentrations were applied (Figure 3.18). In contrast to this, 
substitution of amino acids located within the center of RovC did not affect DNA-binding 
(Figure 3.17). These results perfectly match the MST (Microscale thermophoresis) data 
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obtained by Pooja Sadana that also show DNA-binding to the same protein variants. 
RovC possesses a helix-turn-helix motif at its C-terminus, formed by amino acid residues 
200 to 219 and these motifs are generally known to bind to the major groove of the DNA 
(Garvie & Wolberger, 2001). The RovC protein variant carrying substitutions 
K211E/K215E, amino acids residues located within the HTH motif, exhibited a significantly 
weaker DNA-binding affinity compared to the wild type RovC protein, suggesting that this 
is important for DNA-binding (see Figure 3.17). In addition to the HTH motif, an extended 
basic patch was found to be located at the surface of the RovC dimer, which might also be 
involved in the interaction with the negatively charged DNA backbone (Sadana, 2017).  
 The hexameric ring-like shape of the RovC protein turned out to be unique, for a 
transcriptional activator. In general, these DNA-binding transcriptional regulators exist as 
dimers e.g. Crp and RovA and control transcription of their target genes by directly binding 
to inverted repeats e.g. Crp or palindromic sequences e.g. RovM in the promoter region, 
as described for global regulators such as Crp, RovM and RovA (Kolb et al., 1993; Zheng 
et al., 2004; Quade et al., 2011; Quade et al., 2012). In contrast to this, three RovC dimers 
assemble as a hexamer with an overall molecular weight of about 173 kDa, making it 
much bigger than the above-mentioned regulators. Moreover, for the RovC binding site 
within the T6SS4 promoter region, no palindromic sequence or inverted repeat could be 
detected (see Figure 3.15 A). Hexameric structures proteins usually participate in the 
replication processes such as helicases and replication initiator proteins (Costa et al., 
2008; Boer et al., 2016). Another regulator that exhibits a hexameric ring-shape structure 
is the RNA chaperone Hfq. Despite rather huge structural similarities between Hfq and 
RovC, Hfq functions as an RNA-binding protein that controls its target genes post-
transcriptionally (Vogel & Luisi, 2011). Thus, none of the above-mentioned functions could 
be assigned to RovC, which acts as a transcriptional activator. Nonetheless, hexameric 
structures were also shown for the ArgR protein, controlling arginine biosynthesis in 
dependence on the presence of arginine (Dimova et al., 2000). Moreover, members of the 
LysR-type protein family of transcriptional regulators have been shown to assemble to a 
wide range of oligomeric states, comprising dimers, tetramers and octamers (Quade et al., 
2011; Zhou et al., 2010; Muraoka et al., 2003; Sainsbury et al., 2009). Generally, LysR-
type regulatory proteins consist of two domains, a helix-turn-helix DNA-binding domain 
connected via a linker domain to an effector-binding domain. Thus, the RovC structure 
might exhibit a weak similarity to LysR-type regulatory proteins, although LysR-type 
regulators often require a small molecule ligand to function (Zaim & Kierzek, 2003). So far, 
nothing indicated that RovC needs a cofactor for proper functioning. 
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4.3.2 Direct binding of RovC to the T6SS4 promoter is crucial to induce 
expression of the T6S system 
This study could clearly demonstrate that RovC is a hexameric, ring-shaped DNA-binding 
protein comprising a DNA-binding region located at its surface. Thus, the next objective of 
this work was to examine whether binding to DNA is essential for RovC to induce 
expression of the T6SS operon. For this, selected RovC variants were subcloned under 
the control of the inducible pBAD promoter and tested in the Y. pseudotuberculosis wild 
type strain YPIII for induction of T6SS4’-‘lacZ expression. The expression analysis clearly 
shows that only those RovC protein variants that are still able to interact with the T6SS4 
promoter region could induce expression of the T6SS4’-‘lacZ reporter fusion, emphasizing 
the importance of an intact DNA-binding region (see Figure 3.19 A). In addition, all RovC 
proteins were monitored in a Western blot to assure that every RovC construct is 
expressed under the tested conditions. RovC synthesis was observed for all proteins, 
however, the amount of proteins synthesized in the cell varied significantly (Figure 
3.19 B). Although, different amounts of RovC are synthesized, the protein stability is not 
affected by the amino acid substitutions (Figure 3.20). 
 
4.3.3 RovC overexpression triggers Hcp secretion 
The present study indicates that RovC is an essential factor that strongly activates 
expression of the T6SS4 by directly binding to the T6SS4 promoter. Functional T6SSs are 
described for many bacterial species and are associated with expression and secretion of 
the T6SS structural component and effector protein Hcp. The C. jejuni Hcp1, for example, 
is reported to be a structural component of the T6SS and also functions as an effector by 
exerting cytotoxicity toward HepG2 cells and by interfering with biofilm formation (Pukatzki 
et al., 2007; Mougous et al., 2006; Noreen et al., 2018). Hcp proteins assemble to a 
hexameric structure and build the T6SS tail tube, which can be exported across 
membranes into neighboring cells. Generally, toxic T6SS effectors bind to either the Hcp 
tail tube lumen, the VgrG spike tip or the PAAR domain for delivery (Quentin et al., 2018; 
Silverman et al., 2013; Cianfanelli et al., 2016). In fact, the results obtained in this study 
show that overexpression of RovC does not only induce expression of the T6SS4 but also 
triggers translocation of Hcp into the supernatant (Figure 3.21). Recent data from our 
group clearly demonstrated that RovC-dependent Hcp secretion is completely abolished 
in a ∆T6SS4 strain, emphasizing that the presence of RovC is critical and necessary for 
Hcp secretion and that Hcp is specifically secreted by the T6SS4 in response to RovC 
(Rabsch, 2018). However, for Y. pseudotuberculosis no other effector proteins, that are 
transported into the supernatant through either Hcp or VgrG interaction have been 
identified to date. One possible effector could be a lysozyme-related protein, encoded by 
DISCUSSION 
 
 96 
the T6SS4 gene product YPK_3562. This gene is located immediately downstream of the 
Hcp gene (YPK_3563) within the operon, suggesting that this putative effector might be 
translocated via binding to Hcp. This would be in agreement with lysozyme-like effector 
proteins discovered in Enterotoxigenic E. coli (ETEC), which exert toxic effects toward 
neighboring cells (Ma et al., 2018).  
 T6SSs comprise at least one factor that mediates protein secretion by ATP 
hydrolysis. The AAA+ ATPase ClpV was described to facilitate Hcp translocation and 
secretion across membranes (Mougous et al., 2006). This study investigated Hcp 
secretion in a clpV deficient strain. However, secreted Hcp protein was detected in the 
supernatant of this strain in a RovC-dependent manner (Figure 3.22). Consequently, 
deletion of clpV is not sufficient to prevent Hcp secretion, which leads to the assumption 
that ClpV might rather be important for recycling of sheath proteins than for energizing the 
secretion process. Indeed, ClpV is described to be mainly involved in sheath tubule 
depolymerization by interaction with TssC (Cianfanelli et al., 2016; Douzi et al., 2016; 
Kapitein et al., 2013).  
 Moreover, another T6SS component (TssM) exhibiting ATPase activity was 
recently described to energize T6 secretion in A. tumefaciens (Ma et al., 2012). TssM 
belongs to the IcmF protein family and is reported to be crucial for Hcp secretion in 
V. cholerae (Bönemann et al., 2009; Pukatzki et al., 2006). This might explain why 
secretion was observed in the absence of ClpV. This could be similar in 
Y. pseudotuberculosis, since the T6SS4 cluster harbors both proteins (YPK_3559 
encodes clpV and YPK_3550 encodes icmF).  
  
Taken together, the present study demonstrated that the Yersinia-specific regulator RovC 
is indispensable for the activation of the type VI secretion system 4 of 
Y. pseudotuberculosis. In this work RovC and the T6SS4 could be integrated into a 
regulatory network of factors that control T6SS4 expression, with RovC as its main 
activator. Presence of RovC was shown to be essential in order to induce expression of 
the operon and could not be overcome by overexpression of another T6SS4 activator 
such as RovM. Moreover, the effect of other known T6SS4 regulators, such as the TCS 
OmpR/EnvZ and H-NS, was examined regarding rovC and T6SS4 regulation. In addition, 
this work clearly demonstrated that regulation of RovC underlies a complex regulatory 
mechanism that fine-tunes the expression of rovC under specific conditions for Yersinia 
and is primarily mediated by the global regulator CsrA. CsrA controls expression of RovC 
at the transcriptional and post-transcriptional level. On one hand, it exerts an indirect 
negative effect on rovC transcription but on the other hand, CsrA positively affects RovC 
synthesis post-transcriptionally by stabilizing the mRNA transcript via direct binding. 
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Finally, RovC was demonstrated to be a direct and crucial activator of T6SS4 expression 
that directly interacts with the T6SS4 promoter region and triggers secretion of the T6SS 
effector protein Hcp (Figure 4.1). 
 
  
Figure 4.1: Working model of rovC and T6SS4 regulation. 
At 25°C in stationary growth phase, expression of RovC and the T6SS4 is mainly controlled by the global 
regulator CsrA. CsrA strongly represses rovC transcription, most probably indirectly via the cAMP receptor 
protein Crp. CsrA binding to the rovC mRNA could prevent RNase-mediated degradation, leading to 
stabilization of the rovC transcript. CsrA exerts a positive effect on rovC expression post-transcriptionally by 
inducing RovC protein synthesis. RovC is crucial for the activation of the T6SS4, mediated by direct binding of 
RovC to the T6SS4 promoter. Activation of T6SS4 expression by RovC results in translocation of Hcp into the 
supernatant and could consequently result in secretion of Hcp associated effectors. Expression of the T6SS4 
is also positively regulated by RovM, whereas the response regulator OmpR or the presence of high amounts 
of RovA protein result in repression of the operon. Green arrows and red T bar represent positive and 
negative influences, respectively, and dashed lines indicate indistinct effects on gene expression or protein 
synthesis. 
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5 Outlook 
As shown in the present study, RovC is an important and direct activator of the type VI 
secretion system 4 in Y. pseudotuberculosis. However, so far, no other targets are known 
that are controlled by RovC. It could be advantageous to perform an RNA-sequencing 
approach in the wild type and the ∆rovC strain, being much more sensitive than 
microarray analysis. Moreover, the present study revealed that expression of rovC is 
tightly controlled at the transcriptional and post-transcriptional level, and that both rovC 
mRNA and RovC protein are hardly detectable in the Y. pseudotuberculosis wild type 
strain. It is necessary to search for rovC regulators via a genetic screening approach for 
example by introducing a gene library into the YPIII wild type strain, harboring a 
chromosomally integrated rovC’-‘lacZ reporter fusion. Additionally, a transposon library 
could be generated and used to search for factors that control rovC expression. This could 
elucidate factors (activators or repressors) that control rovC expression under standard 
growth conditions at 25°C. 
 The present work revealed that RovC is crucial for the activation of the T6SS4, 
therefore the activating mechanism should be studied in more detail in the future. For 
example, DNA bandshift assays could be performed to analyze whether RovC activates 
T6SS4 expression via direct interaction with the RNA polymerase or through recruitment 
of the RNA polymerase to the promoter. In addition, the exact binding mechanism of 
RovC to the T6SS4 promoter and the amino acids involved in that process remain to be 
discovered. 
Regarding the post-transcriptional regulation of rovC by CsrA, RNA stability assays 
could provide insight into the RNases participating in the degradation of the rovC 
transcript in the absence of CsrA. For this, known CsrA repressed RNases such as 
RNase E should be analyzed for their role in rovC mRNA degradation in an RNA stability 
assay using the wild type and RNase deletion strain.  
This work discovered that RovC triggers secretion of the T6SS structural 
component and effector protein Hcp into the supernatant. Other T6SS effectors should be 
identified to discover the function of this T6SS4 in Y. pseudotuberculosis. In order to do 
so, mass spectrometry with the Hcp containing supernatant should be compared between 
the wild type and a T6SS4 deletion strain, to identify effectors that are secreted via 
binding to either Hcp or the VgrG tip protein. In addition, the T6SS4 of Yersinia could be 
analyzed for interbacterial competition by comparing survival of prey bacteria between the 
wild type and the T6SS4 mutant strain. As RovC and the T6SS4 were shown to be 
induced primarily at moderate temperatures, potential competitors present in the 
environment  should be used for the assays, as these are the most probable competitors 
of Y. pseudotuberculosis. Furthermore, it could be interesting to examine whether the 
OUTLOOK 
 99 
different T6SS clusters in Y. pseudotuberculosis can compensate each other’s function 
when one cluster is deleted. Since T6SS1 was found to exhibit the strongest expression 
levels, a ∆T6SS1/T6SS4 double mutant strain could be generated and used for 
competition assays. 
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6 Summary 
Type VI secretion systems are versatile nanomachines that exhibit structural similarity to 
contractile bacteriophage tails. Bacteria use their T6SS to deliver toxic effector proteins 
into either prokaryotic or eukaryotic cells. Most commonly, bacteria use their T6SS to 
compete with other bacteria in order to colonize a specific niche. Since assembly, 
contraction and disassembly of T6SSs is energetically costly for bacteria, expression of 
these systems is required to be under tight regulation. Recently, the Type VI secretion 
system 4 of Y. pseudotuberculosis was linked to early virulence gene expression. In this 
context, the newly discovered regulator RovC was identified to be a novel activator of the 
T6SS4 at moderate temperatures in stationary growth phase. RovC is a hexameric protein 
that exhibits a ring-shaped structure. The present study indicated that RovC is a crucial 
and direct activator of T6SS4 expression that interacts with the -10 and -35 region of the 
T6SS4 promoter. In addition, analysis of RovC proteins harboring different amino acid 
substitutions revealed that its DNA-binding region is located at the protein surface. 
Binding of RovC to the T6SS4 promoter is essential in order to induce expression of the 
operon. The present study could also demonstrate that the T6SS4 of 
Y. pseudotuberculosis is functional in vivo, since translocation of Hcp into the supernatant 
was detected in a RovC-dependent manner. 
 Moreover, expression of the T6SS4 was reported to be controlled by the global 
post-transcriptional carbon storage regulator (Csr) system. The Csr system consists of the 
RNA-binding protein CsrA that is antagonized by the small non-coding RNAs, CsrB and 
CsrC. CsrA controls a large number of genes and is essential for Y. pseudotuberculosis to 
cause an infection in mice, and recently, it was implicated in the regulation of the type VI 
secretion system 4 (T6SS4). The present work revealed that CsrA-dependent regulation 
of the T6SS4 is mediated via RovC. Regulation of rovC expression is tightly controlled by 
CsrA at both, the transcriptional and post-transcriptional level. On the transcriptional level 
expression of rovC is indirectly repressed by CsrA. However, the present study revealed 
that CsrA exerts a dual function since post-transcriptionally, CsrA is essential for rovC 
mRNA stabilization via direct interaction with the rovC transcript.  
 In addition, regulation of the T6SS4 has been shown to be mediated by different 
regulators in Y. pseudotuberculosis. Among these are the response regulator OmpR of 
the OmpR/EnvZ TCS, the virulence regulator RovM and the gene silencing protein H-NS. 
The present work showed that OmpR and H-NS play only a minor role in the regulation of 
RovC and the T6SS4. RovM on the contrary was shown to strongly activate expression a 
T6SS4’-‘lacZ reporter fusion comparable to RovC. However, this work revealed that the 
presence of RovM is not essential for the activation of the T6SS4, as deletion of rovM can 
be overcome by ectopic expression of RovC in a ∆rovM mutant but not vice versa. 
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8 Supplementary material  
 
 
Figure S1: CsrA protein purification. 
For CsrA protein purification, the E.coli strain BL21DE3 was transformed with the CsrA-6xHis encoding 
plasmid pAKH172 for CsrA overexpression. The bacteria were inoculated 1:100 from a fresh over night culture 
and grown at 37°C for 3 hours. CsrA expression was induced by addition of 0.5 mM IPTG to the culture for 2h. 
Cells were harvested by centrifugation at 4°C and 6000 rpm. Cell lysis was performed using the French Press 
Cell (3 times with 18.000 psi) in lysis buffer. The cell lysate was spun down for 30 minutes at 4°C and 14.000 
rpm. The supernatant was applied to a Ni-NTA column. Samples were taken and loaded onto a SDS-gel 
followed by Coomassie- staining. M: Prestained protein ladder, F: Flow-through, W1-W4: Washing fractions, 
E1-E6: Elution fractions. 
 
 
 
 
 
 
 
Figure S2: RovC dependent T6SS4 expression requires a Yersinia specific factor.  
Expression of a translational T6SS4’-‘lacZ reporter fusion (pSSE64) was monitored in the E. coli strain 
CC118λpir. Bacteria were transformed with the empty vector pACYC184 (pV) or complemented with the rovC+ 
overexpression plasmid pSSE11 (provC::rovC+). In addition, bacteria were transformed with the empty vector 
pBAD30 (pV) or the inducible rovC+ overexpression plasmid pVK25 (pPBAD::rovC+). Expression of the pBAD 
promoter was induced by addition of 0.1% arabinose to the growth medium. β-galactosidase activity 
(µmol/(mg*min)) was measured in strains grown over night for 16 hours at 25°C in LB medium. The data 
represent the mean ± standard deviation of three independent experiments, carried out in triplicates. Data 
were analyzed by Student’s t test. Asterisks indicate results differing significantly from each other 
(****P<0.0001). 
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Figure S3: Overexpression of RovC in the Y. pseudotuberculosis wild type strain results in a growth 
defect. 
(A) To determine growth of the Y. pseudotuberculosis wild type strain (YPIII) in dependence on 
overexpression of RovC, a growth curve was monitored. The strains were transformed with the empty vector 
pACYC184 (pV) or complemented with the rovC+ overexpression plasmid pSSE11 (provC::rovC+). In addition, 
strains were transformed with the empty vector pBAD30 (pV) or the inducible rovC+ overexpression plasmid 
pVK25 (pPBAD::rovC+). Cultures were inoculated 1:50 from fresh over night cultures and grown for 10 hours. 
Samples were taken every hour. Expression of the pBAD promoter was induced by addition of 0.1% 
arabinose after 2 hours. Cultures without arabinose were used as control. The graph represents bacterial 
growth (y-axis) over time (x-axis) on a logarithmic scale. The data represent the mean ± standard deviation of 
three independent experiments. Asterisks indicate results differing significantly from each other (*P<0.05).  
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Figure S4: Prediction of the rovC mRNA transcript folding. 
Prediction of the secondary structure of the rovC mRNA transcript using Mfold (Zuker, 2003). The 5’UTR 
starts -39 nucleotides relative to the translational start and is indicated with 5’. Numbers indicate the 
nucleotides relative to the rovC transcriptional start site. The GGA-motifs are highlighted in blue, the SD 
sequence is indicated as SD, the beginning of the coding region (AUG) is indicated as START and free 
energy is given as ∆G. 
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